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ABSTRACT OF DISSERTATION
MEASURING GLUTAMATE AND OXYGEN IN BRAIN REWARD CIRCUITS IN
ANIMAL MODELS OF COCAINE ABUSE AND DECISION-MAKING
Drug-specific reward and associated effects on neural signaling are often
studied between subjects, where one group self-administers drug and a separate
group self-administers a natural reinforcer. However, exposure to drugs of abuse
can cause long-term neural adaptations that can affect how an organism
responds to drug reward, natural reward, and their reward-associated stimuli.
Thus, to isolate drug-specific effects it is important to use models that expose the
same organism to all of the aforementioned. Multiple schedules provide a means
of dissociating the rewarding effects of a drug from the rewarding effects of food
within a single animal. Further, drug users do not take drugs in isolation; rather,
they are often faced with several concurrently available commodities (e.g.
monetary goods, social relationships). Thus, using choice measures to assess
the relative subjective value of drug reinforcers in both humans and animals
promotes a translational understanding of mechanisms that govern drugassociated decision-making. Thus, in order to gain a more translational view of
the neurobehavioral mechanisms that underlie drug-associated behavior, in the
first study, glutamate was measured in the nucleus accumbens core (NAcC) and
prefrontal cortex (PrL) in freely-moving rats as they behaved in a cocaine-food
multiple schedule procedure. In the second study, oxygen dynamics were
measured in the orbitofrontal cortex (OFC) of freely-moving rats as they behaved
in a cocaine/food choice procedure. The results from the first study showed that,
in the NAc and PrL, there was an increase in glutamate release when animals
earned cocaine. Further, the number of glutamate peaks that occurred per
cocaine lever press and per cocaine reinforcer was increased compared to food.
In the second study, OFC oxygen dynamics were positively correlated with
cocaine/food choice and generally tracked preference. Further, OFC oxygen
dynamics were greater to cocaine related events. Taken together, these results
showed the feasibility of combining electrochemical measurements with complex
drug-related behavioral procedures. These results also highlight the importance
of the PrL, NAcC, and OFC in the valuation of drug and non-drug commodities.
Overall, these results add to our understanding of the neurobehavioral
mechanisms that guide drug-associated behavior and create more precise
experimental avenues to research potential treatments.
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CHAPTER 1
INTRODUCTION TO GLUTAMATE DYNAMICS IN COCAINE SUBSTANCEUSE DISORDER
Cocaine Substance-use Disorder: General Overview
Substance-use disorders are defined as chronically relapsing disorders,
characterized by compulsion to seek and take the drug, a loss of control in
limiting intake, and the presentation of a negative emotional state when access to
the drug is prevented (American Psychiatric Association, 2013). Substance-use
disorders involving cocaine are a major issue in the United States with
approximately 913,000 Americans affected (NSDUH, 2015). Cocaine misuse or
abuse also accounts for 40% of drug-related emergency room visits with a 52.4%
increase in cocaine overdoses between 2015-2016 (CBHSQ, 2013; MMWR,
2018). Thus, understanding the neurobehavioral mechanisms that lead to
cocaine use and abuse are of paramount importance considering current trends.
The reinforcing properties of cocaine are mostly due to its mechanism of
action on dopamine neurons in the nucleus accumbens (NAc; for review see
Kuhar et al., 1991). Specifically, cocaine functions as an indirect agonist of
dopamine receptors by inhibiting the dopamine transporter (DAT) and causing an
increase in extracellular dopamine levels in the NAc (Kuzcenski, 1983; Kalivas &
Duffy, 1990). This fact initially spurred the production of a large body of research
studying cocaine abuse through the lens of dopamine signaling from the ventral
tagmental area (VTA) to the NAc (see Nestler, 2004 for review). However, in the
last 10-20 years research has shown that many different brain regions and
neurotransmitter systems are important in the acquisition, maintenance, and
relapse seen in those with substance-use disorder (for review see Koob &
Volkow, 2016).
A dysfunction in a number of brain regions are suggested to be involved in
the etiology of cocaine-use disorder beyond those found in the VTA and NAc,
which are primarily involved in the rewarding properties of the drug and the
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conditioning of drug cues (Shultz et al., 1997; Volkow et al., 2003). Some of
these other brain regions include areas of the prefrontal cortex (PFC) such as the
prelimbic (PrL), infralimbic (IL), and orbitofrontal (OFC) cortices (Jentsch &
Taylor, 1999; Hutcheson & Everitt, 2003) as well as areas such as the dorsal
striatum and amygdala (Whitelaw et al., 1996; Belin et al., 2009). For example,
research suggests that cocaine related dysfunctions in areas of the prefrontal
cortex might promote compulsive drug seeking and drug use (Hester & Graven,
2004). Further, the dorsal striatum is primarily involved in ‘habit-like’ formations
that occur with repeated drug exposure (Faure et al., 2005) while the amygdala is
thought to be primarily involved in the negative states experienced during drug
withdrawal (Koob et al., 2014). Further, within these brain regions, dysregulated
neurotransmitter systems are suggested to be driving the maladaptive behavioral
patterns observed in those with addiction issues (Koob & Volkow, 2016).
As mentioned above, dysregulated dopamine signaling is observed in
those with cocaine-use disorder. Specifically, data suggest that drugs of abuse
cause an increase in dopamine levels in the ventral striatum (Kuhar et al., 1991)
and that the steep increase in dopamine levels, along with the binding of
dopamine to D 1 receptors, is responsible for the rewarding properties of drugs
and the subjective feeling of the ‘high’ (Volkow et al., 2003; Caine et al., 2007).
However, other neurotransmitters such as opioid peptides, glutamate, γaminobutyric acid (GABA), serotonin, acetylcholine, and endocannabinoids also
seem to be dysregulated in substance-use disorder (Dani & Heinemann, 1996;
Kalivas, 2009; Sidhpura & Parsons, 2011; Mitchell et al., 2012; Cunningham &
Anastasio, 2014; Vashchinkina et al., 2014). How dysregulations in these
neurotransmitter systems contribute to substance abuse is not yet completely
clear; however, there is evidence that they may all have a role in drug seeking,
drug taking, and relapse (Koob & Volkow, 2016). Of these aforementioned
neurotransmitters, much research has focused on glutamate in the past 10-20
years, especially with regard to the specific role of glutamate in the reinstatement
of drug seeking (Kalivas & Volkow, 2011).
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Research suggests that the infusion of an AMPA glutamate receptor
antagonist into the nucleus accumbens core (NAcC) prevents cocaine-primed
reinstatement whereas the infusion of a D 1/D2 dopamine receptor antagonist fails
to do so (Cornish et al., 1999; McFarland & Kalivas, 2001). Further, cocaineprimed reinstatement causes an increase in dopamine release in animals that
previously self-administered cocaine as well as in yoked-cocaine and yokedsaline controls; however, an increase in glutamate release and drug-seeking
behavior is only observed in animals that previously self-administered cocaine
(McFarland et al., 2003). These data suggest that, while dopamine signaling is
important in abuse behavior (as are other neurotransmitters), glutamate signaling
may be more involved in the long-term plastic changes that promote drug
seeking and drug taking.
In the first part of this dissertation the role of glutamate in cocaine abuse is
explored. The glutamate system in general will be discussed first, including
glutamate-dopamine interactions, followed by the relationship between glutamate
and cocaine-use disorder. The important brain regions involved will be
considered, as will the animal models that contributed to the discussed results.
Glutamate Dynamics Under Baseline Physiological Conditions
Glutamate is the major excitatory neurotransmitter in the mammalian brain
and is necessary for proper cognitive functioning and memory formation (Ozawa
et al., 1988; Platt, 2007). It is thought that glutamate promotes memory formation
and synaptic plasticity through long-term potentiation (LTP) and long-term
depression (LTD) (Lüscher & Malenka, 2012). Here the glutamate system is
discussed with regard to how it functions under ‘normal’, non-diseased
conditions.
Synthesis and Release
Glutamate is synthesized from either glutamine via the enzyme
glutaminase or from α-ketoglutarate (made from the Krebs Cycle) via a
transamination reaction (Anderson & Swanson, 2000; Daikhin & Yudkoff, 2000).
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Glutamate is then taken up by vesicular glutamate transporters (VGLUTs), in an
energy dependent fashion, and packaged into vesicles (Fonnum et al., 1998).
Once packaged into vesicles, glutamate is released into the synaptic cleft in a
Ca2+-dependent fashion (Turner, 1998; Meldrum, 2000). When glutamate is
released it can either bind to pre and postsynaptic glutamate receptors, be
actively taken up by glia and synthesized back into glutamine, be actively
transported by presynaptic neurons and repackaged, or diffuse away from the
synapse (Anderson & Swanson, 2000; Attwell, 2000; Daikhin & Yudkoff, 2000).
Transporters
Research suggests that there are five transporters present in the
mammalian central nervous system (CNS) (Meldrum, 2000). Two of the five
transporters (excitatory amino acid transporter 1 [EAAT1/GLAST] and
EAAT2/GLT-1]) are found on glial cells and are responsible for 90% of glutamate
uptake (Danbolt et al., 1998; Iverson et al., 2009). The remaining three
transporters, EAAT3, EAAT4, and EAAT5, are found postsynaptically in cortical,
cerebellar Purkinje, and retinal neurons, respectively (Danbolt et al., 1998;
Iverson et al., 2009). All transporters are Na+-dependent (Kataoka et al., 1997).
As well as being Na+-dependent, EAAT3-5 are also linked to Cl- channels; thus,
when glutamate binds there is a decrease in synaptic activity via
hyperpolarization, which is thought to be a negative feedback system for
glutamate release (Levy et al., 1998). Once glutamate is taken back up by glia or
neurons it is metabolized and recycled as mentioned above. However, before
glutamate leaves the synaptic space it is free to bind to a number of different
receptor types.
Inotropic Receptors
The three classes of ionotropic glutamate receptors are N-methyl-Daspartate (NMDA), α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
(AMPA), and kainic acid (Meldrum, 2000; Iverson et al., 2009). Each receptor
was identified first by their pharmacology then later by their molecular biology
(Meldrum, 2000; Tzschentke, 2002). Here most attention is given to NMDA and
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AMPA receptors due to their role in cocaine induced synaptic plasticity (for
review see Kalivas, 2009).
NMDA Receptor
The NMDA receptors (NMDARs) are postsynaptic, ligand and voltagegated ion channels that are permeable to Na+, K+, and Ca2+ (Madden, 2002; Kew
& Kemp, 2005). NMDARs are found in their highest concentration in the CA1 of
the hippocampus, thalamus, and cerebral cortex (Riedel et al., 2003). The
NMDAR has several modulatory binding sites: (a) glutamate binding site that
binds the transmitter as well as related agonists, (b) glycine binding site (glycine
is a necessary co-factor for glutamate activation of the NMDAR), (c) a site inside
the receptor that binds phencyclidine (PCP) as well as other non-competitive
antagonists, (d) a voltage-dependent Mg2+ binding site inside the channel, (e) an
inhibitory site located near the mouth of the receptor that causes a voltageindependent block when Zn2+ is bound, (f) a polyamine site that enhances
NMDAR activity when spermine and spermidine are bound at low concentrations
but inhibit the receptor when they are bound at high concentrations (Anson et al.,
1998; Kew et al., 2000; Madden, 2002; Mayer, 2005; Iverson et al., 2009).
NMDARs are composed of different subunits that house the different
regulatory sites mentioned above (Anson et al., 1998; Kew et al., 2000). The two
primary subunits that compose NMDARs are the NR1 subunit and the NR2 (A-D)
subunit (Mori & Mishina, 1995; Meldrum, 2000; Kew & Kemp, 2005). There is
also evidence that NR3A and NR3B subunits exists and that they function to
decrease Ca2+ permeability; however, the exact physiology of these subunits is
not well understood (Nishi et al., 2001; Matsuda et al., 2002; Sasaki et al., 2002).
The glutamate-binding site is located on the NR2 subunit; thus, most functional
NMDARs are heteromeric complexes mostly comprised of the NR1 subunit with
NR2 subunits acting as the functional unit that affects channel kinetics and
sensitivity (Mori & Mishina, 1995; Kew & Kimp, 2005). Note that the glycinebinding site is found on the NR1 subunit and thus it is also necessary for NMDAR
activation (Lynch & Guttmann, 2001).
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The various regulatory sites found on the NMDAR, as well as its voltage
dependence, has prompted the appellation of the NMDARs as ‘coincident
receptors’ (Nestler et al., 2009). The NMDAR opens after the voltage-dependent
removal of the Mg2+ ion, binding of glycine to the NR1 subunit, and the binding of
glutamate to the NR2 subunit (Nowak et al., 1994; Ozawa et al., 1998; Lynch &
Guttmann, 2001). Once the channel opens, Na+ and Ca2+ can enter the neuron
and there is an efflux of K+ (Riedel et al., 2003). Note that the NMDARs role as a
‘coincident receptor’ as well as its permeability to Ca2+ is thought to be the driving
force in this receptors role in synaptic plasticity including the aberrant plasticity
seen in those with cocaine-use disorder (Kalivas, 2009; Lüscher & Malenka,
2012).
AMPA Receptor
AMPA receptors (AMPARs) are found ubiquitously in the brain with the
highest concentrations found in the CA1 and CA3 subregions of the
hippocampus, the cerebral cortex, basal ganglia, thalamus, hypothalamus,
cerebellum, and spinal cord (Blackstone et al., 1992). AMPARs are ligand-gated,
postsynaptic ion channels with two glutamate binding sites (Dingledine et al.,
1999). When glutamate binds to AMPARs there is an influx of Na+ and Ca2+ and
an efflux of K+ (Forman et al., 2008). AMPARs have faster kinetics than NMDARs
and are responsible for the initial component of excitatory postsynaptic potentials
(EPSPs); however, they have a lower affinity for glutamate compared to NMDA
receptors (Dingledine et al., 1999).
AMPARs are tetramers composed of four subunits (GluR1-4; Rosenmund
et al., 1998). The majority of AMPARs contain the GluR2 subunit and can only
pass Na+ and K+ ions; however, the AMPARs that lack the GluR2 subunit are
able to pass Ca2+ (Bowie & Mayer, 1995). AMPARs can also exist in different
‘Flip or Flop’ splice variants that influence the rate of desensitization and the
efficacy of certain allosteric modulators (Kew & Kemp, 2005). Further, evidence
suggests that Ca2+ entering through GluR2-lacking AMPARs may promote the
migration of GluR2-containing subunits to the neuronal membrane (Liu & CullCandy, 2002). These results suggest not only another level of synaptic plasticity
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but also a glutamate/AMPAR self-regulatory mechanism. Interestingly, there is
an increase in GluR2-lacking AMPARs in the NAc after cocaine withdrawal that is
associated with an increase in cocaine craving and relapse (Conrad et al., 2008).
Thus, changes in AMPAR subunit composition may also contribute to cocaineuse disorder.
Kainate Receptor
AMPA receptors and kainate receptors are difficult to dissociate leading to
them often being discussed as one entity (Riedel et al., 2003). Due to this
aforementioned fact, kainate receptors will only be briefly discussed.
Kainate receptors are ligand-gated ion channels located both pre and
postsynaptically (Lerma, 2003). When activated by glutamate, presynaptic
kainate receptors can facilitate or inhibit neurotransmission whereas postsynaptic
receptor stimulation causes slow EPSPs (Kidd & Isaac, 1999; Lauri et al., 2001;
Cossart et al., 2002). Kainate receptors contain two glutamate binding sites that
must be bound to allow Na+ and Ca2+ influx and K+ efflux (Sommer et al., 1991;
Pinaheiro & Mulle, 2006). These receptors are tetrameric complexes of GluR5-7
or KA1-2 subunits (Bleakman et al., 2002). However, only homotetrameric
complexes of GluR5-7 subunits or heterotetrameric complexes of GluR5-7 and
KA1-2 subunits make functional receptors (Bleakman et al., 2002; Alt et al.,
2004). Similar to AMPARs, the GluR5-7 subunits of kainate receptors can be
edited to increase their permeability to Ca2+ (Dingledine et al., 1999). Kainate
receptors are also found in high concentrations in the temporal lobe and show
differential expression between subregions of the hippocampus (Contractor et al.,
2000; Rogawski et al., 2003). Thus, with differential brain expression and varying
permeability to Ca2+, these receptors allow for enhanced complexity when it
comes to synaptic plasticity. Ionotropic receptors are not the only receptors found
within the glutamate system nor are they the only ones potentially affected by
cocaine use. Metabotropic glutamate receptors are also found in the glutamate
system and play an important role in glutamate homeostasis.
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Metabotropic Receptors
Metabotropic glutamate receptors (mGluRs) are seven trans-membrane
spanning G-coupled protein receptors that signal to various second messenger
systems and generally have a slower more modulatory role than ionotropic
receptors (Kunishima et al., 2000; Pin & Acher, 2002). There are currently eight
subtypes of mGluRs that are separated into three groups based on sequence
homology, second messenger system interactions, and pharmacology
(Dingledine et al., 1999; Kunishima et al., 2000). These receptors are critical to
maintaining glutamate homeostasis and research suggests that they are affected
by chronic cocaine abuse (Kalivas, 2009).
Group I mGluRs
Group I mGluRs consist of mGluR1 and mGluR5 metabotropic receptors
(Niswender & Conn, 2010). These receptors are found postsynaptically and have
an excitatory effect on neurons (Coutinho & Knopfel, 2002; Niswender & Conn,
2010). When mGluRs1/5s are bound by glutamate they activate second
messenger systems via Gq proteins, which stimulate phospholipase C (PLC) to
release 1,4,5-triphosphate (IP3) and diacylglycerol (DAG; Hermans & Challiss,
2001). IP3 and DAG function to release Ca2+ from intracellular stores to several
effector proteins (Hermans & Challiss, 2001). DAG also stimulates protein kinase
C (PKC), which can also stimulate several downstream effectors (Hermans &
Challiss, 2001). These receptors can undergo alternate splicing thus increasing
receptor variation and their effect on cellular function (Joly et al., 1995; Pin &
Duvoisin, 1995). When activated, these receptors can also promote synaptic
plasticity via LTP and LTD (Bellone et al., 2008; Kullman & Lamsa, 2008).
Group II mGluRs
Group II mGluRs consist of mGluR2 and mGluR3 metabotropic receptors
(Niswender & Conn, 2010). These receptors are found pre and postsynaptically
on excitatory, inhibitory, and modulatory neurons and when bound by glutamate
have an inhibitory effect (Tamaru et al., 2001; Niswender & Conn, 2010). The
mGluR2/3s are located primarily in the pre-terminal area on presynaptic neurons
and mGluR3s may also be present on glial cells (Tamaru et al., 2001; Ferraguti &
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Shigemoto, 2006). Presynaptic mGluR2/3s can be activated by excess synaptic
glutamate or glutamate release from glial cells via the cystine-glutamate
transporter (xCT; Kalivas, 2009).
The mGluR2/3s work through Gi/o proteins that inhibit adenylyl cyclase
(AC) and cyclic AMP (cAMP) formation (Tanabe et al., 1992; Pin & Duvoisin,
1995). AC and cAMP inhibition cause the release of Gβγ , which then affects
downstream signaling proteins and directly activates K+ channels and inhibits
voltage-sensitive Ca2+ channels (Tanabe et al., 1992; Pin & Duvoisin, 1995).
Note that alternate splicing can increase mGluR2/3s diversity and their effect on
neurons (Sartorius et al., 2006).
Group III mGluRs
Group III mGluRs include mGluR4, mGluR7, and mGluR8 and are
primarily found presynaptically in the active zone of neurons (Niswender & Conn,
2010). When activated by glutamate these neurons inhibit neurotransmitter
release and, due to their location in the active zone, they often regulate neurons
via negative-feedback mechanisms (Niswender & Conn, 2010). These receptors
have different affinities for glutamate with mGluR7 needing a greater
concentration of glutamate to be activated compared to the others (Schoepp et
al., 1999). These receptors are coupled to Gi/o proteins that inhibit AC and cAMP
and promote Gβγ release (Pin & Duvoisin, 1995). Note that the mGluR7/8
receptors show more diversity than mGluR4 receptors because they can be
alternately spliced (Corti et al., 1998; Malherbe et al., 1999).
On a molecular level it should now be clear that the glutamate system is
quite complex and can promote synaptic plasticity in a multitude of ways.
However, the receptors discussed can be found on a myriad of different cell
types and due to this fact glutamate has the ability to regulate many different
types of neurons. Thus, discussed next is a more network-wide view of how the
glutamate system can interact with other neurotransmitter systems. Considering
the scope of this dissertation, how the glutamate system interacts with the
dopamine system will be the primary focus.
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Glutamate System Interactions: A Focus on Dopamine
Research suggests that the glutamate system interacts with several
different neurotransmitter systems including the serotonin, acetylcholine,
norepinephrine, GABA, and dopamine systems (Martin et al., 1998; Egli et al.,
2004; Tseng & O’Donnell, 2004; Li et al., 2006; Parikh et al., 2008). However,
most work has focused on glutamate-dopamine interactions especially in the
addiction field (Sesack et al., 2003; Kalivas & Volkow, 2011). Thus, here the
basics of what is known about non-pathological, homeostatic glutamatedopamine interactions are highlighted.
Anatomical Associations
Midbrain DA neurons project from the VTA to the NAc (termed the
mesolimbic pathway or ‘reward pathway’), from the substantia nigra (SN) to the
dorsal striatum (termed nigrostriatal pathway), and from the VTA to the prefrontal
cortex (termed the mesocortical pathway; Miller et al., 2013). Considering the
mesolimbic and mesocortical pathways have a large role in reward processing
and addiction (Schultz, 2001; Volkow et al., 2004; Berridge, 2007), connections
centering on these regions are highlighted.
Evidence suggests that dopamine neurons from the VTA synapse on to
glutamatergic pyramidal cells in the PFC (Goldman-Rakic et al., 1989).
Dopamine projections from the VTA specifically seem to innervate pyramidal
cells that have projections to the NAc and to the contralateral PFC (Carr et al.,
1999; Carr & Sesack, 2000). There is evidence that dopamine projections from
the VTA may also regulate PFC pyramidal cells indirectly by synapsing on GABA
interneurons (Williams et al., 1992; Condé et al., 1994). Further, evidence
suggests that VTA dopamine may also have extrasynaptic actions on PFC
pyramidal neurons (Sesack, 2002). Reciprocally, research shows that glutamate
neurons from the PFC have projections to the NAc and the VTA (Sesack &
Pickel, 1992; Geisler et al., 2007). Specifically, projections from the PrL innervate
the NAcC and projections from the IL innervate the NAc shell (NAcSh; Geisler et
al., 2007). Further, both the PrL and IL have connections to the VTA (Geisler et
al., 2007). Thus, taken together, there is strong evidence that glutamate and

10

dopamine are strongly linked in the anatomical sense. Note that evidence also
shows a strong molecular and physiological association between these two
systems.
Molecular and Physiological Associations
Beyond their anatomical associations, glutamate and dopamine also
interact on a physiological level. For example, in the PFC, D1 agonists can act
synergistically with glutamate agonists to increase pyramidal cell excitability
whereas D 2 agonists have the opposite effect (Tseng & O’Donnell, 2004).
Specifically, evidence suggests that D 1 stimulation potentiates NMDA-mediated
responses (Tseng & O’Donnell, 2004). Conversely, D2 receptor stimulation has
the downstream effect of inhibiting NMDA receptors and thus weakening the
excitatory response in neurons (Kotecha et al., 2002). Similarly, the stimulation of
D4 receptors in pyramidal neurons in the PFC depressed AMPA receptormediated excitatory synaptic transmission by decreasing AMPA receptors in the
synapse (Yuen et al., 2010).
At the level of the midbrain, research suggests that glutamate projections
from the PFC can regulate phasic dopamine signaling as well as burst firing and
pauses (Grace & Bunney, 1984a; Grace & Bunney, 1984b; Sesack et al., 2003).
Further, evidence shows that NMDA receptors are involved in activating
dopamine neurons in the VTA (Martinez-Fong et al., 1992). Glutamate may also
regulate dopamine release in the NAc indirectly through exciting GABA neurons
(Montaron et al., 1996). Notably, research from the drug addiction field provides
strong support that glutamate release in the NAc from PFC projections is
important in drug-seeking behavior (Kalivas, 2009; Russo et al., 2010)
Glutamate Dynamics in Cocaine-use Disorder
A large amount of research has accumulated over the past 20 years
suggesting that glutamate signaling in brain reward centers may play a key role
in substance abuse (for review see Kalivas, 2004; Kalivas, 2009; Kalivas et al.,
2009). Much of this work has focused primarily on the reciprocal connections
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between the PFC (specifically, the PrL and IL cortices) and the NAc (Cornish &
Kalivas, 2000; McFarland et al., 2003; Kalivas et al., 2005; LaLumiere et al.,
2012). Further, much of this work has focused on cocaine seeking and relapse
and was mostly conducted using animal models (e.g. McFarland & Kalivas, 2001;
Park et al., 2002; Kalivas & McFarland, 2003). Here the evidence for
dysregulated glutamate signaling in cocaine abuse is reviewed, focusing on the
brain regions involved and the models used. This section culminates in
discussing what has been termed “The Glutamate Homeostasis Hypothesis of
Addiction” and with the limitations of current research.
Glutamate in Cocaine-use Disorder: A Brief Look at The Evidence
Historically, drug abuse research has focused on the role of dopamine
signaling in areas of the reward system, such as the NAcC, NAcSh, PrL, and IL,
in promoting and maintaining abuse-like behavior (Berridge & Robinson, 1998).
However, as mentioned above, evidence suggests that glutamatergic signaling
also plays a role in drug-abuse behavior (Kalivas & Volkow, 2011). For example,
the infusion of an AMPA glutamate receptor antagonist into the NAcC prevents
cocaine-primed reinstatement whereas the infusion of a D 1/D2 dopamine receptor
antagonist fails to do so (Cornish et al., 1999; McFarland & Kalivas, 2001).
Evidence also suggests that cocaine reinstatement causes an increase in
dopamine release in animals that previously self-administered cocaine as well as
in yoked controls. However, an increase in glutamate release and drug-seeking
behavior is only observed in animals previously exposed to cocaine (McFarland
et al., 2003). These data suggest that, while dopamine signaling is important in
abuse behavior, glutamate signaling may be more involved in the long-term
plastic changes that promote drug abuse.
Along with an increase in glutamate release, chronic cocaine exposure
may also causes a decrease in basal glutamate levels (via a decrease in the
cystine-glutamate exchanger [xCT]) and a decrease in glutamate uptake (via a
decrease in GLT-1) in the NAcC; an effect that is not seen in animals that only
self-administer food (McFarland et al., 2003; Madayag et al., 2007; Miguens et
al., 2008; Kalivas, 2009; Knackstedt et al., 2010). Further, pharmaceuticals that
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increase extrasynaptic tone on mGluR2/3 receptors or that increase GLT-1
expression and glutamate uptake, normalize glutamate signaling in the NAcC
and reduce cue-induced drug seeking (Tzschentke & Schmidt, 2003; Peters &
Kalivas, 2006; Zhou & Kalivas, 2007).
Evidence also suggests that the inhibition of the PrL prevents the
aforementioned glutamatergic changes in the NAcC and inhibits drug-seeking
behavior (Park et al., 2002; McFarland et al., 2003) suggesting that glutamate
release in the NAcC is primarily from PrL neurons. Conversely, inhibition of
glutamate signaling from the IL to the NAcSh increases drug-seeking behavior
suggesting that different glutamate tracts have different regulatory roles (Peters
et al., 2008). Thus, cocaine-induced changes in glutamate-mediated plasticity
appear to play a key a role in the development of addictive behavior and have
lead to a general hypothesis regarding the role of glutamate in cocaine-use
disorder (for review Kalivas, 2009).
The Glutamate Homeostasis Hypothesis of Addiction
Critical to a homeostatic glutamate system is a balance between
glutamate release and elimination. Again, like all neurotransmitters, glutamate is
released from presynaptic neurons, binds to postsynaptic receptors, and is
eliminated by high-affinity, Na+-dependent transporters (Diamond & Jahr, 1997;
Herman & Jahr, 2007). However, some evidence suggests that the majority of
extracellular glutamate is derived from non-synaptic, glial sources (Warr et al.,
1999; Barbour, 2001). This non-synaptic glutamate is primarily responsible for
regulating perisynaptic mGluRs (Warr et al., 1999; Barbour, 2001) and the xCT is
responsible for approximately 60% of basal extracellular glutamate in the NAcC
(Baker et al., 2002). Generally, ionotropic receptors in the synaptic cleft are not
affected by non-synaptic glutamate due to uptake mechanisms (and, for the
same reason, synaptic glutamate often does not affect perisynaptic mGluRs;
Warr et al., 1999; Barbour, 2001). However, research suggests that all of these
aspects of glutamate signaling are dysregulated by chronic exposure to cocaine.

13

Cocaine-Induced Changes in Glutamate Signaling
Chronic cocaine reduces membrane levels of functional xCT exchangers
thus reducing basal glutamate levels by roughly 50% (Xi et al., 2002; Baker et al.,
2003). This decrease in basal glutamate results in decreased tone on mGluR2/3s
(Moran et al., 2005). Without the inhibitory regulation of these mGluR2/3s,
synaptic glutamate release is increased (McFarland et al., 2003; McFarland et
al., 2004; Miguens et al., 2008). Cocaine also decreases the number of GLT-1
transporters in glial membranes causing decreased glutamate uptake in the
NAcC (Knackstedt et al., 2010). Thus, an increase in release of synaptic
glutamate (due to decreased tone on mGluR2/3s) coupled with a decrease in
glutamate uptake (due to a decrease in GLT-1) is likely the reason an overflow of
synaptic glutamate is seen during cocaine reinstatement (McFarland et al.,
2003). Evidence supports these claims in that activation of the xCT by Nacetylcysteine restores basal glutamate levels and prevents the reinstatement of
cocaine seeking (Baker et al., 2003; Zhou and Kalivas, 2007; Moussawi et al.,
2009). The administration of mGluR2/3 agonists also prevents cocaine
reinstatement (Baptista et al., 2004; Peters & Kalivas, 2006). This mechanistic
link is further strengthened by the fact that N-acetylcysteine activation of xCT
does not prevent cocaine reinstatement if mGluR2/3 antagonists are also present
(Moran et al., 2005). Ceftriaxone was also shown to prevent cue and cocaineinduced reinstatement by increasing GLT-1 levels (Knackstedt et al., 2010).
Cocaine-Induced Morphological Changes
Research shows that dendritic spine head diameter increases in animals
that are in withdrawal from non-contingent cocaine (Shen et al., 2009). Further,
when animals in withdrawal are given acute cocaine injections spine head
diameter changes over a 120-minute time course (Kalivas, 2009). Specifically, an
increase in spine head diameter is seen 45-minutes after injection and a
decrease in diameter is seen 120-minutes after injection (Kalivas, 2009). Of
importance here is the fact that this increase in spine head diameter is likely
caused by an increase in AMPA receptors and the decrease caused by AMPA
receptor internalization (Kalivas et al., 2009). Interestingly, after contingent or
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non-contingent cocaine administration an increase in GluR1 containing AMPA
receptors is seen in the NAc (Boudreau & Wolf, 2005; Conrad et al., 2008).
Further, after extensive periods of withdrawal, AMPA receptors lacking GluR2
subunits are observed (Conrad et al., 2008). If acute cocaine is given after the
withdrawal period there is rapid surface expression of GluR1 containing AMPA
receptors (Anderson et al., 2008). Together, this suggests AMPA receptor
composition and dynamics may play an important role in the progression of
cocaine abuse.
Cocaine-Induced Metabotropic Receptor Changes
Evidence shows that mGluR2/3 receptors are downregulated after noncontingent administration of cocaine (Xi et al., 2002). This decrease in mGluR2/3
function could be due to decreased protein expression, increased receptor
phosphorylation, and/or an upregulation of activator of G protein signaling 3
(AGS3; a negative regulator of mGLuR2/3 function via negative regulation of Gi
coupled signaling; Takesono et al., 1999; Xi et al., 2002; Bowers et al., 2004;
Ghasemzadeh et al., 2009). The upregulation of AGS3 is further supported by
the fact that inhibiting AGS3 restores mGluR2/3 signaling and reduces cocaineseeking behavior (Bowers et al., 2004, Yao et al., 2005; Bowers et al., 2008).
Withdrawal from cocaine has also been shown to decrease the expression of
mGluR1/5 and its binding protein, Homer1b/c, in the NAc (Swanson et al., 2001;
Ary & Szumlinski, 2007; Ghasemzadeh et al., 2009). The importance of the
downregulation of mGluR2/3 and mGluR1/5 is seen in the fact that stimulating
mGluR2/3 signaling attenuates cocaine seeking and inhibiting mGluR1/5 or
downregulating Homer 1 attenuates reinstatement (Chiamulera et al., 2001;
Ghasemzadeh et al., 2003; Tessari et al., 2004; Olive et al., 2005; Peters &
Kalivas, 2006; Palmatier et al., 2008). These data suggest that the
downregulation of mGluR1/5 may be a compensatory mechanism whereas the
downregulation of mGluR2/3 may promote drug-seeking behavior.
Cocaine-Induced Changes in LTP and LTD
Animals in extended withdrawal from cocaine show an increase in the
AMPA/NMDA ratio in the NAcC indicating increased synaptic strength (Kourrich
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et al., 2007; Conrad et al., 2008). Further, cocaine withdrawal also attenuates
LTD in the NAcC (Martin et al., 2006). These results are at odds with convention
because neurons in a potentiated state tend to have a greater dynamic range
towards LTD (Kauer & Malenka, 2007). Evidence suggests that mGluR2/3s and
mGluR1/5 regulate LTP and LTD, respectively; thus, this bidirectional loss in
synaptic plasticity may be due to loss of glutamatergic tone on mGluRs (Grover &
Yan, 1999; Wu et al., 2004; Kauer & Malenka, 2007). Evidence is given to this
claim by the fact that increased xCT activity caused by N-acetylcysteine
increases glutamate tone on mGluRs and restores the ability of neurons to
induce LTP and LTD (Grover & Yan, 1999; Malenka & Bear, 2004; Wu et al.,
2004; Moussawi et al., 2009).
Summary: Mechanisms of Cocaine-Induced Glutamatergic Changes
Following withdrawal from cocaine (after chronic exposure) the key
presynaptic changes that occur in the NAcC are reduced mGluR2/3 signaling
due partially from an increase in AGS3 and partially due to reduced
glutamatergic tone from the xCT (Kalivas, 2009). Under basal conditions there is
also a decrease in metabolic activity in the PFC of those with substance-use
disorder and the firing rates of neurons from the PFC to the NAcC are reduced
(Sun & Rebec, 2006). This fact accounts for decreased basal synaptic release in
the presence of reduced mGluR2/3-mediated inhibition of release (Kalivas,
2009). This decrease in basal synaptic and non-synaptic release may account for
the observed decrease in GLT-1 and the increase in postsynaptic AMPA
receptors (Boudreau & Wolf, 2005; Kourrich et al., 2007; Conrad et al., 2008;
Pendyam et al., 2009). In fact, the cocaine-induced upregulation of GluR2lacking AMPA receptors has been interpreted as homeostatic synaptic scaling in
response to decrease glutamatergic activity (Conrad et al., 2008).
When drug-seeking behavior is reinstated, there is an increase in neuronal
activity in the PFC and an increase in glutamate release in the NAcC (McFarland
et al., 2003; Sun & Rebec, 2006; Madayag et al., 2007; LaLumiere & Kalivas,
2008). The glutamate released from PFC afferents is synaptic and results
partially from decreased mGluR2/3 signaling due to reduced xCT function (Baker
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et al., 2002; Xi et al., 2002). The overflow of glutamate outside of the synapse is
partially due to a down regulation of GLT-1 (Knackstedt et al., 2010). Forty-five
minutes after cocaine administration there is an increase in spine head diameter
due to an increase postsynaptic AMPA receptor expression (Toda et al., 2006;
Anderson et al., 2008; Shen et al., 2009). However, by 120 minutes, glutamate
levels are no longer elevated and the spine head diameter is reduced (Toda et
al., 2006; Kalivas, 2009; Shen et al., 2009). By 120 minutes there is also a
reduction in membrane bound AMPA receptors and a decrease in the
AMPA/NMDA ratio (Thomas et al., 2001; Boudreau et al., 2007; Kourrich et al.,
2007; Shen et al., 2009).
The bidirectional loss of LTP and LTD after cocaine self-administration
suggests that mechanisms indicated in synaptic plasticity are impaired (Martin et
al., 2006; Kourrich et al., 2007; Moussawi et al., 2009). This is likely due to the
cocaine-induced increase in actin cycling, making it difficult to sustain the
morphological changes that accompany the induction of LTP or LTD (Toda et al.,
2006), as well as the decreased glutamatergic tone on mGluRs (Xi et al., 2002;
Baker et al., 2003). The latter reasoning is supported by the fact that Nacetylcysteine restores the induction of LTP and LTD by increasing glutamatergic
tone via increased functioning of the xCT (Moussawi et al., 2009). Note that
further credence is given to the aforementioned fact in that the administration of
N-acetylcysteine also prevents cocaine-seeking behavior (Baker et al., 2003;
Zhou & Kalivas, 2007).
Limitations of Current Research
A limitation of the current research studying glutamate dynamics in models
of substance-use disorder is that studies primarily focus on measuring glutamate
in the NAcC; thus, very little is known about glutamate signaling in the PrL (for
review Kalivas, 2009). Understanding glutamatergic signaling in the PrL could
further aid in elucidating cocaine-specific glutamatergic changes especially
considering the close relationship in glutamate signaling between the NAcC and
the PrL in abuse behavior (McFarland et al., 2003). Also, most data assessing
glutamate release in drug abuse models has primarily focused on reinstatement.
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Thus, cocaine-specific glutamatergic changes that occur during drug taking are
unknown. Also, most studies use microdialysis to collect glutamate measures.
Considering that microdialysis can only collect data on the order of minutes (see
Nandi & Lunte, 2009 for review) specific release events and their kinetics cannot
be measured. Further, microdialysis probes usually sample from a large area on
the order of millimeters (see Nandi & Lunte, 2009 for review) making it hard to
isolate signaling from specific circuits. Thus, methods that collect data on a more
physiologically relevant time scale and that sample from a smaller population of
neurons may elucidate cocaine-specific changes in the glutamate system that
have yet to be detected. Use of different behavioral designs may also aid in
isolating cocaine-specific changes in glutamate signaling.
To date, most preclinical research attempts to study drug-specific neural
changes in animals that only self-administer drug, while controls only selfadminister food, water, or receive yoked saline (Cunningham et al., 2015; Huff &
LaLumiere, 2015; Saddoris et al., 2016). However, controls likely do not have the
same neuronal adaptations as rats with a history of drug taking, limiting the ability
to study drug-specific glutamatergic adaptations that specifically contribute to
drug-taking behavior. This is particularly important when considering that no
persons with substance-use disorder are drug naïve, and they exhibit a wide
array of behavior beyond drug taking that is maintained by non-drug
reinforcement. Thus, to adequately study drug-taking behavior, including drugspecific glutamatergic adaptations, a design must be used that exposes the
same individual to drugs, natural rewards, and their associated cues.
Multiple schedules of reinforcement allow for the study of drug and food
reinforcement, as well as their associated stimulus effects, within a single
individual (Weissenborn et al., 1995; Weissenborn et al., 1996; Carelli et al.,
2000; Stairs et al., 2010). Previous studies have used multiple schedules to study
primary reinforcers as well as the effects of associated conditioned and
discriminative stimuli (Weiss et al., 2000; Weiss et al., 2001; Weiss et al., 2003;
Kearns & Weiss, 2005; Kearns & Weiss, 2007; Weiss et al., 2007). However, no
one to date has utilized multiple schedules to conduct a systematic within-subject
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investigation into how cocaine specifically changes glutamatergic signaling in the
NAcC and the PrL, compared to a natural reinforcer, such as food.
Overview of Experiment 1
Experiment 1 was conducted to increase understanding about the
complex interactions that occur in glutamatergic signaling in the NAcC and PrL
during cocaine self-administration. Specifically, biosensor technology was used
to measure sub-second glutamate release in freely-moving animals behaving in a
cocaine/food multiple schedule. Considering a behavioral procedure was used
that exposed animals to both cocaine and food, it allowed for the isolation of
cocaine-specific glutamatergic adaptations. The overall hypothesis for the
experiment was that cocaine related behavioral events would cause an increase
in glutamate release compared to food related behavioral events. Considering
the connection between the PrL and NAcC glutamate release to cocaine
behavioral events was expected to increase in both brain areas; however, it was
expected that the dynamics of the release events would be markedly different.
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CHAPTER 2
EXPERIMENT 1:
COMBINING MULTIPLE SCHEDULES OF REINFORCEMENT WITH
GLUTAMATE BIOSENSORS TO EXAMINE THE EFFECTS OF COCAINE AND
FOOD ON PRELIMBIC AND ACCUMBAL GLUTAMATERGIC SIGNALING IN
FREELY-MOVING RATS
Introduction
Although there is evidence that glutamate signaling in the PrL and NAcC
are dysregulated in cocaine-use disorder (Park et al., 2002; McFarland et al.,
2003; Kalivas, 2009; Knackstedt et al., 2010) the exact nature of these changes
and their implication for behavior are not fully known. This lack of knowledge
partially comes from the use of methodologies that cannot measure glutamate at
the high temporal and spatial resolution needed to detect fast changes in
glutamate signaling (e.g. McFarland et al., 2003; Nandi & Lunte, 2009). Further,
the use of behavioral paradigms that only expose animals to drug or food (e.g.
Cunningham et al., 2015; Huff & LaLumiere, 2015; Saddoris et al., 2016) make it
difficult to elucidate drug-specific glutamatergic changes. This study was
conducted to address these issues by measuring glutamate with biosensors
capable of detecting physiological relevant changes in glutamate signaling in the
PrL and NAcC while animals behaved in a cocaine-food multiple schedule.
Materials and Methods
Animals
Twenty-two adult male Sprague-Dawley rats (Harlan, Inc.; Indianapolis,
IN, USA) weighing approximately 250-300 g were used for experimentation. Rats
were individually housed in a temperature-controlled environment on a 12:12 h
light:dark cycle with lights on at 0600 h. All rats were acclimated to the colony
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room and handled one week before any experimentation began. All rats had ad
libitum access to food and water during the experiment proper. The Institutional
Animal Care and Use Committee at the University of Kentucky approved all
experimental protocols.
Drugs
Cocaine hydrochloride (COC; NIDA, Rockville, MD) was prepared in 0.9%
sterile saline for self-administration. COC was self-administered at 1.0
mg/kg/infusion (Tella, 1995) based on weight.
Apparatus
Experiments were conducted in an operant conditioning chamber (ENV008, Med Associates) housed within a sound-attenuating compartment (ENV018M, Med Associates). Each chamber was connected to a computer (SG-502,
Med Associates) and ran using MED-PC. Each operant chamber contained a 5.1
cm x 5.1 cm recessed food receptacle (ENV-200R2MA) on the front response
panel with two retractable levers on either side (ENV-122CM; 6 cm above metal
rod floor). Above each lever was one white cue light (ENV-221M; mounted 4.1
cm above each lever). A Sonalert tone (ENV-223 AM) was located above the top
left cue light and another Sonalert tone (ENV-223 HAM) was located above the
top right cue light. A house light (ENV-227M) was placed 17 cm above the metal
floor in the middle of the back wall. Food pellets (45 mg, Dustless Precision
Pellets; Bio Serv) were delivered via a dispenser (ENV-203M-45) placed behind
the food receptacle. COC was delivered through a watertight swivel attached via
tygon tubing to a back-mounted cannula via a syringe pump (PHM-100) located
outside of the sound-attenuating chamber.
Glutamate Biosensor
Microelectrode Array Preparation
Microelectrode arrays (MEAs, S2 configuration; CenMeT, University of
Kentucky) consisting of four platinum recording sites (15 μm x 333 μm) arranged
in dual pairs were first built into an implantable headcap (Figure 2.1A) as
previously described (Rutherford et al., 2007). Briefly, both ends of an ~2.5 cm
long varnished 30 AWG copper wire (RadioShack, Fort Worth, TX) were scraped
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to expose ~ 0.25 cm of copper wire and fluxed (#186 Rosin flux type RMA,
Kester). One end of the wire was soldered (~200 °C) to a gold-plated socket
(Ginder Scientific, Nepean, ON). The other end of the wire was soldered into the
paddle portion of the MEA. This was done four times in order to wire up all four
measuring sites. The four wires containing gold-plated sockets were then
inserted into four holes in a nine-hole ABS plug and the wires were wrapped
around the plug. A Teflon coated, 5 cm long Ag wire (A-M Systems, Carlberg,
WA), which was electroplated to form an Ag/AgCl wire to serve as a reference
electrode once in contact with CSF containing Cl-, was then scraped (~0.25 cm),
fluxed, soldered into a gold-plated socket, and placed in the ABS plug. The
assembly was then covered with a heavy layer of marine quality epoxy and
allowed to cure for at least 48 hours to ensure a waterproof seal (Rutherford et
al., 2007).
MEAs were then configured for selective measures of glutamate (Figure
2.1B). Specifically, a solution of 1% bovine serum albumin (BSA; Sigma-Aldrich,
St. Louis, MO), 0.125% glutaraldehyde (Sigma-Aldrich), and 1% glutamate
oxidase (GluOX; US Biological, Salem, MA) was coated on the bottom two
recording sites of the MEA by syringe application (3 coats) to allow for
conversion of glutamate into α-ketoglutarate and the reporter molecule, peroxide
(Burmeister and Gerhardt, 2001; Day et al., 2006). The top two recording sites
were coated with the BSA/glutaraldehyde matrix (without GluOX) to allow for
background current subtraction thus resulting in a self-referenced glutamate
signal (Burmeister and Gerhardt, 2001). After the MEAs were configured with
enzymes to measure glutamate, they were allowed to cure for at least 72 hours
and then all four recording sites were electroplated with m-phenylenediamine
(mPD; Acros, Fisher Scientific, Waltham, MA). mPD is a size exclusion layer that
eliminates signals from interferent molecules such as ascorbic acid and
dopamine thus allowing for more selective glutamate measurements (Miller et al.,
2015). Electrodes were allowed to sit for at least 24 hours before implantation.
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In Vitro Calibration
Amperometric recordings were collected at 4 Hz using the FAST16 mkIII
electrochemical recording system (Fast Analytical Sensing Technology,
Quanteon, LLC, Nicholasville, KY). Immediately before in vivo implantation, all
electrodes underwent an in vitro calibration to determine sensitivity (slope,
nA/μM), selectivity (glutamate vs. ascorbic acid sensitivity), limit of detection (in
μM, signal-to-noise = 3), and linearity (R2 ≥ 0.9) (Burmeister and Gerhardt, 2001).
In Vivo Implantation
Immediately before surgery all rats were given subcutaneous injections of
carprofen (Rimadyl©, Pfizer, NYC) at a dose of 10mg/kg and 1 mL of 0.9% sterile
saline. All rats were anesthetized using 4% isoflurane (Isothesia, Henry Schein,
Melville, NY). Once anesthetized, animals were placed in a stereotaxic frame
(David Kopf Instruments, Tujunga, CA) and maintained at an isoflurane level of
1-3%. Body temperature was maintained at 37°C using a circulating water bath
attached to a water pad (Gaymar Industries, Orchard Park, NY). Artificial tears
(Henry Schein, Melville, NY) were then applied to rats’ eyes, the rats’ heads were
shaved, and Hibiclens scrub (Mölnlycke Health Care, Norcross, GA) and 70%
ethanol were used to disinfect the surgery site. The skin overlying the skull was
then reflected. A craniotomy was performed exposing the right hemisphere of
either the PrL (AP: +3.2 mm; ML: ±0.8 mm; DV: -3.5 mm [from brain surface]) or
NAcC (AP: +2.0 mm; ML: ±1.5 mm; DV: -7.0 mm [from brain surface]) (Paxinos
and Watson, 2009). A small burr hole was made contralateral to the site of the
craniotomy for implantation of the small Ag/AgCl reference electrode. Three
screws (Amazon supply, part No. B00FN0K02) were then screwed into the skull.
The dura was then reflected where the craniotomy was performed and the MEA
was implanted in the respective brain region and the Ag/AgCl reference was
placed into the contralateral burr hole epidurally. Anterior-posterior and mediallateral coordinates for MEA implantation were calculated relative to bregma and
dorsal-ventral coordinates from the brain surface. The MEA headcap was then
set in place on rats’ skulls using dental acrylic (Ortho Jet Powder and Jet Acrylic
Liquid, Lang Dental Manufacturing Co., Wheeling, IL). The animals were allowed
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to recover for 3 days before the recordings began; they were given carprofen (10
mg/kg) and 1 mL 0.9% sterile saline subcutaneously during this period.
Electrochemical Recordings
Glutamate measurements were performed using the FAST-16 mkIII
recording system using a low noise 4-channel Rat Hat amplifier (Quanteon, LLC,
Nicholasville, KY) system connected through a low-noise commutator (Plastics
One, Inc., Roanoke, VA). For every session, each animal behaved in the
procedure while neurochemical measurements were made at +0.7 V potential vs.
Ag/AgCl reference (able to oxidize the recorder molecule, peroxide [i.e. able to
detect glutamate]).
Establishing Procedures
Rats were first trained to retrieve food pellets from the food receptacle for
two consecutive days. Following magazine shaping, rats were trained to lever
press (left and right, randomly presented) on a fixed-ratio 1 (FR1) schedule of
reinforcement; completion of the FR1 resulted in lever retraction and delivery of a
food pellet. Each session consisted of 15 left and 15 right-lever trials. Rats were
incrementally moved from an FR1 to a terminal FR3 over six days.
Catheter Surgeries
After lever training, rats underwent chronic indwelling jugular catheter
implantation surgery. Rats were anesthetized with a
ketamine/xylazine/acepromazine (75/7.5/0.75 mg/kg) mixture at 0.15 ml/100 g
body weight (i.p.). Next a catheter was inserted into the right jugular vein,
extended under the skin, and exited through the body via an incision on the back.
A cannula attached to the catheter was then implanted in the back. Animals were
given 7 days to recover after surgery.
Drug Self-Administration Training
After recovery, animals self-administered COC on an FR1 in the presence
of a drug discriminative stimulus (cue light over lever). All COC infusions were
paired with a drug conditioned stimulus (solid house light + tone). After 3 days
the FR requirement was increased to an FR3. Animals were then allowed to selfadminister COC until stable responding on the FR3 was reached (> 10 infusion
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earned three consecutive days in a row). Animals were moved on to multiple
schedule training (see below) after stability was reached.
Multiple Schedule Procedure
After stably responding for COC, rats were trained on a multiple schedule
procedure (see Batten & Beckmann, 2018) where each session consisted of 12
alternating 5-minute components (with the first component being randomly
selected). Either drug (6 components) or food (6 components) could be earned in
a component. Each component was separated by 2-minute inter-component
intervals (ICI); a period between components where all stimuli and manipulanda
were off and no reinforcers could be earned. For drug components, the cue light
above the drug lever was used as the discriminative stimulus signaling that lever
presses (FR3) on the COC lever would result in a COC infusion. The COC
infusion was paired with the compound conditioned stimulus of a solid house light
and tone for the duration of the infusion (5.9 seconds). For food components, the
cue light above the food lever served as the discriminative stimulus signaling that
lever presses (FR3) on the food lever would result in food reinforcement. The
food pellet was paired with the conditioned stimulus of a blinking house light (5.9
seconds). During each component, both levers were present with reinforcement
being set up for either COC or food on one lever with the other lever being
inactive (counterbalanced). After stable behavior was reached (overall
discrimination ratio ≥ 75%; see below), the glutamate biosensor was implanted
(see above) into the PrL (n = 11) or NAcC (n = 11) and cemented in place with
dental acrylic (Figure 2.1C). After three days of recovery, glutamate
measurements were collected while animals performed on the multiple schedule
procedure. After all data were collected, animals were euthanatized and the
brains were extracted, flash frozen, and 40 µm slices were prepared using a
cryostat. The slices were stained using Cresyl Violet (Sigma-Aldrich, St. Louis,
MO) and were visualized to confirm biosensor placements into the PrL or NAcC
(Figure 2.2).
Data Analysis
Behavioral data were analyzed by calculating discrimination ratios for the
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entire session (expressed as a percentage) as follows:

𝐷𝐷. 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 =

𝐿𝐿 𝑐𝑐 + 𝐿𝐿𝑓𝑓
× 100
𝐿𝐿 𝑐𝑐 + 𝐿𝐿𝑓𝑓 + 𝐼𝐼𝑐𝑐 + 𝐼𝐼𝑓𝑓

(1)

where Lc represents lever presses for COC during COC components, Lf

represents lever presses for food during food components, Ic represents inactive
lever presses during COC components, and If represents inactive lever presses

during food components. Discrimination ratios were also calculated separately for
COC and food component as follows:

𝐷𝐷. 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 =

𝐿𝐿 𝑅𝑅
× 100
𝐿𝐿 𝑅𝑅 + 𝐼𝐼𝑅𝑅

(2)

where LR represents lever presses for COC or food during the respective

components and IR represents inactive lever presses during COC or food

components. For the overall discrimination ratios, a one-sampled t-test was
conducted comparing the average overall discrimination ratio to 75%. For the
COC and food discrimination ratios, a one-sampled t-test was conducted

comparing the average COC or food discrimination ratios to 50%. Individual
behavioral events were analyzed with linear mixed-effects models (Gelman &
Hill, 2007) using JMP Pro 12.0.0. statistical software (SAS Institute, Inc., Cary,
NC) with subject as a random factor, brain region as a fixed between-subjects
factor, and behavioral events associated with each component as a fixed, withinsubjects factor.
Neurotransmitter data were analyzed using custom MATLAB®-based
software (Quanteon LLC, Nicholasville, KY) and a custom-written MATLAB®
(MathWorks, Inc., Natick, MA) program. Subtracted glutamate data and the
location of respective behavioral events were extracted using the custom
MATLAB®-based software. The glutamate signals related to the behavioral
events were analyzed using the custom-written MATLAB® program. Specifically,
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a glutamate peak was defined as an event that was 5 standard deviations above
the mean of the baseline (Gunaydin et al., 2014). The baseline was defined as
the last 1-minute average of all COC ICI’s for COC components and the last 1minute average of all food ICI’s for food components. Peaks were considered
related to a given behavioral event if they occurred within a 10-second window of
the behavioral event (Malvaez et al., 2015) and were not interrupted by another
type of behavioral event. Figure 2.3 and Figure 2.4 show example glutamate
traces highlighting glutamate events considered to be peaks based on the
previously mentioned criteria. The measures assessed were the absolute
maximum of the glutamate peak (μM), the maximum amplitude of the glutamate
peak above baseline (μM), the percent increase of the glutamate peak above
baseline, the peak width (s), the peak prominence (μM), and the number of
glutamate events that occurred to a given behavioral event. Statistical analyses
were conducted with JMP Pro 12.0.0. statistical software using linear mixedeffects (LME) models (Gelman & Hill, 2007) with subject as a random factor,
brain region as a fixed between-subjects factor, and component as a fixed,
within-subjects factor.
Akaike information criterion (AIC) values were used to compare models;
only statistics from the models that were most likely to describe the data are
presented. Further, differences in AIC values (ΔAICs) were also calculated in
order to assess the relative difference of information loss of all the other models
compared to the best model. Evidence ratios for the best model relative to the
second-best model were calculated from the ΔAICs (Burnham & Anderson, 2002;
Burnham et al., 2011). The evidence ratios indicate the relative strength of the
preferred model to the second-best model. Thus, by using evidence ratios one
can say that the evidence for the preferred model is ‘x’ times stronger than that of
the second-best model.
Where necessary linear regressions were performed and correlation
coefficients, as well as if the slopes of the lines were statistically different than
zero, were assessed. Any interactions were probed using the Tukey HSD, and
statistical significance was defined as p < 0.05.
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Results
Behavioral Responses During Baseline and Recording Conditions
Figure 2.5 shows the overall discrimination ratio for baseline behavior (the
day before MEA implantation) and behavior during glutamate recordings. Overall
discrimination ratios for both baseline [t(21) = 14.22, p < 0.0001] and recording
[t(21) = 3.50, p = 0.002 ] behavior were statistically greater than 75%. Figure 2.6
shows the discrimination ratio for the COC and food components during baseline
(Figure 2.6A) and recording behavior (Figure 2.6B). Discrimination ratios for COC
[t(21) = 13.33, p < 0.0001] and food [t(21) = 19.56, p < 0.0001] during baseline
were statistically greater than 50%. Discrimination ratios for COC [t(21) = 3.03, p
= 0.006] and food [t(21) = 7.09, p < 0.0001] during recording were statistically
greater than 50%.
Total Number Glutamate Peaks Found During COC and Food Components
Figure 2.7 shows the number of glutamate peaks found to behavioral
events per component type and the total number of glutamate peaks found
overall per component type (regardless of behavioral events). Specifically, a
main effect of event type was found with more glutamate peaks occurring to
events during food components compared to COC components (Figure 2.7A)
[F(1,20) = 13.02, p = 0.0018]. This statistic came from the full model (brain x

event type as factors), which had the lowest AIC and was 441.42 times more
likely to describe the data than the second best model that used only event type
as a factor.
Figure 2.7B shows the total number of glutamate peaks found during
components (not just the peaks related to behavioral events). The full model
(brain region x event type as factors) had the lowest AIC and was 158.38 times
more likely to describe the data compared to the model with only event type as a
factor. Specifically, a main effect of event type was found with significantly more
glutamate peaks occurring during COC components compared to food
components [F(1,20) = 4.81, p = 0.040].
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Percentage of Peaks Related to Behavioral Events
Figure 2.8 shows the percentage of glutamate peaks that were related to
behavioral events out of the total number of glutamate peaks found in a session.
Specifically, Figure 2.8A shows that roughly an equal number of glutamate peaks
were found between the PrL (11.51%) and the NAcC (12.19%). When looking
specifically at each brain region, more glutamate peaks were found to food
related events (PrL = 8.32% vs. NAcC = 8.27%) compared to COC related
events (PrL = 3.19% vs. NAcC = 3.92%) in both the PrL (Figure 2.8B) and the
NAcC (Figure 2.8C).
Total Number of Behavioral Events and Total Number of Glutamate Peaks
Related to Behavioral Events
Figure 2.9A shows the total number of behavioral events that occurred
during the COC and food components for rats with electrodes implanted in the
PrL and NAcC. The full model had the lowest AIC and was 376.15 times more
likely to describe the data compared to the model with only event type as a
factor. The full model shows that there was a main effect of event type where a
significantly greater number of behavioral events occurred during food
components compared to COC components [F(1,20) = 17.35, p = 0.0005].
Figure 2.9B shows the number of glutamate peaks that occurred to

behavioral events during COC and food components for rats with electrodes
implanted in the PrL and NAcC. The full model had the lowest AIC and was
441.42 times more likely to describe the data compared to the model with only
event type as a factor. The best model suggests that there was a main effect of
event type where a significantly greater number of glutamate peaks occurred
during food components compared to COC components [F(1,20) = 13.02, p =

0.0018]. Note that this graph is the same graph that was presented in Figure
2.7A with the y-axis changed for the ease of comparison.

Total Number of Glutamate Peaks are Correlated with Behavioral Events
Figure 2.10 shows correlations between the number of glutamate peaks
found to COC or food events during a session and the number of behavioral
events that occurred to COC or food during a session for rats with MEAs
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implanted in both brain regions. Figure 2.10 also shows correlations between the
number of glutamate peaks found per COC or food event in a session (created
by taking the number of glutamate peaks that occurred to a behavioral event and
dividing it by the number of behavioral events) and the number of behavioral
events that occurred in the session. Figure 2.10A (left) shows a significant
positive correlation between the number of glutamate peaks that occurred to
COC events and the number of COC behavioral events that occurred (r = 0.82, p
< 0.001). Figure 2.10A (right) shows a significant negative correlation between
the number of glutamate peaks that occurred per COC event and the number of
COC responses that occurred during a session (r = 0.47, p = 0.03). Figure 2.10B
(left) shows a significant positive correlation between the number of glutamate
peaks that occurred to food events and the number of food behavioral events
that occurred in a session (r = 0.95, p < 0.001). Figure 2.10B (right) shows a
significant negative correlation between the number of glutamate peaks that
occurred per food event and the number of food behavioral events that occurred
during a session (r = 0.47, p = 0.03).
Distribution of Glutamate Peaks Related to Behavioral Events
In order to get an idea of how the glutamate peaks that were related to
behavioral events were distributed, the number of glutamate peaks found to a
given behavioral event was divided by the total number of glutamate peaks found
to all behavioral events and was expressed as a percentage. Figure 2.11
represents the percentage of glutamate peaks that occurred to all the different
behavioral events measured. Specifically, Figure 2.11A shows that there was a
main effect of event type where a statistically greater percentage of glutamate
peaks occurred to the start of food components compared to the start of COC
components [F(1,21) = 9.20, p = 0.006]. This statistic came from a model that

included only event type as a factor and was 2.9 times more likely to describe the
data compared to the full model.
Figure 2.11B shows a main effect of event type where a significantly
greater percentage of glutamate peaks were seen to responses on the food lever
compared to responses on the COC lever [F(1,21) = 13.02, p = 0.002]. This
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statistic came from a model that included only event type as a factor and was
1.97 times more likely to describe the data compared to the full model.
Figure 2.11C shows that there were no statistical differences in the
percentage of glutamate peaks that occurred to COC or food reinforcers [F(1,20)
= 0.44, p = 0.52]. The model for this statistic included only brain region as a

factor and was 1.32 times more likely to describe the data compared to the full
model.
Figure 2.11D shows all head entries into the food receptacle during COC
and food components in rats with electrodes implanted in the PrL and NAcC. The
model with the lowest AIC was the full model; however, the ΔAIC between the
best model and second best model was lower than 4. Thus, the simpler of the
two models (event type only as a factor) was selected. Specifically, a main effect
of event type was found with a significantly larger percentage of glutamate peaks
observed with head entries during food components compared to head entries
during COC components [F(1,21) = 11.46, p = 0.003].

Figure 2.11E shows all head entries into the food receptacle directly after

a COC infusion was earned and all head entries directly after a food pellet was
delivered. Presumably, head entries after a pellet was delivered are ‘eating’
responses. The model with the lowest AIC included only event type as a factor
and was 1.58 times more likely to describe the data compared to the full model.
Significantly more glutamate peaks were observed to head entries for eating
during food components compared to the number of glutamate peaks that
occurred to head entries after COC infusions [F(1,21) = 27.70, p = 0.0001].
Figure 2.11F shows inactive lever responses during COC and food

components. There were no statistical differences in the number of glutamate
peaks observed [F(1,21) = 0.44, p = 0.51]. The model with the lowest AIC

included only event type as a factor and was 1.24 times more likely to describe
the data compared to the full model.

Number of Glutamate Peaks Related to The Beginning of Components
Figure 2.12 shows the number of glutamate peaks that were related to the
beginning of the COC and food components as well as the number of glutamate
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peaks that occurred per component beginning (calculated by dividing the number
of glutamate peaks by the number of COC or food components) in animals that
had electrodes implanted in the PrL and NAcC. Specifically, Figure 2.12A shows
that significantly more glutamate peaks occurred to the beginning of food
components compared to the beginning of COC components [F(1,21) = 9.20, p =
0.006]. The model with the lowest AIC was the full model; however, the ΔAIC
between the best model and second best model was lower than 4. Thus, the
simpler of the two models (event type only as a factor) was selected. Figure
2.12B shows that significantly more glutamate peaks per food component
beginning occurred compared to the beginning of COC components [F(1,21) =
10.08, p = 0.0046]. This statistic came from the model that included only event
type as a factor, which had the lowest AIC and was 13 times more likely to
describe the data compared to the full model.
Number of Glutamate Peaks Related to Lever Presses, Reinforcers, and
Inactive Lever Presses
Figure 2.13 shows the behavior exhibited to lever presses, reinforcers
earned, and inactive lever presses as well as the number of glutamate peaks that
happened to each of those events. Figure 2.13A (left) shows that there was a
significant main effect of event type with a greater number of responses
occurring on the food lever compared to the COC lever [F(1,20) = 18.35, p =

0.0004]. This statistic came from the full model, which was 156.02 times more
likely to describe the data than the model with just event type as a factor. Figure
2.13A (right) shows a main effect of event type with a greater number of
glutamate peaks being observed to responses on the food lever compared to
responses on the COC lever [F(1,20) = 11.96, p = 0.0025]. This statistic came
from the full model, which had the lowest AIC and was 45.83 times more likely to
describe the date than the model that used only event type as a factor.
Figure 2.13B (left) shows a significant main effect of event type with a
greater number of food reinforcers being earned compared to COC reinforcers
[F(1,20) = 16.82, p = 0.0006]. This statistic came from the full model, which had
the lowest AIC and was 6.33 time more likely to describe the data than the model
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with only event type included as a factor. Figure 2.13B (right) shows that there
were no differences observed in the number of glutamate peaks that occurred to
COC or food reinforcers [F(1,20) = 0.04, p = 0.84]. This statistic came from the
full model, which had the lowest AIC and was 29.22 time more likely to describe
the data compared the to the model where only event type was a factor.
Figure 2.13C (left) shows that there were not any statistical differences
between COC and food inactive lever presses [F(1,20) = 0.01, p = 0.92]. This
statistic came from the full model, which had the lowest AIC and was 10.86 times
more likely to describe the data than the model with only event type as a factor.
Figure 2.13C (right) shows that there were no differences observed in the
number of glutamate peaks associated with inactive lever presses [F(1,20) =
0.0013, p = 0.97]. This statistic came from the full model, which had the lowest
AIC and was 18.08 times more likely to describe the data than the model that
used brain region only as a factor.
Number of Glutamate Peaks Per Lever Presses, Reinforcers, and Inactive
Lever Presses
Figure 2.14 shows the behavior exhibited to lever responses, reinforcers
earned, and inactive lever presses as well as the number of glutamate peaks per
each of those events (calculated by taking the number of glutamate peaks that
occurred to an event and dividing it by the amount of behavior that occurred).
Note that the behavior is the same as seen in Figure 2.13 and is only shown in
Figure 2.14 for purposes of comparison.
Figure 2.14A (right) shows a main effect of event type with a greater
number of glutamate peaks occurring per COC lever presses compared to food
lever presses [F(1,21) = 6.26, p = 0.02]. This statistic came from the model with
only event type included as a factor, which had the lowest AIC and was 11.65
times more likely to describe the data compared to the model where only brain
region was a factor.
Figure 2.14B (right) shows a main effect of event type where significantly
more glutamate peaks occurred per COC reinforcer compared to food per
reinforcer [F(1, 21.27) = 67.32, p < 0.001]. This statistic came from the model
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where only event type was included as factor, which had the lowest AIC and was
44.70 times more likely to describe the data compared to the full model.
Figure 2.14C (right) shows that the number of glutamate peaks that
occurred per inactive lever press were not different between COC and food
[F(1,20.16) = 3.35, p = 0.08]. This statistic came from the model where only
event type was included as a factor and was 4.39 times more likely to describe
the data compared to the model where only brain region was a factor.
The Number of Glutamate Peaks Are Correlated with Lever Presses,
Reinforcers, and Inactive Lever Presses
Figure 2.15 shows correlations between lever presses for COC and food
and the number of glutamate peaks that occurred to those events or the number
that occurred to those events per response. Specifically, Figure 2.15A (left)
shows a significant positive correlation between the number of glutamate peaks
that occurred to COC responses and the number of COC responses that
occurred (r = 0.80, p < 0.001). Figure 2.15A (right) shows that there is no
correlation between the number of glutamate peaks that occurred per COC
response and the number of COC responses that occurred (r = 0.076, p = 0.74).
Figure 2.15B (left) shows that the number of glutamate peaks that occurred to
food responses and the number of food responses that occurred are positively
correlated (r = 0.94, p < 0.001). Figure 2.15B (right) shows that the number of
glutamate peaks that occurred per food lever press and the number of food lever
presses that occurred were negatively correlated (r = -0.51, p = 0.01).
Figure 2.16 shows correlations between the number of COC and food
reinforcers earned and the number of glutamate peaks that occurred to each
reinforcer or the number of glutamate peaks that occurred per each reinforcer.
Specifically, Figure 2.16A (left) shows a significant positive correlation between
the number of glutamate peaks that occurred to COC reinforcers and the number
of COC reinforces that occurred (r = 0.84, p < 0.0001). Figure 2.16A (right)
shows that the number of glutamate events that occurred per COC reinforcer and
the number of COC reinforcers that occurred are significantly negatively
correlated (r = -0.44, p = 0.04). Figure 2.16B (left) shows a significant positive
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correlation between the number of glutamate peaks that occurred to the food
reinforcer and the number of food reinforcers that occurred (r = 0.85, p < 0.0001).
Figure 2.16B (right) shows that there was no correlation between the number of
glutamate peaks that occurred per food reinforcer and the number of reinforcers
that were delivered (r = -0.28, p = 0.21).
Figure 2.17 shows correlations between the number of COC and food
inactive lever presses and the number of glutamate peaks that occurred to
inactive lever presses or the number of glutamate peaks that occurred per
inactive lever press. Specifically, Figure 2.17A (left) shows a significant positive
correlation between the number of glutamate peaks that occurred to inactive
lever presses on the COC lever and the number of inactive COC lever presses
that occurred (r = 0.91, p < 0.0001). Figure 2.17A (right) shows that the number
of glutamate peaks that occurred per inactive lever press was not correlated with
inactive COC responding (r = -0.44, p = 0.1). Figure 2.17B (left) shows a
significant positive correlation between the number of glutamate peaks that
occurred to inactive lever presses on the food lever and the number of food
inactive lever presses that occurred (r = 0.91, p < 0.0001). Figure 2.17B (right)
shows that there was no correlation between the number of glutamate peaks that
occurred per food inactive lever press and inactive food responding (r = -0.35, p
= 0.19).
Number of Glutamate Peaks Related to Head Entries, Head Entries After
Reinforcer Delivery, and COC Earned/Eat Head Entries
Figure 2.18 shows the behavior exhibited to head entries, head entries
after reinforcer delivery, and to COC earned and head entries associated with
eating as well as the number of glutamate peaks to each of those events.
Figure 2.18A (left) shows that there were no difference in head entries
during COC or food components [F(1,20) = 0.26, p = 0.62]. This statistic came

from the full model, which was 32.95 times more likely to describe the data than
the model with just event type as a factor. Figure 2.18A (right) shows a main

effect of event type with a greater number of glutamate peaks occurring to food
head entries compared to COC head entries [F(1,20) = 9.02, p = 0.007]. This

35

statistic came from the full model, which had the lowest AIC and was 90.02 times
more likely to describe the data compared to the model where only event type
was a factor.
Figure 2.18B (left) shows a significant main effect of event type with a
greater number eat head entries occurring compared to COC infusion head
entries [F(1,20) = 26.09, p = 0.0001]. This statistic came from the full model,
which had the lowest AIC and was 3.56 times more likely to describe the data
than the model with only event type as a factor. Figure 2.18B (right) shows a
main effect of event type where significantly more glutamate peaks occurred to
head entries after a pellet was delivered compared to head entries during/after a
COC infusion [F(1, 20) = 20.58, p = 0.002]. This statistic came from the full
model, which had the lowest AIC and was 39.25 times more likely to describe the
data compared to the model that included only event type as a factor.
Figure 2.18C (left) shows that there was a main effect of event type with
more eat head entry responses occurring than the number of COC reinforcers
earned [F(1,20) = 16.04 , p = 0.0007]. This statistic came from the full model
which had the lowest AIC and was 3.67 times more likely to describe the data
than the model with only event type as a factor. Figure 2.18C (right) shows that
the number of glutamate peaks that occurred to head entries after a pellet was
delivered was significantly greater than the number of peaks that occurred when
COC was earned [F(1,20) = 6.85, p = 0.02]. This statistic came from the full
model and was 44.82 times more likely to describe the data compared to the
model where only event type was a factor.
Number of Glutamate Peaks Per Head Entries, Head Entries After
Reinforcer Delivery, and COC Earned/Eat Head Entries
Figure 2.19 shows the behavior exhibited to head entries, head entries
after reinforcer delivery, and to COC earned and head entries associated with
eating as well as the number of glutamate peaks that occurred per each of those
events. Note that the behavior is the same as seen in Figure 2.18 and is only
shown in Figure 2.19 for purposes of comparison.
Figure 2.19A (right) shows that there are no statistical differences between
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the number of glutamate peaks that occurred per COC and food head entries
[F(1,19.34) = 4.10, p = 0.06]. This statistic came from the model with only event
type included as a factor, which had the lowest AIC and was 4.01 times more
likely to describe the data compared to the model where only brain region was a
factor.
Figure 2.19B (right) shows that there were no statistical difference in the
number of glutamate peaks that occurred per head entries during/after COC
infusions or after a food pellet was delivered [F(1,14.91) = 0.26, p = 0.62]. This
statistic came from the model where only event type was included as a factor,
which had the lowest AIC and was 1.03 times more likely to describe the data
compared to the model that included only brain region as a factor.
Figure 2.19C (right) shows that the number of glutamate peaks that
occurred per COC reinforcer earned was significantly greater than the number of
glutamate peaks that occurred per eating response [F(1,19.91) = 85.71, p <
0.0001]. This statistic came from the model where only event type was included
as a factor and was 57.69 times more likely to describe the data compared to the
full model.
The Number of Glutamate Peaks Are Correlated With Head Entries, Head
Entries After Reinforcer Delivery, and COC Earned/Eat Head Entries
Figure 2.20 shows correlations between the number of COC and food
head entries and the number of glutamate peaks that occurred to each type of
head entry as well as the number or glutamate peaks that occurred per each
head entry. Specifically, Figure 2.20A (left) shows a significant positive
correlation between the number of glutamate peaks that occurred to head entries
during COC components and the number of COC head entries that occurred (r =
0.95, p < 0.0001). Figure 2.20A (right) shows that the number of glutamate peaks
that occurred per COC head entry and the number of COC head entries that
occurred were not correlated (r = -0.32, p = 0.24). Figure 2.20B (left) shows a
significant positive correlation between the number of glutamate peaks that
occurred to head entries during food components and the number of food head
entries that occurred (r = 0.93, p < 0.0001). Figure 2.20B (right) shows that there
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was no correlation between the number of glutamate peaks that occurred per
food head entry and the number of food head entries that occurred (r = -0.21, p =
0.87).
Figure 2.21 shows correlations between the number of COC and food
head entries that occurred after reinforcer delivery and the number of glutamate
peaks that occurred to each type of head entry as well as the number or
glutamate peaks that occurred per each head entry. Specifically, Figure 2.21A
(left) shows a significant positive correlation between the number of glutamate
peaks that occurred to head entries during/after a COC infusion and the number
of COC infusion head entries that occurred (r = 0.82, p < 0.0001). Figure 2.21A
(right) shows that the number of glutamate peaks that occurred per COC infusion
head entry and the number of COC infusion head entries that occurred are not
correlated (r = -0.13, p = 0.63). Figure 2.21B (left) shows a significant positive
correlation between the number of glutamate peaks that occurred to food head
entries after a pellet was delivered and the number of food pellet head entries
that occurred (r = 0.91, p < 0.0001). Figure 2.21B (right) shows that there was no
correlation between the number of glutamate peaks that occurred per food pellet
head entry and the number of food pellet head entries that occurred (r = -0.21, p
= 0.87).
Glutamate Peaks Percent Increase From Baseline for Lever Presses,
Reinforcers Earned, and Inactive Lever Presses
Figure 2.22 shows the behavioral events that occurred to lever presses,
reinforcers, and inactive lever presses and the percent increase from baseline of
the glutamate peaks to the different behavioral events. Note that the behavior is
the same as seen in Figure 2.13 and thus was already statistically analyzed and
is only shown in Figure 2.22 for purposes of comparison. Specifically, Figure
2.22A (right) shows the percent increase from baseline of the glutamate peaks to
responses on the COC and food lever. No statistical differences were observed
[F(1,20) = 1.71, p = 0.21]. This statistic came from the full model, which had the
lowest AIC and was 11.36 times more likely to describe the data than the model
with only brain region as a factor.
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Figure 2.22B (right) shows a significant main effect of event type where
there was a greater percent increase above baseline for glutamate peaks when
COC was earned compared to when food was earned [F(1,19.56) = 5.03, p =
0.037]. This statistic came from the full model, which had the lowest AIC and was
10.33 times more likely to describe the data than the model with only event type
as a factor.
Figure 2.22C (right) shows that there were no statistical differences in the
percent increase for glutamate peaks above baseline for inactive lever presses
[F(1,17.12) = 0.40, p = 0.54]. This statistic came from the full model, which had
the lowest AIC and was 18.08 times more likely to describe the data than the
model with only brain region as a factor.
Glutamate Peaks Percent Increase From Baseline for Head Entries, Head
Entries After Reinforcer Delivery, and COC Earned/Eat Head Entries
Figure 2.23 shows the behavioral events that occurred to food receptacle
head entries, head entries associated with COC infusions and eating, and COC
earned and eating and the percent increase from baseline of the glutamate
peaks to the different behavioral events. Note that the behavior is the same as
seen in Figure 2.18 and is only shown in Figure 2.23 for purposes of comparison.
Specifically, Figure 2.23A (right) shows the percent increase from baseline of the
glutamate peaks for COC and food head entries. There was an event type x
brain region interaction with a greater percent increase seen to COC head
entries compared to food head entries in the PrL [F(1,14.64) = 9.39, p = 0.008].
This statistic came from the full model, which had the lowest AIC and was 363.22
times more likely to describe the data than the model with only brain region as a
factor.
Figure 2.23B (right) shows that there were no percent baseline differences
in glutamate to eat head entries and COC infusion head entries [F(1,14.2) = 2.47,
p = 0.14]. The model with the lowest AIC was the full model; however, the ΔAIC
between the best model and second best model was lower than 4. Thus, the
simpler of the two models (event type only as a factor) was selected.
Figure 2.23C (right) shows that there were no statistical differences in the
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percent increase from baseline for glutamate peaks between eating head entries
and COC earned [F(1,17.64) = 2.25, p = 0.15]. The model with the lowest AIC
was the full model; however, the ΔAIC between the best model and second best
model was lower than 4. Thus, the simpler of the two models (event type only as
a factor) was selected.
Discussion
To the knowledge of the author this is the first study to examine how COC
affects glutamatergic signaling in the PrL and NAcC compared to a natural
reinforcer (food) within subject using a multiple schedule procedure. The results
from this experiment showed differential glutamate signaling to COC and food
related behavioral responses with the directionality of these differences being
similar between brain regions. Specifically, it was found that the percentage of
glutamate peaks related to COC or food behavioral events was roughly equal
between the PrL and NAcC. Within each brain region, it was also observed that
the percentage of glutamate peaks related to food behavioral events was
approximately 2.5 times greater than the percentage of glutamate peaks related
to COC behavioral events. Overall, the number of COC behavioral events was
positively correlated with the number of glutamate peaks that occurred to COC
behavioral events, and the number of food behavioral events was positively
correlated with the number of glutamate peaks found to food behavioral events.
Interestingly, this trend tended to reverse when correlating behavioral responses
with the number of glutamate peaks that occurred per response. Thus, the
number of glutamate peaks that occurred per behavioral response generally
increased as the number of behavioral responses decreased; this relationship
was most pronounced with COC lever presses and when the COC reinforcer was
earned. Lastly, it was also found that there was a greater percent increase from
baseline in glutamate when COC was earned compared to when food was
earned.
Previous work has shown that glutamate neurotransmission in the NAcC
and the PrL are involved in drug seeking and relapse (McFarland et al., 2003;
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Kalivas et al., 2005). Specifically, evidence suggests that the glutamate
projections from the PrL to the NAcC and ventral tagmental area (VTA) are
especially important in promoting drug seeking and cue-induced relapse (Kalivas,
2004). For example, pharmacological inhibition of the prefrontal cortex prevents
cue-induced reinstatement and associated glutamate release in the NAcC
(McFarland et al., 2003; McLaughlin & See, 2003). Further, evidence suggests
that COC induced reinstatement increases glutamate release in the NAcC
(Kalivas, 2009; Pendyam et al., 2009). In this study, after every session, the rats
went approximately 24 hours without drug, which could have caused a
withdrawal state. Thus, when the rats began to self-administer COC, it could be
thought of as similar to COC primed reinstatement. This could account for the
increased glutamate release observed to COC delivery compared to food
delivery (Figure 2.22B). Evidence also suggests that COC self-administration
increases glutamate levels above baseline after approximately 60 minutes in rats
chronically exposed to COC (Miguens et al., 2007). The sessions here were
approximately 82 minutes; thus, the observed increase in glutamate is also in line
with previous self-administration studies. Further, considering the link between
the PrL and NAcC in drug-seeking behavior (e.g. McFarland et al., 2003;
McLaughlin & See, 2003) it is not surprising that glutamate release was in the
same direction in both brain regions. It is worth noting that an increase in
glutamate release above baseline was observed to COC delivery even though
more food was earned than COC on average (Figure 2.22B). This disparity
between glutamate signaling and behavior suggests that the increase in
glutamate release observed is specific to COC and is not just due to the number
of reinforcers earned. Note that differences in the number of glutamate peaks
that occurred to behavioral events were also found.
A significant increase in the number of glutamate peaks was observed to
food events compared to COC events (Figure 2.9B, Figure 2.12A, Figure 2.13,
and Figure 2.18). This result is somewhat contradictory to the studies that show
an increase in the probability of glutamate release during COC reinstatement and
self-administration compared to food controls (Moran et al., 2005; Madayag et
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al., 2007; Miguens et al., 2007; Kalivas 2009). However, as mentioned, most
studies looking at the effects of COC on glutamate use separate animals for
experimental (COC) and control (food/saline) conditions (e.g. McFarland et al.,
2003; Miguens et al., 2007). Thus, the increase in the number of glutamate
events to food related behavioral events compared to COC related behavioral
events observed here could be due to the fact that all animals in this study were
exposed to both reinforcers. Further, using multiple schedules, Carelli et al.
(2000, 2002) found that neural populations in the NAc showed differential firing
patterns to COC vs. natural reinforcers. However, in the Carelli study,
electrophysiology was used; thus, what type of cells (dopaminergic, GABAergic,
glutamatergic, etc.) were more active to COC vs. the natural reinforcer is
unknown. Considering this fact, it is possible (albeit unlikely) that glutamatergic
cells fire more frequently to food compared to COC, which may explain the
results presented here. In fact, there is evidence that food-related events cause
glutamate release in the PrL and NAcC (e.g. Batten et al., 2018), which gives
some support to this idea. However, it is more likely that more glutamate peaks
were observed to food events compared to COC events due to the fact that
animals on average had more history with food than COC (Figure 2.9A; Figure
2.13A/B). This is especially so considering that differential reinforcer experience
has been shown to affect drug/food preference and corresponding brain activity
compared to when reinforcer history is held constant (Chow 2018; Beckmann et
al., 2019). However, more research will need to be conducted to adequately
explain the discrepancies between these results and the current literature.
Another important finding in this study was that the number of glutamate
peaks that occurred to a given behavioral event was positively correlated to that
respective event (Figure 2.10). This finding is similar to glutamate measures
taken from the basolateral amygdala and OFC in other behavioral paradigms
(Malvaez et al., 2015, Malvaez et al., 2019). However, while these results are
reassuring, they should be interpreted with caution because it is possible that the
number of glutamate peaks increased simply because the amount of behavior
increased. Thus, it could be that more glutamate peaks were more likely to be
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found simply because more behavior occurred. That being said, there is
evidence that the NAcC does not participate in the processing of movements
(Schultz et al., 1992; Carelli & Deadwyler, 1997). Also, the relationship between
the number of glutamate peaks and the number of behavioral responses was not
1:1 suggesting that the number of glutamate peaks may be encoding something
other than just movement. Further, the correlation for inactive lever presses (an
action that could be considered to have less value in the current paradigm;
Figure 2.17) was generally stronger (albeit not by much) than those associated
with a reinforcer (lever presses, delivery; Figure 2.15 and Figure 2.16). Thus, this
could indicate that the number of glutamate peaks for inactive lever presses has
more to do with motor responses whereas reinforcer-related responses have to
do with motor activity as well as the value of the action. The fact that there were
statistical differences to reinforcer related lever presses but not inactive lever
presses lends some support to this idea (Figure 2.13A/C). Further, the number of
peaks that occurred to the start of the food component was greater than the
number of peaks that occurred to the start of the COC component (Figure
2.12A). Considering that there were an equal number of COC and food
components it would suggest that this difference is not simply due to the number
of components that occurred. While not completely comparable to other behavior
(when the component starts the animal is not engaging in a programmed
response) it suggests that the number of glutamate peaks is encoding something
more than just responses. Nevertheless, these results have the potential to be
confounded.
In an attempt to control for the problematic nature of the number of peaks
analysis discussed above we divided the number of glutamate peaks that
occurred to a specific event by the number of responses that occurred.
Standardizing the number of peaks to the number of behavioral responses in
theory should control for the disproportionate number of responses between
event types thus creating a measure that is less confounded by the amount of
behavior. The number of glutamate peaks that occurred per response type is
informative in two ways: (1) the measure creates quick metric for assessing how
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the number of peaks and behavior are directly related (i.e. less than 1 means
there were a greater number of behavioral responses than peaks, equal to 1
means that the number of behavioral responses and the number of peaks were
equal, and greater than 1 means that more peaks were observed than behavioral
responses) and (2) shows the number of glutamate peaks that occurred per a
behavioral event (on average). Interestingly, when the data were expressed as
the number of glutamate peaks that occurred per event type (Figure 2.14 and
Figure 2.19) more glutamate peaks were observed per COC lever press and per
COC reinforcer earned. Thus, even though more glutamate peaks are associated
with food lever presses overall, there are more glutamate peaks generated per a
single COC lever press and per a COC reinforcer. Thus, when looking at this
measure, there is a dissociation between behavior and glutamatergic activity.
This result is similar to what has previously been found in the literature (e.g.
McFarland et al., 2003; Miguens et al., 2007; Kalivas, 2009 for review) in that
chronic exposure to COC causes an increase in the probability of synaptic
glutamate release.
As mentioned, the number of glutamate peaks to a behavioral event is
positively correlated with the number of responses that occurred (Figures 2.10
[left]). However, the number of glutamate peaks that occurred per behavioral
event was either not correlated or was negatively correlated with the number of
behavioral responses that occurred (Figures 2.10 [right]). For example, there
seems to be no relationship between the number of glutamate peaks that
happened per COC lever press and the number of COC lever presses that
occurred (Figure 2.15A [right]). However, there is a significant negative
correlation between the number of glutamate peaks that occurred per food lever
press and the number of food lever presses that were exhibited (Figure 2.15B
[right]). This suggests that as the number of food responses decreased the
number of glutamate peaks that occurred per food lever press increased.
Conversely, the relationship between reinforcers earned was switched; thus, as
the number of COC reinforcers decreased the number of glutamate peaks
observed per COC reinforcer increased (Figure 2.16A [right]). This relationship is
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counterintuitive based on previous literature showing positive correlations
between glutamate and behavior using a similar ‘rate’ measure (Malvaez et al.,
2015). However, based on previously mentioned research, it is likely more peaks
are seen per COC event due to the pharmacology of the drug. Nevertheless,
more research needs to be conducted in order to better understand this
relationship.
As highlighted above a potential weakness of this study is in interpreting
the meaning of glutamate frequency data in relation to behavior. While effort was
taken separate frequency of release and frequency of behavior, it is likely that
these measures are still partially confounded. Thus, it is difficult to say for certain
that there were reinforcer specific effects. Further, even though animals were
exposed to both reinforcers they could still only respond for one reinforcer at a
time. Also, the reinforcer histories were not controlled. These latter two factors
make it difficult to say anything about brain representations of value in relation to
these two reinforcers or the actions taken to earn them. It is also worth noting
that all glutamate measurements in these experiments were taken from the right
hemisphere of both brain regions. However, others (e.g. McFarland et al., 2003;
LaLumiere et al., 2008) have conducted similar experiments and have collected
their data by either counterbalancing hemispheres or collapsing data from both
hemispheres into a single data point. Thus, these previous studies suggest that
robust hemispheric differences in glutamate signaling do not exist in the PrL and
NAcC at least in relation to appetitive behavior. Therefore, only having right
hemisphere data in this study likely did not skew these results.
In conclusion, the results presented here show that the percentage of
glutamate peaks found between the PrL and NAcC are approximately equal.
Within a given brain region a larger percentage of glutamate peaks were found to
food related events compared to COC related events. Likewise out of all the
glutamate peaks found to behavioral events, the majority were related to foodassociated behavior. Overall, there were no differences in glutamate signaling
between brain regions; however, there was evidence of glutamate specific
signaling to different behavioral events. Namely, more glutamate peaks were
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observed to food lever presses than COC lever presses. However, the number of
glutamate peaks that occurred per COC lever presses was greater than the
number that occurred per food lever press. Similarly, the number of glutamate
peaks that occurred per COC reinforcer earned was greater than the number that
occurred per food reinforcer earned. There was also a significant percent
increase above baseline in glutamate when the COC reinforcer was earned
compared to when the food reinforcer was earned. Taken together, these data
suggest that differential glutamate signaling does exist between COC and food
related events in the PrL and NAcC.
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Figure 2.1 Biosensor Setup & Implantation
(A) Example of an implantable biosensor highlighting the different components
of the headcap and the overall size (~ 2.2 cm). (B) S2 Biosensor Image. Green
shaded sites: contain GluOx and thus can generate hydrogen peroxide (H2O2)
from glutamate, which can be oxidized by the biosensor. Blue shaded sites:
sentinel sites that contain an inert protein matrix and thus can only measure
background current but not glutamate; the sentinel sites are subtracted from the
glutamate recording sites to acquire basal glutamate levels in the brain (termed
self-referencing). mPD excludes ascorbic acid (AA) and other large molecules
(DA; DOPAC) by size thus stopping them from reaching the platinum recording
surfaces. (C) An example of a rat with a glutamate biosensor implant and an
indwelling backmount catheter. Note that the animal is hooked up to the FAST
recording system and drug syringe pump.
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Figure 2.2 Glutamate Biosensor Placements
The black circles represent the approximate placement of the tip of the glutamate
biosensor for each subject (n = 11/brain region) in (A) The prelimbic cortex (PrL)
and (B) The nucleus accumbens core (NAcC).
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Figure 2.3 Glutamate Traces to COC and Food Components in The PrL and
NAcC
(A) Example of a glutamate trace during a COC component (left) and a food
component (right) from the PrL. (B) Example of a glutamate trace during a COC
component (left) and a food component (right) from the NAcC. Note that the red
lines above the traces indicate all locations where a glutamate peak was
detected.
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Figure 2.4 Glutamate Traces to COC and Food Events in The PrL and NAcC
(A) Example of a glutamate trace during a COC event (left) and a food event
(right) from the PrL. (B) Example of a glutamate trace during a COC event (left)
and a food event (right) from the NAcC. Note that the black-hatched lines
represent lever presses and the red- and green-hatched lines represent COC
infusions and food deliveries, respectively. The black triangles represent
glutamate peaks associated with lever presses. The red triangles represent
glutamate peaks associated with a COC infusion. The green triangles represent
glutamate peaks associated with earned food pellets. Note that there are no
black or green triangles on the PrL food trace because, due to the timing of
events, the only peaks found were to the responses/reinforcer.
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Figure 2.5 Overall Discrimination Ratios For Baseline & Recording
Behavior
The overall discrimination ratios for baseline behavior (session before biosensor
implantation) and for behavior during glutamate recordings were significantly
greater than 75%. One-sample t-test, *p < 0.05. Data represented as mean ±
SEM.
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Figure 2.6 Discrimination Ratios for COC and Food Components for
Baseline & Recording Behavior
(A) Baseline behavior discrimination ratios during the COC component and the
food component were significantly greater than 50%. (B) Recording behavior
discrimination ratios during the COC component and the food component were
significantly greater than 50%. One-sample t-test, *p < 0.05. Data represented as
mean ± SEM.
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Figure 2.7 Total Number of Glutamate Peaks Found To Behavioral Events in
Each Component vs. The Total Number of Peaks Found in Each
Component
(A) Significantly more glutamate peaks were found to behavioral events during
food components compared to COC components. (B) Significantly more
glutamate peaks were found overall (not just those related to behavioral events)
during COC components compared to food components. LME, *p < 0.05. Data
represented as mean ± SEM.
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Figure 2.8 The Percentage of Glutamate Peaks Related to Behavioral
Events Relative to The Total Number of Glutamate Peaks Found in Both
Brain Regions
(A) Roughly an equal number of glutamate peaks were found to behavioral
events between the PrL and the NAcC. (B) More glutamate peaks were found to
food related events compared to COC related events in the PrL. (C) More
glutamate peaks were found to food related events compared to COC related
events in the NAcC. Note that the distribution of peaks to COC and food related
events are roughly equal between brain regions.
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Figure 2.9 Total Number of Behavioral Events & Total Number of Glutamate
Peaks to Behavioral Events During Components
(A) Significantly more behavior was exhibited during food components compared
to COC components in rats with biosensors implanted in both brain regions. (B)
Significantly more glutamate peaks were observed to food related events
compared to COC related events in rats with biosensors implanted in both brain
regions. LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 2.10 Correlation Between Total Number of Glutamate Peaks to
Behavioral Events & Total Number of Behavioral Events
(A) The total number of glutamate peaks found to behavioral events for COC
during a session and the total number of COC behavioral events that occurred in
a session was significantly positively correlated (left); the number of glutamate
peaks that occur per COC event was significantly negatively correlated with the
number of COC responses (right). (B) The total number of glutamate peaks
found to food behavioral events during a session and the total number of food
behavioral events that occurred during a session were significantly positively
correlated (left); the number of glutamate peaks that occurred per food event was
significantly negatively correlated with the number of food responses (right). Note
the difference in scale between COC and food. Linear regression, *p < 0.05.
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Figure 2.11 Distribution of Glutamate Peaks To Behavioral Events
(A) The percentage of glutamate peaks that occurred was greater to the
beginning of the food components compared to the beginning of the COC
components. (B) The percentage of glutamate peaks that occurred was greater
to responses on the food lever compared to responses on the COC lever. (C)
There were no statistical differences in the percentage of glutamate peaks that
occurred when COC was earned compared to when food was earned. (D) A
greater percentage of glutamate peaks occurred to head entries into the food
receptacle during food components compared to head entries during COC
components. (E) A significantly greater percentage of glutamate peaks occurred
to head entries related to eating compared to head entries after COC infusions.
(F) No statistical differences were observed to inactive lever presses during the
COC and food components. LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 2.12 Number of Glutamate Peaks That Occurred To The Beginning of
COC and Food Components
(A) Significantly more glutamate peaks occurred to the beginning of food
components compared to the beginning of COC components. (B) Significantly
more glutamate peaks per component occurred to the beginning of the food
components compared to the beginning of the COC components. LME, *p <
0.05. Data represented as mean ± SEM.
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Figure 2.13 The Number of Glutamate Peaks That Occurred to Lever
Presses, Reinforcers, & Inactive Lever Presses
(A) Significantly more food lever presses were observed compared to COC lever
presses (left); a greater number of glutamate peaks occurred to food lever
presses compared to COC lever presses (right). (B) Significantly more food
reinforcers were earned compared to COC reinforcers (left); there were no
differences in the number of glutamate peaks that occurred between COC and
food reinforcers (right). (C) There were no differences in the number of COC or
food inactive lever presses (left); there were no differences in the number of
glutamate peaks that occurred between COC and food inactive lever presses
(right). LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 2.14 The Number of Glutamate Peaks That Occurred Per Behavioral
Event for Lever Presses, Reinforcers, & Inactive Lever Presses
(A) A greater number of glutamate peaks occurred per COC lever press
compared to per food lever press. (B) A greater number of glutamate peaks
occurred per COC reinforcer compared to per food reinforcer. (C) There were no
differences in the number of glutamate peaks that occurred per inactive lever
press. LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 2.15 Correlations Between The Number of Glutamate Peaks & The
Number of Lever Presses That Occurred for COC and Food Responses
(A) There was a significant positive correlation between the number of glutamate
peaks observed and the number of COC events that occurred (left); there was no
correlation between the number of glutamate peaks observed per COC lever
press and the number of COC lever presses that occurred (right). (B) There was
a significant positive correlation between the number of glutamate peaks that
were observed to food lever presses and the number of food lever presses that
occurred (left); there was a significant negative correlation between the number
of glutamate peaks observed per food lever press and the number of food lever
presses that occurred (right). Note the difference in scale between COC and
food. Linear regression, *p < 0.05.
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Figure 2.16 The Number of Glutamate Peaks That Occurred to COC and
Food Reinforcers
(A) The number of glutamate peaks observed to COC reinforcers was positively
correlated with the number of COC reinforcers earned (left); the number of
glutamate peaks that occurred per COC reinforcer was significantly negatively
correlated with the number of COC reinforcers that occurred (right). (B) The
number of glutamate peaks observed was significantly positively correlated with
the number of food reinforcers earned (left); there was no correlation between
the number of glutamate peaks observed per food reinforcer and the number of
food reinforcers earned (right). Note the difference in scale between COC and
food. Linear regression, *p < 0.05.
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Figure 2.17 The Number of Glutamate Peaks That Occurred to COC and
Food Inactive Lever Presses
(A) The number of glutamate peaks observed to COC inactive lever presses was
positively correlated with the number of COC inactive lever presses that occurred
(left); the number of glutamate peaks observed per COC inactive lever press was
not correlated with the number of COC inactive lever presses that occurred
(right). (B) The number of glutamate peaks observed was significantly positively
correlated with the number of food inactive lever presses that occurred (left);
there was no correlation between the number of glutamate peaks observed per
food inactive lever press and the number of food inactive lever presses that
occurred (right). Note the difference in scale between COC and food. Linear
regression, *p < 0.05.
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Figure 2.18 The Number of Glutamate Peaks That Occurred to Head Entries,
Head Entries After Reinforcers, & COC Earned vs. Eating
(A) No differences were observed between COC and food head entry responses
(left); the number of glutamate peaks that occurred was greater for food head
entries compared to COC head entries (right). (B) Significantly more head entry
responses occurred after a food pellet was delivered compared to when a COC
infusion was earned (left); the number of glutamate peaks that occurred to head
entries after a pellet was delivered was greater than head entries during/after a
COC infusion (right). (C) Significantly more head entries occurred after a food
pellet was delivered compared to the number of COC reinforcers earned (left);
significantly more glutamate peaks were observed to eating responses than to
COC infusions earned (right). LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 2.19 The Number of Glutamate Peaks That Occurred Per Behavioral
Event for Head Entries, Head Entries After Reinforcers, & COC Earned vs.
Eating
(A) No differences were observed for the number of glutamate peaks that
occurred per head entry responses (right). (B) No differences were observed in
the number of glutamate peaks that occurred per head entries after reinforcer
delivery (right). (C) More glutamate peaks were observed per COC reinforcer
earned compared to eating responses (right). LME, *p < 0.05. Data represented
as mean ± SEM.
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Figure 2.20 The Number of Glutamate Peaks That Occurred to COC and
Food Head Entries During Components
(A) The number of glutamate peaks observed to COC head entries was
positively correlated with the number of COC head entries that occurred (left);
The number of glutamate peaks that occurred per COC head entry was not
correlated with the number of COC head entries that occurred (right). (B) The
number of glutamate peaks observed to food head entries was significantly
positively correlated with the number of food head entries that occurred (left);
there was no correlation between the number of glutamate peaks that occurred
per food head entry and the number of food head entries that occurred (right).
Note the difference in scale between COC and food. Linear regression, *p < 0.05.
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Figure 2.21 The Number of Glutamate Peaks That Occurred to COC and
Food Head Entries After Reinforcer Delivery
(A) The number of glutamate peaks observed to COC head entries after COC
infusions was positively correlated with the number of COC infusion head entries
that occurred (left); The number of glutamate peaks that occurred per COC
infusion head entry was not correlated with the number of COC infusion head
entries that occurred (right). (B) The number of glutamate peaks to food pellet
head entries was significantly positively correlated with the number of food pellet
head entries that occurred (left); there was no correlation between the number of
glutamate peaks that occurred per food pellet head entry and the number of food
pellet head entries that occurred (right). Note the difference in scale between
COC and food. Linear regression, *p < 0.05.
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Figure 2.22 Percent Increase From Baseline For Glutamate Peaks to Lever
Presses, Reinforcers, & Inactive Lever Presses
(A) No percent baseline glutamate differences were observed in relation to lever
presses (right). (B) A greater percent increase from baseline was seen when the
COC reinforcer was earned compared to the food reinforcer (right). (C) No
percent baseline glutamate differences were observed in relation to inactive lever
presses (right). LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 2.23 Percent Increase From Baseline For Glutamate Peaks to Head
Entries, Eat/Infusion Head Entries, & COC Earned/Eat Head Entries
(A) A greater increase in the glutamate percent baseline was observed to COC
head entries compared to food head entries in the PrL (right). (B) No percent
baseline differences were observed to head entries after/during COC infusions or
after a food pellet was delivered (right). (C) No differences in percent baseline
glutamate measures were observed between COC earned and eat head entries
(right). LME, *p < 0.05. Data represented as mean ± SEM.
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CHAPTER 3
INTRODUCTION TO OXYGEN DYNAMICS AND DECISION-MAKING IN
COCAINE-USE DISORDER
Choice Behavior in Cocaine-Use Disorder
In recent years, researchers have begun to use choice measures to
assess the relative value of drug reinforcers in both animals and humans (Rush
et al., 2010; Thomsen et al., 2013; Banks et al., 2015), promoting a translational
understanding of mechanisms that govern drug-associated choice behavior.
Furthermore, there is increasing evidence that the somewhat commonplace
notion that substance abuse is governed by compulsive, habitual-like response
relations that are insensitive to alternative consequences (Volkow and Morales,
2015) is incompatible with drug-associated choice behavior. For example, the
current most effective behavioral and pharmacological treatments for human
stimulant abuse disorders are based on offering either a non-pharmacological
(contingency management; Schierenberg et al., 2012) or pharmacological
(replacement therapy; Stoops and Rush, 2013) alternative to the abused
stimulant, indicating sensitivity to alternative consequences. In preclinical
models, conditions thought to produce compulsive, habit-like drug taking do not
readily alter drug-associated choice behavior (Ahmed, 2010), and choice
behavior is resistant to compulsive, habit-like response relations (Kosaki and
Dickinson, 2010). Although it is clear that choice behavior is heavily linked to
substance-use disorder and treatment sensitivity, the neurobehavioral
mechanisms that govern drug-associated decision-making, including how the
brain encodes and weighs valuations for both drug and non-drug reinforcers, is
currently unknown.
Evidence suggests that both the limbic system and prefrontal areas of the
brain are important in value-based decision-making (for review Kable & Glimcher,
2009). Specifically, the nucleus accumbens (NAc) and orbitofrontal cortex (OFC)
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are particularly important in the creation and weighing of subjective value signals
(for review Shultz, 1997; Padoa-Schioppa, 2007; O’Doherty et al., 2017). For
example, electrophysiology recordings from the NAc show that different neuronal
populations respond to natural rewards vs. cocaine when the two reinforcers are
presented in isolation (Carelli, 2002). Further, choice data suggests that
dopamine release in the NAc tracks choices that result in a higher magnitude
reward (Sackett et al., 2017). Similarly, electrophysiology studies in non-human
primates show that neurons in the OFC may represent both the ‘offer value’ and
the ‘chosen value’ of two qualitatively different goods of varying magnitudes
(Padoa-Schioppa, 2007). Further, choice data from rodents suggest that different
neuronal populations in the OFC respond to saccharin vs. cocaine and that an
increase in either of these populations firing rates precedes the chosen option
(Guillem & Ahmed, 2017). Collectively, the aforementioned findings suggest that
the NAc and the OFC are involved in value-based decision-making processes in
general and in relation to choices involving drugs of abuse.
A general proxy for increased neuronal activity in a given brain region is
increased oxygen consumption (Ogawa et al., 1992). Further, direct measures of
oxygen in the rodent brain produce similar results as human studies using bloodoxygenated-level-dependent (BOLD) functional magnetic resonance imaging
(fMRI) thus showing translational viability (Francois et al., 2016; Li et al., 2016).
For example, research from rodents where BOLD signals and oxygen measures
were obtained simultaneously shows that these two measures are strongly
correlated (r = 0.8; Lowry et al., 2010). Further, oxygen data collected in freelymoving rats shows that oxygen measures from the NAc are sensitive to reward
receipt and changes in reward magnitude (Francois et al., 2012). Similarly,
differential oxygen signaling is seen in the NAc and the prefrontal cortex to food
predictive and non-predictive discriminative stimuli suggesting that oxygen
measures are also sensitive to changes in reward-related events between brain
regions (Francois et al., 2014). Thus, measuring oxygen should help further
elucidate the role of certain brain regions in decision-making.
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Herein decision-making processes are reviewed including mathematical
models used to further understand choice behavior. Neurobiological mechanisms
of choice are then discussed with a special focus on the role of the OFC. The use
of oxygen as a measure of brain activity is then discussed. This chapter
concludes by tying together decision-making processes with what is known about
OFC function in cocaine abuse as well as briefly describing the proposed
experiments.
Mechanisms of Choice Behavior: An Overview
A formal study of choice did not come about until Blaise Pascal published
his work, Pensées (1670). However, it was not until Adam Smith published The
Wealth of Nations (1776) that the field of study known as classical economics
began. The ideas set forth in classical economics were then refined by Vilfredo
Pareto (1906) whose work began the neoclassical revolution. Neoclassical
economists such as Paul Samuleson (1938), von Neumann and Morgenstern
(1944), and Hendrik Houthhakker (1950) further refined the ideas of early
economists by making models of utility, choice, and preference more
parsimonious. However, the later work of the psychologists Daniel Kahneman
and Amos Tversky (1979) presented new ideas on choice behavior in an attempt
to better explain discrepancies observed between neoclassical models and
actual human decisions, ideas that later developed into the field of behavioral
economics. Recently, the emerging field of neuroeconomics have used the
principles of neoclassical and behavioral economics and taken them a step
further by attempting to understand how the brain functions to make decisions.
Here the basics of what is known about how organisms make choices
from an economic and psychological perspective are discussed. A specific focus
is given to the idea of utility and the neoclassical framework (economic
perspective) and the matching law (behavioral perspective) because these ideas
serve as a foundation for this section of the dissertation. The neuroeconomic
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view of choice is also discussed with a special focus on the role of the OFC in
decision-making processes.
The Economic Perspective of Choice
There are many basic economic principles and economic theories geared
toward understanding choice. To discuss all economic principles and theories is
out of the scope of this dissertation. Thus, here I focus on two major economic
components: utility and the general perspective of neoclassical economics.
Utility
Utility is defined as a hidden variable representing the amount of
satisfaction a good or service generates (Glimcher, 2001). A utility function is a
mathematical function that ranks alternatives according to their utility (Bernoulli,
1738). Historically, the utility function is represented as a monotonically
increasing, decelerating function, although it is possible for this function to take
on many forms (Glimcher, 2001). According to economic theory, utility cannot be
directly measured considering it is a hidden variable (Bernoulli, 1738). Thus, at
best, one may be able to say something about utility based on choices but not
the other way around (Samuelson, 1938). Further, the utility of goods are
considered ordinal in nature; thus, one can say that a certain good has more
utility than another (based on preference) but cannot comment on how much
more utility one good generates compared to another (Pareto, 1906).
Nevertheless, utility is a basic component of economic theory and is a principle
component of neoclassical economic models.
Neoclassical Models in Economics
Three major models are usually discussed when considering neoclassical
economics: the Weak Axiom of Revealed Preferences (WARP), the Generalized
Axiom of Revealed Preferences (GARP), and Expected Utility Theory. WARP,
developed by Paul Samuelson in the 1930’s, essentially states that if an
economic agent chooses good A over good B and never chooses good B over
good A (i.e. shows stable preference) then that subject can be described as
behaving exactly as if a utility-like representation guided their choice
(Samuelson, 1938; Glimcher, 2001; Glimcher et al., 2009). While this theory may
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seem laughably simple it was critical in advancing neoclassical thought in that it
made predictions about choice behavior and constrained the concept of utility
(i.e. stated choice conditions in which you could construct an ordinal scale of
utilities). Importantly, WARP created a more parsimonious framework for
economics that could be used and extended upon to better predict a subject’s
choices.
In the 1940’s Hendrik Houthhakker extended the ideas set forth in WARP
by developing the GARP model. GARP assumes that choosers can never be
satiated and posits that if a an economic agent prefers A over B and B over C
then the same chooser indirectly prefers A over C (Houthhakker, 1950; Glimcher,
2001; Glimcher et al., 2009). Again, this model may seem extremely simple but it
advanced existing theory in two major ways: (1) it allowed for economists to
make choice predictions between pairs of objects that the subject had never
been presented with based on previous choices and (2) showed that if a subject
obeys the axioms of GARP it is the same as saying they have a monotonic utility
function. Thus, GARP extended predictions to choice sets that subjects had yet
to encounter and suggested the class of utility functions that were being used to
guide these choices. However, there are still shortcomings of GARP, namely that
it does not create a framework to understand choice under uncertainty.
Starting with essentially the same core features of GARP, von Newman
and Morgenstern (1944) developed Expected Utility Theory in an attempt to
describe choices under uncertainty. In developing their theory these economists
added three additional pieces to the core axioms of GARP. First, these scholars
defined the objects of probabilistic choice, which is formally called a “lottery” (von
Newman and Morgenstern, 1944; Glimcher, 2001). In their terms, a lottery is
composed of a probability and a value (e.g. 25% [probability] of gaining a single
good [value]). Second, they proposed the continuity axiom, which states that if a
chooser prefers A to B and B to C then preference should not change if there is a
probability p of winning A to winning B with certainty plus C with a probability 1-p
(von Newman and Morgenstern, 1944; Glimcher, 2001). The third axiom
proposed was the independence axiom that states that if a chooser prefers some
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probability of A to some probability of B then an irrelevant option added to both
sides of the choice relation will not change preference (von Newman and
Morgenstern, 1944; Glimcher, 2001). Expected Utility adds two major advances
in understanding choices for those that follow its axioms: first, a chooser behaves
as if they make choices by calculating the product of probability and utility;
second, by observing the choices one makes between two goods at different
probabilities it allows one to measure how much more one good is preferred over
the other (e.g. if a chooser prefers 50% chance of A to 100% chance of B then
they prefer A twice as much; Glimcher, 2001). This last point is important
because it strengthens the cardinal notion of utility and mostly circumvents
treating utilities as only ordinal objects (see Glimcher, 2001 for a discussion on
this topic).
All three of these neoclassical theories have three major principles in
common (principles that are seen in just about every aspect of modern economic
thought). The first is that economic theories assume that subjects have stable
preferences. Second, these theories assume that all economic agents are errorfree choosers. Third, economists assume that choosers behave to maximize their
utility given the behavior of others and thus yield equilibrium behavior (Santos &
Chen, 2009). Thus, what these theories and their axioms propose is the idea of
how a given economic agent should distribute their choices in a given setting. If
said agent chooses in a way compliant with the axioms of these theories they are
considered to be rational actors.
The Rational Decision-Maker
At a basic level an economic agent is considered to be rational if they
show consistent and stable preferences between choice sets (Glimcher, 2001).
The so-called “homo economicus” is assumed to take into account available
information, probabilities of events, the potential costs and benefits in
determining preference, and to consistently make choices that maximize their
utility (for review Becker, 1976; Sen 2008; Blume & Easley, 2016). Specifically,
two basic assumptions of the rational actor are that they have complete
preferences (i.e. they either prefer A > B, B > A, or are indifferent [A = B]) and
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show transitivity in their choices (i.e. if they prefer A > B > C then they will prefer
A > C; for review Becker, 1976; Sen 2008; Blume & Easley, 2016). If an
economic agent fails to comply with the axioms of the above theories or their
assumptions then neoclassical economists view this agent as irrational in which
case the above theories are falsified for that individual and cannot accurately
describe their choice behavior (Glimcher, 2001; Santos & Chen, 2009). Even
though the concept of the rational actor has taken the field of economics far, it is
not without criticism on both philosophical and empirical grounds.
One weakness of the concept of the rational decision-maker is that if the
subject does not follow the discussed axioms their choice behavior cannot be
adequately described (for discussion see Glimcher, 2001). Thus, this leaves
several situations in which choice behavior cannot be predicted. More
importantly, empirical evidence suggests that, more often than not, economic
agents do not exhibit rationality in their choices (see Santos & Chen, 2009 for a
discussion of this topic). Thus, these issues suggested to scholars that new
theories on decision-making needed to be developed in order to mitigate the
aforementioned discrepancies. Generally speaking, it was scholars from the field
of psychology that worked to this end.
The Psychological Perspectives of Choice
Upon the realization that consumers regularly violate standard economic
assumptions about choice, scholars began to add concepts from psychology and
sociology to current economic theory in an attempt to formulate new concepts to
account for these violations. The study of decision-making from this perspective
has become known as behavioral economics and is best exemplified by the work
of Daniel Kahneman and Amos Tversky.
Another perspective on choice that sought to better describe the irrational
behavior observed in economics is rooted in the field of behaviorism and is best
exemplified by the work of Richard J. Herrnstein. Through laboratory
observations, Herrnstein concluded that the relative rate of responding between
two options was equal to the relative rate of reinforcement for those options, a
concept he termed matching, and whose mathematical formulation has become
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known as the matching law. Further, he described a theory that is an extension of
the matching law termed melioration. Here the concepts inherent in behavioral
economics are briefly discussed. However, most attention is given to the
matching law and its extensions because of the central role it plays in this
dissertation.
Behavioral Economics: Basic Concepts
Behavioral economics was born out of the idea that principles from
psychology could improve the neoclassical models of choice behavior (Glimcher
et al., 2009). Specifically, behavioral economics proposes models that impose
limits on rational calculation, willpower, and self-interest and aims to codify those
limits formally and explore their implications through experiments and
mathematical theory (Glimcher et al., 2009). Three major components seem to
make up the behavioral economic framework.
The first component of the behavioral economic framework was
highlighted by Kahneman and Tversky (1979) with the development of prospect
theory. Prospect theory sought to explain the discrepancies observed from
expected utility theory concerning choices made under uncertainty. Prospect
theory proposed to account for these discrepancies by: (1) framing the value of
choices as either gains or losses and (2) framing these choices in a referencedependent fashion. The implication from this theory is that decision makers
naturally frame their choices as gains or losses from a particular reference point.
The S-shaped form of this value function is such that the slope for gains is
shallower than the slope for losses. Thus, a loss will decrease value more than
an equal sized gain will increase value. The development of prospect theory
eventually led to potential explanations for why choosers are loss-averse as well
as helped to explain other phenomenon such as the reflection effect and the
endowment effect (Kahneman & Tversky, 1979; Tversky & Kahneman, 1981;
Kahneman et al., 1990).
The second component of the behavioral economic foundation deals with
heuristics or the idea that people reduce the complex task of assessing
probabilities and determining value to simple judgment rules (Tversky &
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Kahneman, 1974). Generally, heuristics can work quite well; however, they can
lead to systematic errors in judgments. An example is estimating distance based
on the clarity of an object. Usually when an object is perceived as sharp it is
thought to be closer than one that is seen as blurry. However, basing distance
estimations simply off of how sharply an object appears can cause errors in
judgment because several variables can affect an object’s clarity (e.g. weather,
light) thus causing an object to appear closer or further than it is in actuality.
Considering this idea, it was thought that understanding how choosers use
heuristics to guide their choices could provide another potential basis for better
understanding decision-making.
The third component deals with social preferences or how choosers value
choices when those choices affect other people (Glimcher at al., 2009). This
interest in social preferences developed from the observation that self-interests
hypotheses fail to predict choices when choosers are in strategic interactions
(Cramerer & Fehr, 2006). Thus, it is thought that by understanding how choosers
make choices when they are taking others’ welfare in account could strengthen
choice predictions in some arenas. Collectively, the goal of behavioral economics
is to develop mathematical systems that take these components into account in
order to explain empirical facts and make more accurate choice predictions.
The Matching Law
In 1961 Richard Herrnstein published his initial study providing evidence
for matching. In this study Herrnstein gave pigeons choices between two
concurrently available options with different variable interval schedules of
reinforcement operating on each option. Herrnstein’s independent variable was
the rate of reinforcement delivery and his dependent variable was the number of
responses for each option. He then compared the number of responses emitted
and the number of reinforcers earned across each option. What he found was
that the relative rate of responding for an alternative equaled the relative rate
reinforcement obtained for that alternative, a relationship he termed matching.
Herrnstein (1970) formally stated the aforementioned experimental results in
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what become known as the matching law. The matching law follows the following
form:
𝐵𝐵1
𝑅𝑅1
=
𝐵𝐵1 + 𝐵𝐵2
𝑅𝑅1 + 𝑅𝑅2

(3)

where B1 is the behavior (i.e. total responses) allocated to Alternative 1, B2 is the

behavior allocated to Alternative 2, R1 is the number of reinforcers earned under
Alternative 1, and R2 is the number of reinforcers earned under Alternative 2.

Research shows that equation 3 does a good job of describing choice

behavior when strict matching occurs. However, there are situations in which
equation 3 does not adequately describe choice behavior (Baum, 1974,1979).
One such situation is the occurrence of overmatching where an organism
allocates relatively more behavior to the alternative that provides more
reinforcement than would be predicted by equation 3 (Baum, 1979). Another
example is undermatching, where relatively more behavior is allocated to the
alternative that provides less reinforcement (Baum, 1974, 1979). Another
example is bias, where the amount of behavior allocated to one alternative is
higher or lower regardless of the rate of reinforcement for that alternative (Baum,
1974). Further, equation 3 was limited in describing choice behavior between
options with varying reinforcer magnitudes and varying delays to reinforcement
as well as in other choice scenarios (for review see McDowell, 2005). This fact
prompted scholars to formulate an updated matching model in order to better
describe choice behavior in the above situations. This model became known at
the generalized matching law (Baum, 1974) and takes the form:
𝐵𝐵1
𝑅𝑅 𝑎𝑎
= 𝑐𝑐 � 1 �
𝐵𝐵2
𝑅𝑅2

(4)

where B1, B2, R1, and R2 are the same as in equation 3, a is the slope, and c is

the y-intercept. Note that the generalized matching law can be modified to the

concatenated generalized matching law by adding the dimensions of reinforcer
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magnitude, delay, and/or frequency of reinforcement in order to better describe
choice situations in which these variables are manipulated (Baum & Rachlin,
1969; Rachlin, 1971; Killeen, 1972). Together, these two versions of the
matching law have been shown to accurately describe choice behavior in a
multitude of situations (see McDowell, 2005 for examples).
The matching law is an aggregate and descriptive model; thus, it can only
describe choice behavior at the molar level and cannot characterize moment-bymoment choices (Corrado et al., 2009). This contrasts with the economic models
discussed above, which are all normative, aggregate models that prescribe a
pattern of behavior for the choices at hand (Corrado et al., 2009). However, the
matching law and the economic models discussed above do share similarities in
that they are both relativistic and that the matching law, in some scholar’s
opinions (and this is contentiously debated), is consistent with utility maximization
(see Herrnstein, 2000 for a discussion of this topic). Nevertheless, there is
evidence that the matching law and its extensions better describes choice
behavior that is considered irrational by neoclassical economic theory
(Herrnstein, 2000).
In summary, the matching law is a is a descriptive, aggregate model that
characterizes choice behavior by focusing on the consequences of one act
relative to another and how choices are allocated based on these consequences.
However, even though this model is generally thought of as aggregate, with a
few simple extensions, the matching law can be extended to describe molecular
(local) choice behavior (e.g. Herrnstein & Prelec, 1991). This is a point discussed
in the next section.
Melioration: The Molecular Mechanism of Matching
Melioration can be thought of as the dynamic, choice-by-choice process
that leads to matching behavior on an aggregate molar scale (Herrnstein, 2000).
In essence melioration is thought to be the mechanism that gives rise to
matching (Commons et al., 1982). Simply stated, melioration is the concept that,
given a choice between two options, the option with the higher rate of local
reinforcement will be chosen (Herrnstein & Vaughan, 1980). For example, given
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two alternatives, if B1 earns a higher rate of reinforcement than B2 behavior will

shift toward B1. If the time distribution between B1 and B2 earn equal rates of

reinforcement then equilibrium (matching) has been reached. However, if B1

earns more reinforcement at all time allocations, then at equilibrium B1 replaces

B2 (Commons et al., 1982). Formally this relationship can be expressed as:
𝑅𝑅𝐷𝐷 =

𝑅𝑅1 𝑅𝑅2
−
𝑡𝑡1
𝑡𝑡2

(5)

where RD is the difference between local reinforcement rates for the behavior of
two alternatives, R1 is the local reinforcement obtained from alternative 1, R2 is

the local reinforcement earned from alternative 2, t1 is the time allocated to

alternative 1, and t2 is the time allocated to alternative 2. Note that when RD > 0

time allocation shifts to t1, when RD < 0 time allocation shifts towards t2, and
when RD = 0 equilibrium is reached. In the scenario where RD = 0 then:
𝑅𝑅1 𝑅𝑅2
=
𝑡𝑡1
𝑡𝑡2

(6)

thus, equation 4 is the matching law for time allocation between the two
alternatives (Commons et al., 1982).
Theoretically, melioration and maximization theory from economics are
similar in several respects. Both are hedonic, utilitarian theories to the extent that
behavior is assumed to be driven by psychological consequences. Further, both
theories involve adapting choice behavior in such a way that betters the state of
the chooser (Commons et al., 1982; Herrnstein, 1990). However, the theories
differ in that melioration calls for responding only to the difference in local
reinforcement between options whereas maximization requires the selection of
the largest aggregation of reinforcement across choices (Commons et al., 1982;
Herrnstein, 1990). Evidence also suggests that melioration does a better job of
predicting behavior particularly of the type considered irrational from a
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neoclassical economist’s point of view (Herrnstein, 1990; Herrnstein, 2000). That
being said, as with all theories, melioration does have its limitations.
One limitation of melioration, as with many behavioral psychology
theories, is that most studies employ animals as experimental subjects in a
controlled laboratory setting (Herrnstein & Heyman 1979; Herrnstein & Vaughan,
1980; Mazur, 1981; Vaughan, 1981). Thus, it is possible that the process of
melioration does not generalize to humans behaving in the marketplace.
However, as Kagel et al. (1995) discussed, it is likely that a theory that does not
accurately make predictions in more simplistic choice situations will not
generalize to more complex choice situations. Thus, by experimenting with
animals one can, at the very least, rule out inadequate theories. That being said,
there is evidence that human behavior is consistent with the theory of melioration
and matching (Tunney & Shanks, 2002). Thus, by showing that a theory holds up
across many different species, it is likely that that the theory describes a basic
process inherent to all organisms (Kagel et al., 1995).
There are also psychophysical limitations to melioration. Considering
melioration assumes that an organism compares local rates of reinforcement it
requires the organism to transform objective local rates into subjective local rates
(Commons et al., 1982). The parameters of this transformation are not known;
thus, there may be between-subject variability in this transformation that result in
different equilibrium states even though the organism is meliorating and matching
(Commons et al., 1982). In turn, an absence of knowledge about this
transformation process could decrease the predictability of this theory.
There are also limitations on the ability of melioration to describe choice
behavior across choices that result in different classes of reinforcement
(Commons et al., 1982). With a few exceptions (e.g. Miller 1976) melioration has
mostly been studied using reinforcers of single classes, which has prompted
some scientists to suggest that it cannot be extended to describe choice
situations across different types of commodities (Hursh, 1978; Rachlin et al.,
1981). However, recently, there have been experiments showing that matching
behavior holds when choice options include different classes of reinforcers (e.g.
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Hutsell et al., 2015; Beckmann et al., 2019) suggesting that this theory likely will
generalize to these types of choice situations.
In summary, melioration is thought to be the dynamic process that leads to
matching behavior on an aggregate scale. From a theoretical perspective
melioration has fundamental similarities and differences with maximization
theory. Specifically, melioration is able to describe behavior in certain choice
situations that neoclassical economic theories fail to describe. This has led to the
general idea (supported by laboratory evidence) that organism allocate their
behavior optimally when doing so also satisfies melioration and matching and
that when matching and optimization make divergent predictions, behavior is
often closer to matching than it is to maximization (Herrnstein, 1990).
Neuroeconomics: Decision-Making and The Brain
Neuroeconomics is an emerging field that uses principles from economics,
psychology, and neuroscience in order to better understand and predict
economic decisions (Zak, 2004; Glimcher et al., 2009). Neuroeconomic studies
have been conducted in order to better understand decision-making under
uncertainty, during games, and in the realm of finance (just to name a few;
Glimcher et al., 2009; Frydman & Cramerer, 2016). Generally, all of this research
aims to answer three basic questions: (1) how does the brain assign value to the
objects of choice?, (2) how does the brain compare these valuations?, and (3)
how is this value information used to produce choices? (Glimcher, 2011). What
follows are the basics of what are known about these three processes. This
section ends with a specific discussion of the role of the OFC in choice behavior
considering the scope of this dissertation.
How Might The Brain Encode Value?
Evidence suggests that the brain utilizes different valuations systems
depending on the type of options being considered (Rangel, 2009). The three
valuation systems generally discussed are those that calculate Pavlovian
valuations, habit valuations, and goal valuations (Balleine et al., 2009). Pavlovian
valuations are those that are computed in situations where outcomes occur
independent of any action, habit valuations are those computed in stimulus-
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response situations, and goal valuations are those computed in situations where
we are concerned with the outcome of an action (Balleine et al., 2009). All of
these valuations systems have specific advantages and play a role in economic
decisions (Rangel, 2009); however, to date most research has focused on goaldirected actions and their valuations (Kable & Glimcher, 2009). Due to the larger
body of research and the scope of this dissertation, only goal-directed valuations
and actions will be generally discussed.
The best way to begin to consider the concept of goal-directed value (or
valuation in general) at the level of the brain is to start with a simple thought
experiment: how would you choose between one apple and four apples? If it is
assumed that more is better than less then, on a neural level, the magnitude of
these commodities just need to be represented and compared (Levy & Glimcher,
2012). However, what if you were faced with choosing between a few fluid
ounces of water and two apples? In this case, one cannot just simply compare
the magnitude between two commodities in order to make a decision but instead
has to take into account the commodity types, their magnitudes, as well as
several different attributes (taste, health benefits, metabolic state, etc.; Levy &
Glimcher, 2012). Theoretically, all of the attributes for a given commodity have to
be transformed into a single value signal and the value signals between
commodities have to be represented on a common scale in order for
comparisons to be made and choices initiated (Glimcher, 2011; Levy & Glimcher,
2012).
Work has shown that the medial prefrontal cortex (mPFC) and the ventral
striatum encode the subjective value of both immediate and delayed rewards on
a common scale (Kable & Glimcher, 2007). Evidence has also shown that activity
in the mPFC and striatum correlate with choices associated with gains and
losses (Tom et al., 2007). Note that similar findings have also been observed in
choices involving risk and ambiguity (Levy et al., 2009). Evidence also suggests
that neurons in the OFC encode the subjective value of goods on a common
scale (Padoa-Schioppa & Assad, 2006) whereas the striatum may be more
involved in encoding the subjective value of actions (Lau & Glimcher, 2008). This
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difference in goods- vs. action-based valuations has raised the question of how
goods-based subjective value and action-based subjective value are used by the
brain to guide choice. There is evidence that these two valuations are
interconnected (Horwitz et al., 2004); however, this sentiment remains
controversial and has yet to be resolved (Padoa-Schioppa & Assad, 2006;
Padoa-Schioppa & Assad, 2008). Nevertheless, regardless of the controversy on
how specific valuations are interconnected (including the role of specific brain
regions), there is general agreement that dopamine signaling is involved in value
encoding (Balleine et al., 2009; Schultz, 2009)
In his seminal paper, Wolfram Schultz and colleagues (1997) showed that
dopamine signaling in the midbrain reflected information about the value of
rewards through what he called ‘reward-prediction errors’. In fact, data has
shown that the firing rate of dopamine cells is linearly correlated with model
derived reward prediction errors (Bayer & Glimcher, 2005). This evidence
suggested that the dopamine system might be responsible for encoding a
teaching signal that can be used to learn the subjective value of actions based on
past experience (Schultz, 2009). For example, in studies where conditioned cues
predict rewards of different magnitudes or probabilities, the dopaminergic
response scales with magnitude or probability (Fiorillo et al., 2003; Tobler et al.,
2005). Further, dopamine neurons project to brain regions shown to be important
in evaluating choices (e.g. Haber, 2003). Thus, taken together, research
suggests that the dopamine system is critical for learning the subjective value of
goods and actions (Kable & Glimcher, 2009). However, how dopamine signaling
and ‘reward-prediction errors’ work in different choice scenarios and in different
brain regions in relation to value is not fully understood (Balleine et al., 2009).
To summarize, it is generally agreed upon that value has to be computed
and compared on a common scale in order for choices to be made. Evidence
suggests that the dopamine system and brain regions such as the striatum and
frontal cortex are important in encoding subjective value. However, it is not clear
yet how all of these aspects coherently and cohesively function together to
encode value.
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How Might The Brain Compare Values and Initiate Choice?
Theoretically, in order for a choice to be made, values must be compared
and the highest value selected. It has been shown both behaviorally and through
economic models, that this process is somewhat stochastic in nature (McFadden,
1974). For example, if two objects of choice have similar subjective values the
object with the least value is occasionally selected. This begs the question of
how, in the brain, values are represented, compared, and passed on to motor
circuits to initiate choice. Some of the most interesting work attempting to answer
this question has come from studying the primate saccadic system in perceptual
choice.
Evidence in monkeys shows that, when presented with two options in
different locations, activity in the superior colliculus increases in the area of the
topographic map associated with the location of the more valued option while the
activity in all other areas decreases (Glimcher & Sparks, 1992). This suggests a
winner-take-all mechanism for action selection in this area (Van Gisbergen et al.,
1981). Further, when the two options were of equal value there was only weak
activity in both areas (Glimcher & Sparks, 1992). Subsequent studies have
shown that activity in these two movement sites, before a period of burst of
activity, was graded. For example, if the probability that a saccade would yield
reinforcement was increased or decreased then firing in this area would increase
or decrease, respectively, before any action was taken (Basso & Wurtz, 1998;
Dorris & Munoz, 1998). This observation led to further research where the activity
of the lateral intraparietal cortex (LIP; an area upstream of the superior colliculus)
was recorded when monkeys were given a choice between two options that
varied in the magnitude and probability of reinforcement.
Researchers found that activity in area LIP, before the burst of collicular
activity discussed above, was a linear function of both probability and magnitude
(Platt & Glimcher, 1999). This work led to the idea that the fronto-parietal network
of saccade control areas formed a topographic map of value for each saccade
(Kable & Glimcher, 2009). Thus, the choice mechanism for saccades is thought
be a competitive process where the area of the topographic map associated with
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the most neural activity initiates the choice for that option. Further work has
concluded that firing rates in these brain areas encode the subjective value for a
particular saccade relative to other saccade options (Dorris & Glimcher, 2004).
These data suggest that firing rates in the fronto-parietal regions are not ‘menu
invariant’ like those in the OFC and striatum. Thus, the OFC and striatum may
encode absolute subjective values whereas the fronto-parietal areas rescale
these absolute values (presumably through some normalization mechanism) in
order to magnify the difference between the two options before a choice is
initiated (Kable & Glimcher, 2009 for discussion).
Evidence also supports the idea that activity in area LIP carries stochastic
information about the likelihood that a given saccade would yield reinforcement
(Shadlen et al., 1996; Shadlen & Newsome, 2001). Further it has been shown
that firing rates in area LIP increase as more information about whether or not a
given option will be reinforced increases. However, this increase in activity
seems to be bounded (Roitman & Shadlen, 2002; Churchland et al., 2008); thus,
once firing rates reach a certain threshold, a choice is initiated. Research has
shown that this threshold represents a value threshold for movement selection
(i.e. choice initiation; Kiani et al., 2008). Thus, when the value of any saccade
reaches the value threshold, that saccade is immediately initiated. This line of
work has also shown that the intrinsic stochasticity of this neural system gives
rise to the stochasticity observed in choice behavior (Shadlen et al., 1996;
Shadlen & Newsome, 2001).
Together this research highlights two types of choice mechanism
depending on the type of choice situation. In reaction-time types of scenarios it
appears that the threshold mechanism predominates such that when a given
value is reached, a choice is initiated. However, in economic-style scenarios
(where reaction time is not a factor) the winner-take-all mechanism seems to
predominate. Note that there are choice situations where both of these
mechanisms are at work (Lo & Wang, 2006, Wong & Wang, 2006; Wang, 2008).
However, exactly how these different systems work to compare value and initiate
choices is not fully understood at this time.
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The Role of The OFC in Valuation and Choice
The OFC was first thought as being important in decision-making
processes when it was observed that people with OFC lesions perform
abnormally in gambling tasks and have choice deficits in simple preference tasks
(Rahman et al., 1999; Fellows & Farah, 2007). Further, evidence from imaging
studies showed that the OFC was more active in situations that involved choice
oppose to those that did not (Arana et al., 2003). Early electrophysiology studies
also showed that neuron firing patterns in the OFC were sensitive to qualitative
differences between goods, motivational states (e.g. hunger, satiety, etc.), and to
the magnitude between goods (Thorpe et al., 1983; Rolls et al., 1989; Wallis,
2007). Further, lesion studies have shown that decreased OFC function is
associated with increased violations in transitivity and causes a decreased
sensitivity to reinforcer devaluation (Camille et al., 2011; West et al., 2011).
Studies have also collected evidence suggesting that neurons in the OFC
encode the subjective value of goods during economic choice.
In one experiment, monkeys had a choice between two different juices of
varying magnitudes and the subjective values of the options were calculated from
their choices (Padoa-Schioppa & Assad, 2006). It was found that when the two
choices were presented, OFC neurons fired at a rate proportional to the value of
either of the of the two goods (what the authors termed the ‘offer value’). When a
choice was made, OFC neurons fired at a rate proportional to the relative value
of the two goods (‘chosen value’). These researchers also found OFC neurons
that responded to the type of good earned. The ‘chosen value’ was also found to
be independent of the visuo-motor contingencies of the choice, further
suggesting that these neurons are encoding the subjective value of the chosen
juice.
Neurons in the OFC also seem to fire in a ‘menu invariant’ way (i.e.
neurons fire similarly regardless of the items being compared in the choice set)
when a monkey is making choices between different pairs of goods (PadoaSchioppa & Assad, 2008). This ‘menu invariance’ is suggested to be a potential
reason for the observation of transitive choices and is consistent with the
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independence required of utility-like representations (Houthakker, 1950; Platt &
Padoa-Schioppa, 2009). Thus, the fact that OFC neurons appear to be ‘menu
invariant’ provides stronger evidence that the OFC may be encoding subjective
values (Kable & Glimcher, 2009).
There is also evidence from human BOLD fMRI studies that the OFC
encodes the subjective value of delayed monetary reinforcers, probabilistic
reinforcers, and qualitatively different goods (FitzGerald et al., 2009; Levy et al.,
2009; Peters & Buchel, 2009). Further, human studies have also suggested that
the OFC encodes the subjective value of qualitatively different goods by
transforming value into a common scale (Smith et al., 2010; Levy & Glimcher,
2011). Recent research also suggests that value comparisons may also take
place in the OFC.
Evidence from computational modeling suggests that neurons in the OFC
are capable of performing value comparisons for goods-based decisions
(Rustichini & Padoa-Schioppa, 2015). Specifically, the model showed that a
biophysically compatible neural network comprised of ‘offer value’, ‘chosen
value’, and good-specific cells can generate binary decisions. This model also
reproduced experimental observations such as choice hysteresis. Further, there
is evidence that the variability of OFC neurons can account for the variability
observed in choice behavior (Conen & Padoa-Schioppa, 2015). Recent evidence
also suggests that the subjective value of goods and the subjective value of the
actions necessary to obtain them are integrated in the OFC (Cai & PadoaSchioppa, 2014). Taken together, there is a myriad of evidence suggesting that
the OFC likely has an important role in value encoding and the comparison of
value between goods. However, there are studies that make the role of the OFC
a bit less clear.
With regard to the encoding of value, it is not clear whether or not the OFC
encodes values in a cardinal fashion (e.g. Padoa-Schioppa & Assad, 2008) or in
an ordinal fashion (e.g. Tremblay & Schultz, 1999). Further, some evidence
suggests that the inactivation of the OFC does not affect economic choice
(Gardner et al., 2017). Some have even suggested that the OFC has more to do
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with representing the current state of a choice task at any point in time as oppose
to having anything to do with the encoding of value per se (Wilson et al., 2014;
Sharpe et al., 2019). It is worth noting that some of these discrepancies are
suggested to be due to differences in OFC structure/function between animal
models (Feierstein et al., 2006). Nevertheless, the exact role of the OFC in
subjective value encoding, value comparison, and choice is currently not clear.
Brain Oxygen Dynamics As A Measure of Neural Activity
As seen above it should be clear that measuring neuronal activity is
imperative in order to understand how value, value comparisons, and choices are
represented at the level of the brain. Further, the use of BOLD fMRI, a measure
based on oxygen, is used readily in human choice experiments in attempt to
dissect the function of brain regions during choice. It is also possible to measure
oxygen directly in animal models using implantable biosensors (see below).
Using oxygen measures in order to say something about neural activity is central
to this section of the dissertation. Thus, different modes of measuring oxygen,
how they relate to each other, and how they relate to neural activity are briefly
reviewed. Experiments showing that oxygen measures are sensitive to brain
changes in reward-related behavior are also discussed.
Brain Oxygen and Neural Activity: Are They Related?
Interestingly, the brain comprises 2% of the body’s weight but is
responsible for using 25% of the body’s energy (Zhang & Raichle, 2010). The
brain uses the majority of its allotted energy primarily to restore membrane
potential after neurons fire (Attwell & Iadecola, 2002). However, the brain
maintains a small energy reserve; thus, the vascular system is the primary
source of metabolic substrates (Pellerin, 2008). Considering this fact, it is thought
that hemodynamic responses in the brain are related to cerebral energy
metabolism (Attwell & Iadecola, 2002).
The hemodynamic response consists of changes in blood flow, blood
volume, and oxygenation (Lowry et al., 2010). During neural activity, an increase
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in oxygen usage is followed by a larger increase in cerebral blood flow and
increased blood volume (Fox & Raichle, 1986; Malonek et al., 1997). Evidence
suggests that there is a linear relationship between cerebral blood flow,
integrated synaptic activity, and neuronal firing rates (Mathiesen et al., 1998;
Ngai et al., 1999; Smith et al., 2002). However, the exact functional relationship
between neural activity and the hemodynamic response is a point of contention
(Sheth et al., 2004).
The BOLD Signal and Functional Magnetic Resonance
The blood-oxygen-level-dependent (BOLD) magnetic resonance signal is
used in order to obtain functional imaging of the brain (Attwell & Iadecola, 2002).
The BOLD signal is based on oxygenation changes that occur due to the
mismatch between cerebral blood flow and neuronal oxidative metabolism
(Ogawa et al., 1992). Specifically, the signal reflects the loss of oxygen from
hemoglobin, causing its iron to become paramagnetic, which affects the
magnetic field of surrounding water molecules (Ogawa et al., 1990). Increases in
cerebral blood flow decrease paramagnetic deoxyhemoglobin and produce a
positive BOLD signal (Buxton & Frank, 1997). Conversely, a decrease in cerebral
blood flow and an increase in deoxyhemoglobin (presumably due to increased
oxidative metabolism) produces a negative BOLD signal (Duong et al., 2000).
BOLD functional magnetic resonance imaging (fMRI) has become a staple
in neuroscience as a non-invasive way of mapping regional activity of the brain
while certain tasks are being performed. BOLD fMRI has spatial resolution at the
micron level and can be used on animals as well as humans (Jones et al., 2005).
However, one major limitation of BOLD fMRI is that it restricts the mobility of the
participant thus limiting experimental design techniques (this issue is particularly
problematic in animals studies; Lowry et al., 2010). Thus, other techniques that
can measure oxygen in animals could produce more fruitful research.
Electrochemical Measures of Oxygen
Oxygen is a reactive, electron-accepting species whose properties allow it
to be measured using constant potential amperometry (Li et al., 2016). By

98

applying a constant potential of -0.6 V vs. reference, oxygen can be reduced at
the surface of an electrode by a one-step (A) or two-step (B and C) process:
O2 + 4H + + 4e− → 2H2 O2

(A)

O2 + 2H + + 2e− → H2 O2

(B)

H2 O2 + 2H + + 2e− → 2H2 O

(C)

during this reduction process, electrons are transferred to oxygen producing a
negative current proportional to the concentration of oxygen at the surface of the
electrode (Hitchman, 1978; Li et al., 2016; Ledo et al., 2017).
A basic two-electrode unit is used to measure oxygen in the brain
consisting of the measuring electrode and a reference electrode (O’Neill et al.,
1998; Ledo et al., 2016). The measuring electrode is placed in the brain region of
interest and is where oxygen reduction takes place. The reference electrode is
placed superficially between the dura mater and the brain and acts to balance
the current passing through the measuring electrode (O’Neill et al., 1998; Ledo et
al., 2017). The two-electrode unit is attached to a potentiostat that ensures the
desired potential of -0.6 V is applied (O’Neill et al., 1998; Ledo et al., 2017). Both
carbon fiber electrodes and platinum surface electrodes can be used to measure
oxygen in the brain (Bolger & Lowry, 2005; Kealy et al., 2013; Ledo et al., 2017).
These electrodes have high spatial (μm) and temporal resolution (ms) along with
high sensitivities, low limits of detection, and a linearity of R2 > 0.9 (Bolger et al.,
2011; Ledo et al., 2017). These electrodes can be used to monitor oxygen
dynamics in the brains of feely-moving animals (Francois et al., 2016; Solis et al.,
2017). This allows for oxygen dynamics to be measured as animals exhibit
different behavior (McHugh et al., 2012; Francois et al., 2016).
The BOLD Signal and Electrochemical Measures: Translational Efficacy?
As mentioned above BOLD fMRI is primarily used in human decisionmaking research as well as some animal research. However, a primary limitation
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in using BOLD fMRI, especially in animal research, is the restriction this
methodology imposes on experimental design. As discussed, in vivo
electrochemistry has the capacity to alleviate these experimental design
restrictions; however, this begs the question as to whether electrochemical
oxygen measures are consistent with BOLD fMRI measures? If not then
performing electrochemical oxygen measures in animal models is a futile
endeavor if our goal is to advance knowledge about human processes.
Fortunately, electrochemistry and BOLD fMRI are shown to produce similar
results.
Evidence suggests oxygen measures from electrochemistry and BOLD
fMRI measures are highly correlated (Lowry et al., 2010). Specifically, these
authors took electrochemical measures and fMRI measures simultaneously in
rats while manipulating available oxygen. They found that the responses to the
two measures were strongly correlated (r = 0.79). Further, research has shown
that reward related signals measured in the NAc of rats share characteristics to
similar studies in humans using BOLD fMRI (Knutson & Cooper, 2005; Francois
et al., 2012). Data has also shown that ketamine produces the same effect on
brain oxygen as measured by electrochemistry in rats and by BOLD fMRI in
humans (Francois et al., 2016). Further, environmental cues were shown to
produce similar effects in the PFC wheter measured in rats using
electrochemistry or in humans using BOLD fMRI (Howe et al., 2013). Taken
together, these data suggest that using in vivo electrochemistry in rodents has
translational efficacy in elucidating mechanisms of human brain function.
Is Oximetry Capable of Measuring Changes in Reward Processing?
As mentioned above there is evidence that measuring oxygen dynamics in
animals has translational efficacy. However, considering the scope of this
dissertation, it is important to assess if oxygen amperometry measures (oximetry)
are capable of detecting changes in reward sensitivity.
Research shows that oxygen increases in the NAc following a lever press
for a food reinforcer (Francois et al., 2012). Further, these researchers also found
that oxygen signals were sensitive to changes in reinforcer magnitude and
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motivational state. Oxygen measures in rats also show similarities to human fMRI
data where increases in oxygen to the presentation of a positively associated
conditioned stimulus are attenuated by ketamine administration (Francois et al.,
2016). Evidence has also shown that oxygen in the NAc increases to the
presentation of arousing stimuli (Solis et al., 2017). Further, an increase in
oxygen is observed in the PFC when rats correctly discriminate between actions
that result in reinforcement (Howe et al., 2013). In another study, an increase in
NAc oxygen was seen to responses for an option that resulted in reinforcement
whereas an increase in infralimbic cortex oxygen was seen for responses that did
not result in reinforcement (Francois et al., 2014). Oxygen measures from the
amygdala also show a greater increase to a conditioned stimulus paired with a
foot shock compared to a neutral conditioned stimulus (McHugh et al., 2014).
Thus, taken together, there is ample evidence to suggest that oximetry in animals
is translatable to humans and capable of detecting changes in the reward
system.
Connecting The Dots: Decision-Making, The Brain, and Cocaine Abuse
As mentioned in the beginning of this chapter, the somewhat
commonplace notion that substance abuse is governed by compulsive, habituallike response relations that are insensitive to alternative consequences (Volkow
and Morales, 2015) is incompatible with drug-associated choice behavior.
Evidence for this is seen by the fact that the current most effective behavioral
and pharmacological treatments for human substance-use disorders are based
on offering either a non-pharmacological (e.g. contingency management) or
pharmacological (e.g. replacement therapy) alternative to the abused drug; thus,
indicating sensitivity to alternative consequences (Schierenberg et al., 2012;
Stoops and Rush, 2013). Further, in preclinical models, conditions thought to
produce compulsive, habit-like drug taking do not readily alter drug-associated
choice behavior (Ahmed, 2010), and choice behavior is resistant to compulsive,
habit-like response relations (Kosaki and Dickinson, 2010). Thus, these data
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suggest that in order to produce more effective treatments for substance-use
disorder, it is critical to understand the neurobehavioral mechanisms of drugassociated choice.
Cocaine-Related Choice in Humans
The concepts from behavioral economics, discussed in length earlier,
provide a framework for better understanding substance-use disorder especially
in regard to the value of a commodity, the substitutability of qualitatively different
reinforcers, and the idea of opportunity cost (Rachlin et al., 1976, 1980; Hursh,
1980; Hursh et al., 2005; Bickel et al., 2014). For example, Bickel et al. (1995)
reanalyzed several data sets showing a multitude of substitutes exist for many
different drugs of abuse across species. Further, contingency management, a
program where abstinence is reinforced, decreases abuse behavior for several
different drugs including cocaine (Higgins et al., 1993; Schierenberg et al., 2012).
The decrease in abuse behavior seen in contingency management is presumably
through increasing the opportunity cost of using drugs and by also allowing the
participant to come into contact with other reinforcers that may substitute for the
drug of abuse (Bickel et al., 2014). Similarly, agonist replacement therapy can
function to decrease cocaine abuse in that the pharmacotherapy itself can
substitute for the abused drug (Collins et al., 2006; Stoops & Rush, 2013). Note
that animal research shows similar results to human work suggesting
translational efficacy. Thus, more invasive experiments can be conducted in
animals to explore the neurobehavioral mechanisms of drug choice
Cocaine-Related Choice in Animal Models
Early work in rats showed that presenting an animal with a concurrently
available non-drug option could decrease the amount of cocaine an animal would
administer (e.g. Carroll et al., 1989). Further, it has been shown that the
opportunity to earn a sweet solution in a cocaine autoshaping procedure can
delay or prohibit drug-taking behavior (Carroll & Lac, 1993). Sweet solutions
have also been shown to decrease cocaine choice (Lenoir et al., 2007; Cantin et
al., 2010; Madsen & Ahmed, 2015). Research has also shown that increasing the
magnitude of an alternative reinforcer or increasing the work requirement needed
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to earn cocaine can separately decrease cocaine choice (Nader & Woolverton,
1991; Thomsen et al., 2013). Further, exercise on a running wheel can also
compete to decrease cocaine-taking behavior (Cosgrove et al., 2002). Evidence
also suggests that context, current intoxication state, extended access to drug,
and previous choices can influence drug-related choice behavior (Lenoir et al.,
2013; Vandaele et al., 2016; Kearns et al., 2017). Contingency management has
also been replicated in animals (e.g. LeSage, 2009) creating an exciting
opportunity to further explore the neurobehavioral mechanisms of this treatment.
Taken together, these data suggest that environmental manipulations can
function to decrease cocaine-taking behavior either through substitution or
opportunity cost.
There is also non-clinical evidence that pharmaceuticals can decrease
cocaine-taking behavior via substitution. For example, evidence suggests that
chronic d-amphetamine can decrease choices for cocaine (Thomsen et al.,
2013). Similarly, evidence also shows that diazepam can selectively decrease
choices for cocaine (Augier et al., 2011). Further, acute aripiprazole has also
been shown to decrease cocaine choice behavior (Thomsen et al., 2008). This
research not only suggests that there is potential to find pharmacological
treatments for cocaine abuse through animal models but also creates an
opportunity to explore the neurobiology of drug-related choice behavior (Ahmed
et al., 2013).
Cocaine-Related Choice Behavior and The Brain: Focus on the OFC
Evidence suggests that abnormalities exist in the OFC of those with
substance abuse issues (Rogers et al., 1999; London et al., 2000). For example,
cocaine abusers show a decrease in baseline OFC activity after acute withdrawal
and after long periods of abstinence (Volkow & Fowler, 2000). However, when
cocaine abusers are shown drug-related cues they show hyperactivity in the OFC
that positively correlates with the magnitude of their craving (Maas et al., 1998).
Interestingly, those with substance abuse issues are also shown to behave
similarly on behavioral tasks as those with OFC lesions further supporting that
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changes in OFC function occur in drug abuse (Chudasama & Robbins, 2003;
Schoenbaum et al., 2003; Schoenbaum & Setlow, 2004).
Evidence from animals has also shown that stimulant self-administration
causes a decrease in dendritic spine density in the OFC suggesting decreased
synaptic plasticity after drug exposure (Crombag et al., 2004). Further, work from
rats and monkeys suggest that cocaine administration decreases the ability of
subjects to use the value of a predicted outcome to guide their behavior as seen
in experiments using discrimination reversals (Jentsch et al., 2002; Schoenbaum
et al., 2006). Further, evidence from rats suggest that cocaine causes a
decreased ability to learn reinforcer devaluations which is an effect also seen in
rats with OFC lesions (Schoenbaum & Setlow, 2005). Recent work suggests that
there are different neurons in the OFC that fire before drug and non-drug choices
are made, suggesting that these neurons may encode values for the different
options further suggesting a role for the OFC in value-based decision-making
involving drugs of abuse (Guillem & Ahmed, 2017).
Overall, research suggests that cocaine affects OFC function leading to
issues with assigning and comparing the value of goods and outcomes. The
effect cocaine has on the OFC is thought to make it difficult for those with
substance abuse to incorporate predictive information into their decision-making
leading these individuals to continue to seek drugs even though it often leads to
negative consequences (Schoenbaum et al., 2006). Thus, further studying the
role of the OFC in drug-related decision-making will lead to a better
understanding of substance abuse and create avenues for potential treatments to
be discovered.
Limitations of Current Research
While there is evidence that the OFC is involved in value-based choice
behavior between qualitatively different goods, no work has assessed oxygen
dynamics during choices involving drug vs. non-drug alternatives. Further, in
most drug vs. non-drug choice procedures the dose of drug is held constant (e.g.
Lenoir et al., 2007; Cantin et al., 2010; Madsen & Ahmed, 2015) making relative
value assessments more difficult. Another issue in studying drug-related
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decision-making in free-choice procedures is that these procedures do not
control for the positive feedback function between choices and experienced
reinforcement (e.g. Ahmed et al., 2013). Considering that differential histories
with drug reinforcers can cause neural adaptations and changes in associated
value (Nestler, 2001; Kalivas & O’Brien, 2008), separating out effects from drug
intake vs. preference becomes difficult. Further, free-choice procedures allow for
disproportionate experience with each alternative. For example, repeated
choices for one option causes an overall loss for the other option; thus,
differences in choice histories can cause systematic biases making changes in
the value of one alternative not easily detectable due to insufficient experience
with each alternative (McCarthy & Davidson, 1979, 1981; Johnstone & Alsop,
1999). Thus, in order to adequately study choice behavior one must use a
procedure that controls for the positive feedback function between choices and
experienced reinforcement as well as reinforcement history.
Overview of Experiment 2
Experiment 2 aimed to further investigate the role of the OFC during
value-based decision-making for drug and non-drug commodities. This was
accomplished by concurrently measuring oxygen dynamics in the OFC during a
novel choice procedure that controlled for both the feedback function between
choices and experienced reinforcement as well as reinforcement history. Thus,
this procedure allowed for the disassociation of drug intake from preference
effects. The overall hypothesis for the proposed experiments was that oxygen
would increase in the OFC as a function of increasing preference for either
commodity.
Additionally, experiment 2 examined how increasing the magnitude of the
food reinforcer changed cocaine relative subjective value and oxygen dynamics
in the OFC. Considering that magnitude manipulations have been shown to
change preference and brain signaling (Nader & Woolverton, 1991; Sackett et
al., 2017) it was hypothesized that increasing the magnitude of the food
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reinforcer would decrease the relative subjective value of cocaine. Additionally, it
was hypothesized that OFC oxygen would track this change in relative subjective
value.
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CHAPTER 4
EXPERIMENT 2:
EXPLORING THE ROLE OF THE ORBITOFRONTAL CORTEX IN DRUGRELATED DECISION-MAKING USING OXIMETRY IN FREELY-MOVING
RATS
Introduction
Evidence suggests that the OFC has a critical role in value-based
decision-making (Padoa-Schioppa & Assad, 2006; Murray et al., 2007; Cai &
Padoa-Schioppa, 2015). Further, there is evidence that cocaine use and abuse
can affect OFC function potentially causing errors in value-based decisionmaking (Volkow & Fowler, 2000; Crombag et al., 2004; Schoenbaum & Setlow,
2005; Guillem & Ahmed, 2017). However, the exact role of the OFC in decisionmaking, especially during drug vs. non-drug choice, is not fully understood.
Factors that have impeded this knowledge in non-clinical studies are the use of
choice procedures that: (1) do not control for the positive feedback function
between choices and experience reinforcement (e.g. Ahmed et al., 2013), (2) that
do not control for reinforcement history (see McCarthy & Davidson, 1979, 1981;
Johnstone & Alsop, 1999 for discussion), and (3) that do not change the
magnitude of the drug or non-drug option (e.g. Lenoir et al., 2007; Cantin et al.,
2010; Madsen & Ahmed, 2015). All of these issues make dissociating the effects
of preference from intake difficult as well as making the relative subjective value
of reinforcers hard to determine (see Beckmann et al., 2019 for discussion). This
study was designed to address these issues by measuring OFC oxygen (via
oximetry) in freely-moving rats behaving in a novel drug vs. food choice
procedure that controls for the positive feedback function, reinforcer history, and
that better assesses the relative subjective value of the two reinforcers by
comparing varying magnitudes of each.
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Materials and Methods
Animals
Six adult male Sprague-Dawley rats (Harlan, Inc.; Indianapolis, IN, USA)
weighing approximately 250-300 g were used for experimentation. Rats were
individually housed in a temperature-controlled environment on a 12:12 h
light:dark cycle with lights on at 0600 h. All rats were acclimated to the colony
room and handled a week before any experimentation began. All rats had ad
libitum access to food and water during the experiment proper (with the
exception of specific manipulations; see below). All experimental protocols were
conducted according to the 2010 NIH Guide for the Care and Use of Laboratory
Animals (8th addition) and were approved by The Institutional Animal Care and
Use Committee at the University of Kentucky.
Drugs
Cocaine hydrochloride (COC; National Institute on Drug Abuse, Bethesda,
MD) was prepared in 0.9% sterile saline for self-administration. COC was selfadministered in a range from 0-1.0 mg/kg/infusion based on weight.
Apparatus
Experiments were conducted in operant conditioning chambers (ENV-008,
Med Associates) housed within a sound-attenuating compartment (ENV-018M,
Med Associates). Each chamber was connected to a computer (SG-502, Med
Associates) and ran using MED-PC. Each operant chamber contained a 5.1 cm x
5.1 cm recessed food receptacle (ENV-200R2MA) on the front response panel
with two retractable levers on either side (ENV-122CM; 6 cm above metal rod
floor). Above each lever was one white cue light (ENV-221M; mounted 4.1 cm
above each lever). A Sonalert tone (ENV-223 AM) was located above the top left
cue light and another Sonalert tone (ENV-223 HAM) was located above the top
right cue light. A house light (ENV-227M) was placed 17 cm above the metal
floor in the middle of the back wall. Food pellets (45 mg, Dustless Precision
Pellets; Bio Serv) were delivered via a dispenser (ENV-203M-45) placed behind
the food receptacle. COC was self-administered via a syringe pump (PHM-100)
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located outside of the sound-attenuating chamber. COC was pumped through a
watertight swivel attached via tygon tubing to a back-mounted cannula.
Oxygen Biosensor
Microelectrode Array Preparation
Oxygen biosensors were prepared in the same fashion as described in
Chapter 2 with the exception that these electrodes did not need to be coated with
enzymes or plated with mPD in order to increase sensitivity or selectivity.
In Vitro Calibration
Amperometric recordings were collected at 100 Hz using the FAST16
mkIII electrochemical recording system (Fast Analytical Sensing Technology,
Quanteon, LLC, Nicholasville, KY). Before in vivo implantation, all electrodes
underwent an in vitro calibration to determine sensitivity (slope, nA/μM), limit of
detection (in μM, signal-to-noise = 3), and linearity (R2 ≥ 0.9). Calibrations took
place in 20 mL of 0.05 M, pH 7.4 PBS Lite at 37°C. The system was purged with
nitrogen and 3 additions of 4.95 μM oxygen was used to generate the calibration
curve. These methods were adapted from Ledo et al. (2017).
In Vivo Implantation
Oxygen biosensor implantation was the same as discussed in Chapter 2
with the exception that the electrodes were implanted in the OFC (AP: +3.7 mm;
ML: ±1.7 mm; DV: -3.8 mm [from brain surface]) (Paxinos and Watson, 2009).
Oxygen biosensor implantation occurred once stable baseline (1 pellet) choice
behavior was reached, defined as no statistical difference in a or s parameters
(see below) over a three-day period after rats learned to discriminate COC
doses.

Electrochemical Recordings
Oxygen measurements were performed at -0.6 V potential vs. Ag/AgCl
reference (able to reduce [measure] oxygen) using the FAST-16 mkIII recording
system equipped with a low noise 4-channel Rat Hat amplifier (Quanteon, LLC,
Nicholasville, KY) system connected through a low-noise commutator (Plastics
One, Inc., Roanoke, VA). Setting the potential to -0.6 V vs. Ag/AgCl reference
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allowed oxygen to be measured at the platinum surfaces of the electrode through
a one-step reaction (Ledo et al., 2017) (Figure 4.1).
Establishing Procedures
Rats were first trained to retrieve food pellets from the food receptacle for
two consecutive days. Following magazine shaping, rats were trained to lever
press (left and right, randomly presented) on a fixed-ratio 1 (FR1) schedule of
reinforcement; completion of the FR1 resulted in lever retraction and delivery of a
food pellet. Each session consisted of 15 left- and 15 right-lever trials. Rats were
incrementally moved from an FR1 to a terminal FR3 over 6 days. After stable
responding on an FR3, an orienting response was added to the response chain.
Specifically, each trial was signaled by illumination of the house light and a
contingent head entry response into the food receptacle caused house light
offset and either left or right lever extension. Completion of the FR3 requirement
caused lever retraction and food pellet delivery. Each session consisted of 15
left- and 15 right-lever trials. Response-chain training lasted 3 days. These
procedures were adapted from Beckmann et al. (2019).
Catheter Surgeries
Catheter surgeries were conducted in the same manner as described in
Chapter 2.
Drug Self-Administration Training
After recovery, animals self-administered COC (1.0 mg/kg/infusion) via
completion of a single lever (left or right, counterbalanced) FR1 response. Drug
infusions (0.1 mL over 5.9 seconds) were paired with a cue light conditioned
stimulus. Sessions lasted 1 hour and the FR requirement was increased to an
FR3 over a 6-day period. After stable responding on an FR3, rats were moved on
to lever discrimination training where the house light signaled the beginning of
the trial. A contingent head entry response caused house light offset and the
extension of either the left or right lever. Fulfillment of the FR3 response
requirement caused lever offset and either a drug infusion or a food pellet
(counterbalanced; the drug lever will remain the same as in previous training with
the opposite lever being the food lever). Both the drug infusion and food pellet
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were paired with a cue light (5.9 seconds) over the respective lever. Sessions
ended when 5 of each reinforcer was earned. Rats were trained on this
procedure for 5 days. This training was adapted from Beckmann et al. (2019)
Choice Procedure: Controlled Reinforcer Ratio Schedule
After lever discrimination training rats were placed on the controlled
reinforcer ratio (CRR) choice procedure (Stubbs and Pliskoff, 1969; McCarthy &
Davison, 1984; Beckmann et al., 2019) for COC vs. food. Importantly,
experiments from our lab (e.g. Beckmann et al., 2019) have shown that this
procedure allows for the dissociation of reinforcer intake from preference by
controlling for the distribution of reinforcers experienced. Thus, this procedure
removes the potential confounding of differential reinforcer experience with
preference by keeping the drug- and food-taking histories of all animals the
same. Specifically, each session was divided into 5 blocks where the animal
could choose between a single 45 mg food pellet and COC (0, 0.032, 0.1, 0.32,
and 1 mg/kg/infusion; determined by pump time; infusions increase as a function
of block). Food pellet delivery was accompanied by lever retraction and cue light
onset (5.9 seconds) over the respective lever for all blocks. COC infusions were
accompanied with lever retraction and cue light illumination over the respective
lever for the duration of the infusion (0, 0.189, 0.59, 1.89, and 5.9 seconds;
increasing as a function of block). Each block was signaled by a tone pattern
discriminative stimulus played for the duration of each trial block (1.8/0, 1.5/0.3,
0.9/0.9, 0.3/1.5, and 0/1.8 seconds of 40/29 kHz ratio). All blocks were separated
by a 2-minute interblock interval (IBI) where all manipulanda were off. Each block
was separated into 6 trials (3 food trials; 3 COC trials). The house light signaled
the beginning of the trial. An orienting response into the food receptacle caused
house light offset and the extension of both levers. Reinforcement was randomly
set up for either food or COC in a given trial. Regardless of which lever the rat
chose to respond on, the response requirement (FR3) for the randomly
determined reinforcer had to be completed and the reinforcer earned (forced
choice responses) in order to advance to the next trial. It is important to note that
responses on the alternative lever that is not set up for reinforcement were
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recorded as preferred (choice) responses. After completing the response
requirement for the available reinforcer, the levers retracted and the cue light
above the respective lever was illuminated as described above. If the rat
changed over to respond on the alternate lever before the FR requirement was
completed for the scheduled reinforcer the FR requirement was reset. Each trial
was separated by a 20-second intertrial interval (ITI). A block ended after
completion of all 6 trials. After stable responding on the choice procedure all rats
were implanted with the oxygen biosensor (see above and Chapter 2).
Food Restriction and Magnitude Manipulations
After oxygen data were collected at choice baseline (i.e. when only 1 food
pellet was delivered; n = 6) rats were then placed on the exact same choice
procedure; however, this time each completed FR requirement on the food lever
resulted in 4 food pellets (n = 3). After oxygen data were collected with the 4pellet manipulation, animals were food restricted and put on the same 4-pellet
choice procedure (4 food pellet + FR) and oxygen data was again collected (n =
3). After all data were collected, animals were euthanatized and the brains were
extracted, flash frozen, and 40 µm slices were prepared using a cryostat. The
slices were stained using Cresyl Violet (Sigma-Aldrich, St. Louis, MO) and were
visualized to confirm biosensor placement into the OFC (Figure 4.2). Note that
due to experimental issues one brain was visualized without the use of staining
or a microscope.
Data Analysis
Choice data were expressed as percent choice for COC as follows:

𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 =

𝐶𝐶𝐶𝐶𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃
× 100
𝐶𝐶𝐶𝐶𝐶𝐶𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 + 𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃

(7)

where COCPreferred represents the total number of preferred responses on the COC

lever (i.e. responses on the COC lever when COC was not available) and

FoodPreferred represents the total number of preferred responses on the food lever

(i.e. responses the food lever when food was not available). Additionally, a
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version of the generalized matching law (GML), a quantitative model relating
differential reinforcer value to choice behavior, was applied to the data (Baum &
Rachlin, 1969; Killeen, 1972; Beckmann et al., 2019). The form of the GML that
was used is:
𝐵𝐵𝑑𝑑
100
=
1 + (𝑎𝑎⁄𝑥𝑥 )𝑠𝑠
𝐵𝐵𝑑𝑑 + 𝐵𝐵𝑓𝑓

(8)

where B represents behavior (i.e. preferred responses) for either drug (d) or food
(f), x represents the dose of COC available, a represents a free parameter that

determines the dose at which the relative value of food and drug are equivalent
(scaled in drug dose units; drug/food exchange rate), and s is the slope of the

function that represents the sensitivity to the relative magnitude between drug
and food. The GML was fit to the choice data using nonlinear mixed-effects

(NLME) modeling using R Studio (Version 1.1.383) statistical software (Pinheiro
et al., 2007) with subject as a random factor and the food manipulation (1 pellet,
4 pellet, and 4 pellet + FR) as a fixed, within-subject factor.
Brain oxygen data were analyzed using custom MATLAB®-based software
(Quanteon LLC, Nicholasville, KY) and a custom-written MATLAB® (MathWorks,
Inc., Natick, MA) program. Oxygen data and the location of respective behavioral
events were extracted using the custom MATLAB®-based software. The oxygen
signals related to the behavioral events were analyzed using the custom-written
MATLAB® program. Specifically, an oxygen peak was defined as an event that
was 5 standard deviations above the mean of the baseline (Gunaydin et al.,
2014). The baseline was defined as the last 1-minute average of the IBI before a
given block. For example, the baseline for block 1 was the average of the 1minute interval before the block began, the baseline for block 2 was the average
of the 1-minute interval before block 2 began, etc. Oxygen peaks were
considered related to a given behavioral event if they occurred within a 20second window of the behavioral event and were not interrupted by another type
of behavioral event. Figure 4.3 and Figure 4.4 show example oxygen traces
highlighting oxygen events considered to be peaks based on the previously
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mentioned criteria. Measures assessed were the absolute maximum of the
oxygen peak (μM), the maximum amplitude of the oxygen peak above baseline
(μM), the percent increase of the oxygen event above baseline, the peak width
(s), the peak prominence (μM), and the number of oxygen events that occurred
to a given behavioral event. Statistical analyses were conducted with JMP Pro
12.0.0. statistical software using linear mixed-effects (LME) models (Gelman &
Hill, 2007) with subject as a random factor and food manipulation, block (COC
dose), and event type (e.g. COC vs. food) as fixed, within-subject factors. Note
that there were some instances where event type was not a factor (such as in the
total number of oxygen peaks that occurred per session or per block [see
below]), in these cases the full model did not include event type as a factor.
Akaike information criterion (AIC) values were used to compare models;
only statistics from the models that were most likely to describe the data are
presented. Further, differences in AIC values (ΔAICs) were also calculated in
order to assess the relative difference of information loss of all the other models
compared to the best model. Evidence ratios for the best model relative to the
second-best model were calculated from the ΔAICs (Burnham & Anderson, 2002;
Burnham et al., 2011). The evidence ratios indicate the relative strength of the
preferred model to the second-best model.
Where necessary linear regressions were performed and correlation
coefficients, as well as if the slopes of the lines were statistically different than
zero, were assessed. Any interactions were probed with contrasts (NLME) or the
Tukey HSD (LME), and statistical significance was defined as p < 0.05.
Results
Choice Behavior During Recordings For All Manipulations
Figure 4.5 shows choice behavior (expressed as percent COC preference)
during oxygen recordings for all manipulations. The version of the GML
mentioned above (equation 8) was fit to the data points and analyzed via NLME.
The model with the lowest AIC was the model that had the s parameter set as a
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global parameter, which was 5.03 times more likely to describe the data than the
model that allowed the s parameter to vary between animals. Specifically, it was

found that, compared to the baseline condition (a = 0.29; s = 2.52), the 4-pellet +

FR manipulation (a = 0.53; s = 2.52) significantly increased the drug/food

exchange rate [F(2,66) = 14.10, p < 0.0001]. There were no differences between

the 1-pllet (baseline condition) and the 4-pellet manipulation (a = 0.21; s = 2.52).
However, contrasts revealed that the drug/food exchange rate for the 4-pellet
manipulation was significantly decreased compared to the 4-pellet + FR

manipulation [F(1,66) = 27.90, p < 0.0001].
Overall Behavioral Responses Per Trial
Figure 4.6 shows the overall responses (all forced and preferred lever
responses for COC and food) as a function of block (COC dose) for all
manipulations. There were no statistical difference between the 1-pellet, 4-pellet,
and 4-pellet + FR manipulations as a function of block [F(2,6.59) = 4.72, p =
0.054]. Note that all AIC values were approximately the same (ΔAIC < 0.6) thus
the statistic reported was from the full model.
Behavioral Responses Per Preferred COC and Food Trials
Figure 4.7 shows all COC and food responses (forced choice and
preferred choice lever presses) per preferred choice trial for the 1-pellet (Figure
4.7A), 4-pellet (Figure 4.7B), and 4-pellet + FR (Figure 4.7C) manipulations.
Specifically, there was a block x event type interaction where the number of COC
responses per preferred trial increased as a function of block and the number of
food response per preferred trial decreased as a function of block [F(1,4.83) =
20.89, p = 0.007]. There was also a manipulation x event type interaction where
food responses for the 4-pellet + FR manipulation were significantly greater than
food response for the 1-pellet and 4-pellet conditions and COC responses for the
4-pellet + FR condition [F(2,6.99) = 6.16, p = 0.03]. These statistics came from
the full model, which had the lowest AIC and was 84.35 times more likely to
describe the data compared to the model that included only block and event type
as factors.
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Behavioral Responses To Head Entries, Preferred Choices, & Head Entries
After Reinforcer Delivery
Figure 4.8 shows behavioral responses to head entries, preferred
responses, and head entries after reinforcer delivery. Specifically, Figure 4.8A
shows a main effect of event type where the number of head entries that
occurred during trials were significantly greater than the number of head entries
that occurred to initiate trials [F(1,3.66) = 9.44, p = 0.04]. This statistic came from
the full model (block x manipulation x event type), which had the lowest AIC and
was 1.14 x 109 times more likely to describe the data compared to the model that
included manipulation and event type as factors. It is worth noting that this finding
is not surprising considering that the number of head entries to initiate trials was
procedurally bounded (6 initiations/block) whereas all other head entries were
not.
Figure 4.8B shows that there was a block (COC dose) x event type
interaction where COC preferred responses increased as a function of COC dose
and food preferred response decreased as a function COC dose [F(1,4.83) =
25.10, p = 0.005]. There was also a manipulation x event type interaction where
food preferred responses for the 4-pellet + FR condition were significantly greater
than all other preferred responses across conditions [F(2,6.92) = 5.86, p = 0.03].
These statistics came from the full model, which had the lowest AIC and was 6.5
x 105 times more likely to describe the data compared to the model that included
block and event type as factors.
Figure 4.8C shows a main effect of event type where more head entry
responses occurred after a food pellet was delivered (‘eating’ responses)
compared to head entry responses during/after a COC infusion [F(1,4.45) =
39.25, p = 0.002]. This statistic came from the model that included block and
event type as factors, which had the lowest AIC and was 3.89 x 106 times more
likely to describe the data compared to the full model.
Total Number of Oxygen Peaks That Occurred in A Choice Session
Figure 4.9 shows the total number of oxygen peaks that occurred overall
and to behavioral events over choice sessions between manipulations. There
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were no statistical difference in the total number of oxygen peaks that occurred
between manipulations (Figure 4.7A) [F(2,3.97) = 0.25, p = 0.79]. There were
also no differences in the number of oxygen peaks that occurred to behavioral
events (Figure 4.9B) [F(2,4.40) = 4.80, p = 0.08] or in the percentage of oxygen
peaks that occurred to behavioral events [F(2,3.80) = 4.44, p = 0.10] (Figure
4.9C) in a session across manipulations.
Total Number of Oxygen Peaks That Occurred in A Choice Session Per
Block
Figure 4.10 shows the total number of oxygen peaks that occurred overall
and to behavioral events per block across manipulations. There were no
differences observed in the total number of peaks that occurred per block (Figure
4.10A) [F(2,3.93) = 0.52, p = 0.63]. This statistic came from the full model (block
x manipulation), which had the lowest AIC and was 1.5 x 106 times more likely to
describe the data compared to the model that included only manipulation as a
factor.
Figure 4.10B highlights that there was a main effect of block with the
number of oxygen peaks occurring to events decreasing as a function of block
[F(1,3.50) = 12.27, p = 0.031]. This statistic came from the full model, which had
the lowest AIC and was 3.70 x 103 times more likely to describe the data than the
model with only manipulation as a factor.
Figure 4.10C shows that there were no differences in the percent of
oxygen peaks that occurred to events per block [F(2,4.23) = 1.37, p = 0.35]. This
statistic came from the full model, which had the lowest AIC and was 796.32
times more likely to describe the date than the model with only manipulation as a
factor.
Number of Oxygen Peaks That Occurred Per Preferred COC and Food Trial
Figure 4.11 shows the number of behavioral responses that occurred per
COC and food preferred trials (left) and the number of oxygen peaks that
occurred during COC and food preferred trials (right). Note that the behavior was
analyzed in Figure 4.8 and is shown in Figure 4.11 only for purposes of
comparison. Specifically, there were no statistical differences that occurred per
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COC or food preferred trials between the 1-pellet (Figure 4.11A), 4-pellet (Figure
4.11B), and 4-pellet + FR (Figure 4.11C) conditions [F(2,6.60) = 0.30, p = 0.75].
Correlations Between The Number of Oxygen Peaks and The Number of
Responses That Occurred Per Preferred COC and Food Trials
Figure 4.12 shows correlations between the number of oxygen peaks that
occurred per preferred COC and food trial and the number of responses that
occurred per COC and food preferred trial. Specifically, Figure 4.12A (left) shows
that there was no correlation between the number of oxygen peaks that occurred
per preferred COC trial and the number of responses that occurred per preferred
COC trial for the 1-pellet condition (r = 0.025, p < 0.90). Figure 4.12A shows that
there was a significant positive correlation between the number of oxygen peaks
that occurred per COC trial and the number of behavioral responses per trial for
the 4-pellet (middle; r = 0.85, p < 0.0001) and 4-pellet + FR (right; r = 0.64, p =
0.01) conditions.
Figure 4.12B (left) shows that the number of oxygen peaks that occurred
per preferred food trial and the number of behavioral responses per preferred
food trial were not correlated for the 1-pellet condition (r = 0.25, p = 0.17). Figure
4.12B shows that the number of behavioral responses per preferred food trial
and the number of behavioral responses per preferred trial were significantly
positively correlated for the 4-pellet (middle; r = 0.68, p = 0.005) and 4-pellet +
FR conditions (right; r = 0.92, p < 0.0001).
Number of Oxygen Peaks That Occurred To Behavioral Events
Figure 4.13 shows the number of oxygen peaks that occurred to forced
trials (where reinforcers could be earned on an FR3) across all manipulations.
Specifically, Figure 4.13 shows that there were no differences in the number of
oxygen peaks that occurred to forced COC choices compared to forced food
choices across the 1-pellet (Figure 4.13A), 4-pellet (Figure 4.13B), and 4-pellet +
FR (Figure 4.13C) manipulations [F(1,3.72) = 6.81, p = 0.06]. This statistic came
from the model that included only event type as a factor, which had the lowest
AIC and was 1.48 times more likely to describe the data compared to the model
that used block and event type as factors.
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Figure 4.14 shows the number of oxygen peaks that occurred when each
reinforcer was earned. Specifically, the results show a main effect of event type
where a greater number of oxygen peaks occurred to earning the COC reinforcer
compared to earning the food reinforcer for the 1-pellet (Figure 4.14A), 4-pellet
(Figure 4.14B), and 4-pellet + FR (Figure 4.14C) conditions [F(1,4.55) = 30.20, p
= 0.004]. The results also showed a main effect of block where the number of
oxygen peaks increased as a function of block (COC dose) for the 1-pellet
(Figure 4.14A), 4-pellet (Figure 4.14B), and 4-pellet + FR (Figure 4.14C)
conditions [F(1,2.60) = 12.59, p = 0.04]. The model with the lowest AIC was the
full model; however, the ΔAIC between the best model and second best model
was lower than 4. Thus, the simpler of the two models (block x event type as
factors) was selected.
Figure 4.15 shows the number of preferred responses to COC and food as
a function of block (left) and the number of oxygen peaks that occurred to the
preferred responses as a function of block (right). Note that the behavioral data
was analyzed in Figure 4.8 and is presented here only for purposes of
comparison. Specifically, Figure 4.15 shows that there are no statistical
differences in preferred responses across the 1-pellet (Figure 4.15A), 4-pellet
(Figure 4.15B), and 4-pellet + FR (Figure 4.15C) conditions [F(2,3.66) = 2.29, p
= 0.23]. This statistic came from the model that included block and manipulation
as factors, which had the lowest AIC and was 1.92 times more likely to describe
that data compared to the model that included block and event type as factors.
Note that the best model and the second best model did not have a ΔAIC less
than 4 and thus both models were equally as likely to describe the data.
However, due to the fact that both models were of equal complexity, the model
with the lowest AIC was chosen. Neither model showed significance.
Correlation Between The Number of Oxygen Peaks That Occurred to
Preferred Choices and COC Preference
Figure 4.15 highlighted that no statistical differences were observed with
the number of oxygen peaks that occurred to preferred choices. However, there
were significant relationships between the number of oxygen peaks that occurred
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to preferred responses and COC preference, which are highlighted in Figure
4.16. Specifically, Figure 4.16A (left) shows that the percentage of oxygen peaks
that occurred to preferred COC choices relative to all preferred choices
(expressed as a percentage by substituting the number of preferred responses in
equation 7 with the number of oxygen peaks to preferred responses) was
positively correlated with COC preference for the 1-pellet condition (r = 0.63, p =
0.01). Figure 4.16A (middle) shows that no correlation was observed between
the number of oxygen peaks that occurred to COC preferred responses and
COC preference for the 1-pellet condition (r = 0.26, p = 0.30). Figure 2.16A (right)
shows that the number of oxygen peaks that occurred to preferred food choices
was negatively correlated with COC preference for the 1-pellet condition (r = 0.38, p = 0.04).
Figure 2.16B (left) shows that the percentage of oxygen peaks that
occurred to preferred COC choices relative to all preferred choices was not
correlated with COC preference for the 4-pellet condition (r = 0.76, p = 0.14).
Figure 2.16B (middle) shows that no correlation was observed between the
number of oxygen peaks that occurred to COC preferred responses and COC
preference for the 4-pellet condition (r = 0.75, p = 0.05). Figure 2.16B (right)
shows that the number of oxygen peaks that occurred to preferred food choices
was not correlated with COC preference for the 4-pellet condition (r = -0.41, p =
0.16).
Figure 2.16C (left) shows that the percentage of oxygen peaks that
occurred to preferred COC choices relative to all preferred choices was positively
correlated with COC preference for the 4-pellet + FR condition (r = 0.99, p =
0.0001). Figure 2.16C (middle) shows that the number of oxygen peaks that
occurred to COC preferred responses was positively correlated with COC
preference for the 4-pellet + FR condition (r = 0.96, p = 0.002). Figure 2.16C
(right) shows that the number of oxygen peaks that occurred to preferred food
choices was not correlated with COC preference for the 4-pellet + FR condition (r
= -0.37, p = 0.18).
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Percent of Oxygen Peaks to Events Per Block Relative to The Number That
Occurred to Specific Event Over A Session
Figure 4.17 shows how the number of oxygen peaks that occurred to
forced COC and food responses were distributed as a function of block relative to
the number of oxygen peaks found to forced responses over a session.
Specifically, no statistical differences were found between the 1-pellet (Figure
4.17A), 4-pellet (Figure 4.17B), and 4-pellet + FR conditions (Figure 4.17C)
[F(2,22.01) = 2.95, p = 0.07]. This statistic came from the full model, which had
the lowest AIC and was 512.86 times more likely to describe the data compared
to the model that included block and manipulation as factors.
Figure 4.18 shows how the number of oxygen peaks that occurred to COC
and food reinforcers was distributed as a function of block relative to the number
of oxygen peaks found to each reinforcer over a session. Thus, each reinforcer is
relative to the total found for that specific reinforcer in a session. Specifically,
there was a main effect of block where the percentage of oxygen peaks
increased as a function of block for the 1-pellet (Figure 4.18A), 4-pellet (Figure
4.18B), and 4-pellet + FR (Figure 4.18C) conditions [F(1,3.47) = 12.21, p = 0.03].
This statistic came from the full model, which had the lowest AIC and was 77.09
times more likely to describe the data compared to the model that included block
and event type as factors.
Figure 4.19 shows how the number of oxygen peaks that occurred to
preferred COC and food responses were distributed as a function of block
relative to the number of oxygen peaks found to each preferred response over a
session. Specifically, there was a block x event type interaction where the
percentage of COC preferred responses increased and the percentage of food
preferred responses decreased as a function of block for the 1-pellet (Figure
4.19A), 4-pellet (Figure 4.19B), and 4-pellet + FR conditions (Figure 4.19C)
[F(1,52.31) = 25.21, p < 0.0001]. This statistic came from the full model, which
had the lowest AIC and was 471.07 times more likely to describe the data
compared to the model that included block and event type as factors.
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Number of Oxygen Peaks That Occurred Per Preferred Choice Responses
Figure 4.20 shows the number of oxygen peaks that occurred per
preferred response as a function of block for all manipulations. Specifically, no
statistical differences were observed between the 1-pellet (Figure 4.20A), 4-pellet
(Figure 4.20B), or 4-pellet + FR (Figure 4.20C) conditions [F(1,5.51) = 2.41 p =
0.18].
Figure 4.21 shows correlations between the number of oxygen peaks that
occurred per preferred event (expressed as a percentage by substituting the
number of preferred responses in equation 7 with the number of oxygen peaks
that occurred per preferred response) and percent COC preference. Specifically,
no correlations were observed in the 1-pellet (Figure 4.20A; r = 0.31, p = 0.26), 4pellet (Figure 4.20B; r = 0.01, p = 0.99), or 4-pellet + FR (Figure 4.20C; r = 0.20,
p = 0.70) conditions.
Discussion
The results from these experiments showed that the COC/food exchange
rate (a) increased in the 4-pellet + FR condition compared to baseline (1-pellet
condition). Conversely, the COC/food exchange rate decreased in the 4-pellet

condition compared to the 4-pellet + FR condition. There was also a significant

positive correlation between the number of oxygen peaks that occurred per
preferred COC and food trial and the amount of behavior that occurred in each
preferred trial in the 4-pellet and 4-pellet + FR conditions. There were no
differences in the number of oxygen peaks that occurred to forced COC
responses compared to forced food responses. However, a greater number of
oxygen peaks were observed when COC was earned compared to when food
was earned. There were no statistical differences observed in the number of
oxygen peaks that occurred to COC and food preferred responses. However, the
number of oxygen peaks that occurred during COC preferred responses were
generally positively correlated with COC preference and the number of oxygen
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peaks that occurred to preferred food responses was generally negatively
correlated with COC preference.
Although not significant, it was surprising that the COC/food exchange
rate decreased (an increase in drug preference) when 4 food pellets could be
earned compared to the 1-pellet condition (Figure 4.5). This is contradictory
based on previous work in monkeys that showed that increasing the magnitude
of the food reinforcer decreased drug preference (Nader & Woolverton, 1991).
However, the COC/food exchanged rate increased (decreased drug preference)
when 4 pellets could be earned and rats were food restricted, a finding that is
supported by previous work (Beckmann et al., 2019). These results suggest that
drug preference increased in the 4-pellet condition because rats became sated
on food pellets, which presumably increased the relative subjective value of
COC. Importantly though, these data are in line with other published reports
showing that environmental manipulations, including changing reinforcer
magnitude, can affect drug-related decision making (Carroll & Lac, 1993; Nader
& Woolverton, 1991; Schierenberg et al., 2012; Hutsell et al., 2015; Chow, 2018;
Beckmann et al., 2019).
The number of oxygen peaks that occurred per COC and food preferred
trials between the manipulations was not statistically different (Figure 4.11).
However, the number of oxygen peaks that occurred to preferred COC trials was
positively correlated with the number of response that occurred during preferred
COC trials and the number of oxygen peaks that occurred during preferred food
trials was positively correlated with the number of responses that occurred during
preferred food trials for the 4-pellet and 4-pellet + FR conditions (Figure 4.12).
Considering brain oxygen measures could be a proxy for neuronal activity
(Mathiesen et al., 1989; Ngai et al., 1999; Smith et al., 2002) this finding is
somewhat similar to other work that found that neuronal activity in the rat OFC
was positively correlated with COC choice (Guillem & Ahmed, 2017). It is not
clear why there was not a positive correlation in the 1-pellet condition. However,
this finding is similar to that of Chow (2018) who found no correlation between
the percent of COC cFos+ cells and COC preference when reinforcer history was
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held constant. Considering the magnitude of food and the hunger state of the
animal were the only differences between the 1-pellet condition and the others, it
suggests that these factors may be driving the positive correlations observed.
The fact that neuronal firing patterns in the OFC are shown to be sensitive to
qualitative differences between goods, motivational states (e.g. hunger, satiety,
etc.), and to the magnitude between goods lends support to this claim (Thorpe et
al., 1983; Rolls et al., 1989; Wallis, 2007). That being said, more work will need
to be conducted the better understand this relationship.
The number of oxygen peaks that occurred to COC forced choice
responses was not statistically different compared to those observed to food
forced choice responses (Figure 4.13); further, how oxygen peaks were
distributed over blocks relative to each response type was also not different
(Figure 4.17). That being said, the number of oxygen peaks to COC forced
choices tended to be greater compared to forced food choices (or at least
followed a similar pattern). Considering there were an equal number of forced
COC and food trials per block, the forced choice responses were equal between
the two commodities (with the exception of change over delays, which were
minimal). Thus, there were generally a greater number of oxygen peaks seen to
forced COC responses compared to forced food response even though the
responses were approximately equal between response types, lending support to
this effect being COC specific. This result is consistent with previous literature
that showed that OFC activity during COC sampling was greater than the activity
observed during food sampling (Guillem & Ahmed, 2017). Unexpectedly, the
oxygen response to forced COC responding was especially obvious in the first
block when the completion of the FR requirement resulted in no COC delivery.
Considering the COC lever was associated with COC in the other blocks and all
animals were well trained, the increase in the number of oxygen peaks observed
in the first block could be due to cue reactivity to the COC lever considering that
BOLD activity in the OFC has been associated with craving (Risinger et al.,
2005). Likewise, the association between the COC lever and COC delivery could
be why the number of oxygen peaks was generally greater to forced COC
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responses overall (if we assume that drug-paired stimuli create more associative
strength compared to food-paired stimuli, which is a possibility; see discussion in
Batten & Beckmann et al., 2018). Note that only oxygen peaks associated with
lever presses are included in the forced analysis. Thus, this measure should not
have been influence by reinforcer delivery. That being said, after the first forced
COC trial in the second block COC is affecting the brain. Considering acute COC
administration has been shown to increase BOLD activity in the OFC (Kufahl et
al., 2005) it is possible that the changes in the number of oxygen peaks observed
(after the second block) are due to the pharmacological properties of COC.
However, considering the differences observed in this study between forced
response and reinforcer delivery, it suggest that the difference seen in forced
COC lever presses may have more to do with cue associative strength oppose to
COC pharmacology.
It is also worth noting that the number of peaks for the forced COC
responses generally followed a U-shaped pattern (with this being most
pronounced in the 4-pellet + FR condition). Although not perfectly comparable
considering difference in the experimental paradigm, this is similar to the findings
of Padoa-Shcioppa & Assad (2006) who found that certain neurons in the OFC
tracked the value of the chosen offer (where the magnitude of juices B:A were
manipulated) creating a similar U-shaped firing pattern. Specifically, in the
Padoa-Shcioppa & Assad (2006) study the U-shaped pattern in neuronal firing
was increased when choices were exclusively for one juice and decreased as
choices neared equivalency. In this study, only the magnitude of COC was
manipulated within a given session. However, it appears that the number of
oxygen peaks for forced COC and food responding are closest together around
the COC/food exchange rate for each manipulation (where food pellets and COC
are considered equal) and becomes more disperse as one moves away from this
point of COC/food equivalency. Considering this general trend, it may suggest
that this represents some relative encoding of value. However, note that in this
experiment the preference measure is independent of forced responses. Thus,
oxygen changes in forced trials should not directly relate to choice preference
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making these findings hard to compare to Padoa-Shcioppa & Assad (2006) as
well as difficult to interpret.
Note that there was no difference in the number of oxygen peaks that
occurred to forced food responses between pellet manipulations. This result is
somewhat contradictory to previous research showing that activity in the OFC
was greater for responses for food reinforcers of greater magnitude when they
were presented independently (Guillem & Ahmed, 2017). Assuming that the food
manipulations here could be considered similar to independent presentations
(considering the food manipulations did not happen within session), one may
have expected to find parallel increases in the intercept of the forced choice food
responses as a function of food manipulation (where the intercept increased as a
function of manipulation with the 1-pellet condition being the lowest, the 4-pellet
condition being in the middle, and the 4-pellet + FR condition being the greatest).
It is possible that this difference did not occur because the difference in
magnitude in this study was only 4 times greater whereas in the Guillem &
Ahmed (2017) study the magnitude difference was 5 times greater. Nevertheless,
taken together with results from the literature, the forced choice findings, even
though not significant, lend support to the idea that responses associated with
COC increase OFC activity.
Statistical differences were observed when the reinforcer was earned
(Figure 4.14). Namely, there was a main effect of reinforcer where the number of
oxygen peaks was increased when COC was earned compared to when food
was earned. Again, this is similar to results showing that neuronal activity
increased in the OFC to actions associated with a COC reinforcer compared to a
food reinforcer (Guillem & Ahmed, 2017). Further, the increased activity to COC
reinforcer delivery observed here is also similar to studies showing increased
OFC activity to drug-related cues and to acute COC administration (Kufahl et al.,
2005; for review Dom et al., 2005; Risinger et al., 2005; for review Schoenbaum
et al., 2006). Considering the number of reinforcers per block is held constant,
this again suggests a dissociation between COC and food events. However,
considering the drug was being delivered when the increase in oxygen peaks
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were observed it is likely this increase in oxygen has more to do with the direct
effects of COC oppose to changes in value per se. Interestingly, when looking at
the percentage of oxygen peaks that occurred to each reinforcer per block
relative to the number that happened over the whole session there is a general
increase as a function of block (i.e. no longer an main effect of reinforcer; Figure
4.18). This effect seems to be driven mostly be an increase in the percentage of
oxygen peaks that occur to food reinforcers with largest percentage of peaks
being observed in the last block (when COC can be earned at its highest dose). It
is not clear why this occurred. However, it is possible that the drug being present
in the system caused a general increase in OFC activity overall which could
account for the increase in the number of food peaks in the last block. Again,
overall these data suggest that the oxygen changes to reinforcer delivery have
more to do with direct drug effects than subjective value encoding.
Unlike most choice studies, here the major measure of choice preference
is responses on the COC or food lever when reinforcement is not available. No
differences were observed in the number of oxygen peaks to preferred choice
responses (Figure 4.15). However, there was a block x event type interaction
when looking at the percentage of oxygen peaks that occurred to each response
per block relative to the session (Figure 4.19). Further, there were also significant
correlations between the number of oxygen peaks observed to COC and food
preferred responses and COC preference (Figure 4.16). Specifically, the percent
of oxygen peaks observed to preferred COC responses (calculated by replacing
the number of preferred responses in equation 7 with the number of oxygen
peaks that occurred to preferred responses) was positively correlated with COC
preference in the 1-pellet and 4-pellet + FR conditions (Figure 4.16A and Figure
4.16C). These correlation seem to be driven by a general positive correlation with
the number of oxygen peaks that occur to COC preferred responses and COC
preference and a general negative correlation between the number of oxygen
peaks that occur to food preferred responses and COC preference (however, not
all of these correlations were significantly different from zero). Note that no
significant correlations were observed in the 4-pellet condition, although the
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general trend is the same. It is unclear why the correlations in the 4-pellet
condition were not significant; however, it likely due to an interaction between a
low sample size and general brain stochasticity. Nevertheless, these results are
similar to others found in the literature. For example, Guillem and Ahmed (2017)
found that neuronal activity in the OFC was positively correlated with COC
preference. However, Chow (2018) found no correlation between the percent
COC cFos+ cells in the OFC and COC preference. Considering the procedure
used here and that of Chow (2018) are the same it is unclear why these results
differ. However, it could be due to the fact that the oxygen measures shown here
were collected in real-time and are a bit more dynamic than cFos measures.
Conversely, it could be that the cFos measure is a more accurate representation
of neural activity than oxygen measures. Thus, the exact reason for the
discrepancy between these two studies will have to be further explored.
Nevertheless, this study, Chow (2018), and Beckman et al. (2019) all support the
idea that preference is a relative measure determined by different reinforcement
dimensions (e.g. frequency, magnitude) and not drug intake (Iglauer & Woods,
1974; Anderson et al., 2002).
In this experiment many of the behavioral responses were held constant
between COC and food events including the number of forced responses and the
number of reinforcers earned. Thus, with these measures the number of oxygen
peaks found should, in theory, be less confounded by the number of behavioral
responses because this was held constant. However, the number of preferred
choice responses was free to vary and was susceptible to being confounded with
the amount of behavior that occurred in a similar way as was discussed in
Chapter 2. Thus, in order try and control for this issue the number of oxygen
peaks that occurred per preferred response were divided by the number of
preferred responses that occurred. When this was done no statistical differences
or correlations were observed (Figure 4.20 & Figure 4.21). These data suggest
that any differences seen to preferred responses was only observed because of
the amount of the behavior that occurred. However, it is worth noting that there
was not a 1:1 relationship between the number of oxygen peaks that occurred to
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preferred responses and the number of preferred response that occurred
suggesting that these results were not completely confounded. Further, there
were a number of measures here where behavior was held constant and the
number of oxygen peaks that occurred still differed in a meaningful direction
lending credence to these data. This is especially so when looking at the
preferred trial data (Figure 4.11 & Figure 4.12) because those data showed a
similar trend and they included all oxygen peaks that happened in the trial not
just those associated with behavior. Nevertheless, these results should be
interpreted cautiously especially in the 4-pellet and 4-pellet + FR conditions
considering the low sample size.
In summary, this study showed the feasibility of coupling oximetry and
drug self-administration with freely-moving choice studies. The major findings of
this study were that environmental manipulations (namely food magnitude
changes) shift COC preference. Further, it was found that responses associated
with COC and earning COC caused more oxygen activity in the OFC than events
related to food. Further, there was evidence that OFC oxygen (as measured
through the number of oxygen peaks that occurred) followed COC preference.
Thus, overall these data suggest that the OFC may play a role in the subjective
valuations that occur in drug-related decision-making.
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Figure 4.1 Oxygen Biosensor
The above figure shows an oxygen biosensor headcap (bottom left). At the tip of
the electrode (enlarged picture) oxygen is reduced at all four platinum sites via
the highlighted, one-step reaction.
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Figure 4.2 Oxygen Biosensor Placements
The circles represent the approximate placement of the tip of the oxygen
biosensor for n = 6 subjects in the orbitofrontal cortex (OFC).
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Figure 4.3 Oxygen Traces From The OFC During Block 1 and Block 5
(A) Example of an OFC oxygen trace from the 1-pellet condition during Block 1
(left) and Block 5 (right) with (B) lines representing behavioral events. The redhatched lines above all traces represent the location of oxygen peaks based off
criteria. The green lines represent forced food choices (lever presses and pellet
delivery), the blue lines represent preferred choices for food, the red lines
represent forced COC choices (lever presses and COC delivery), and the grey
lines represent preferred COC choices. Note the difference in the x-axis scale
bar between traces.
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Figure 4.4 Magnified Oxygen Traces From The OFC During Block 1 and
Block 5
OFC oxygen traces (magnified from Figure 4.3) from the 1-pellet condition during
Block 1 (left) and Block 5 (right) with lines representing behavioral events. The
red-hatched lines above both traces represent the location of oxygen peaks
based off criteria. The green lines represent forced food choices (lever presses
and pellet delivery), the blue lines represent preferred choices for food, the red
lines represent forced COC choices (lever presses and COC delivery), and the
grey lines represent preferred COC choices.
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Figure 4.5 Choice Behavior For All Manipulations During Electrode
Recordings
Compared to baseline (1 pellet; *a = 0.29; s = 2.52), 4-pellets + FR increased the
drug/food exchange rate

(*a = 0.53; s = 2.52). There were no differences

between the 4-pellet condition and baseline (a = 0.21; s = 2.52). The 4-pellet

drug/food exchange rate (*a = 0.21) was significantly decreased compared to the
4-pellet + FR condition. NLME, *p < 0.05. Data represented as mean ± SEM.
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Figure 4.6 Total Number of Lever Responses Per Trial As A Function of
Block
There were no significant differences in the number of lever responses per trial
as function of block across manipulations. Data points represent the average
forced and preferred lever responses across animals for a given block. LME, p >
0.05. Data represented as mean ± SEM.
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Figure 4.7 Number of Responses Per Preferred COC and Food Trial As A
Function of Block
COC responses per preferred COC trial significantly increased and food
responses per preferred food trial significantly deceased as a function of block for
the (A) 1-pellet, (B) 4-pellet, and (C) 4-pellet + FR conditions. Food responses
per preferred food trials for the 4-Pellet + FR condition are also significantly
greater than food responses for the 1-pellet and 4-pellet conditions and COC
responses for the 4-pellet + FR condition. . LME, *p < 0.05. Data represented as
mean ± SEM.
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Figure 4.8 Behavioral Responses To Head Entries, Preferred Choices, &
Head Entries After Reinforcer Delivery
(A) More head entry responses were seen throughout the session compared to
those that initiate the trial. Note that the number of head entries to initiate a trial
was procedurally constrained (constant at 6/block) whereas all other head entries
were unbounded. (B) COC and food preferred choice responses significantly
changed (in different directions) as a function of block. The number of food
responses in the 4-pellet + FR condition was also significantly greater than all
other preferred responses across conditions. (C) More head entry responses
were observed after food reinforcer delivery compared to after COC reinforcer
delivery. LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 4.9 Total Number of Oxygen Peaks Found in Session and to
Behavioral Events
(A) There were statistically no differences in the number of oxygen peaks that
occurred overall between manipulations over a choice session. (B) No
differences were observed between manipulations in the number of oxygen
peaks that occurred to behavioral events in a session. (C) The percentage of
oxygen peaks that occurred to behavioral events over a session was not different
between manipulations. LME, p > 0.05. Data represented as mean ± SEM.
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Figure 4.10 Total Number Peaks Found Per Block Overall & to Behavioral
Events
(A) There were no differences observed to the overall number of peaks that
occurred per block across manipulations. (B) The total number of oxygen peaks
related to behavioral events significantly decreased as a function of block. Note
that the inset is presented to highlight the block main effect. (C) No differences
were observed in the percent of oxygen peaks related to behavioral events as a
function of block. LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 4.11 The Number of Oxygen Peaks That Occurred Per COC and
Food Preferred Trials As A Function of Block
There were no differences in the number of oxygen peaks (regardless of
behavioral events) that occurred per preferred COC or food trials for the (A) 1pellet (right), (B) 4-pellet (right), and (C) 4-pellet + FR (right) conditions. LME, p >
0.05. Data represented as mean ± SEM.
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Figure 4.12 Correlation Between The Number of Oxygen Peaks That
Occurred Per COC or Food Preferred Trial & The Number of Responses
That Occurred Per Preferred Trial
(A) There was no correlation between the number of oxygen peaks that occurred
per preferred COC trial and the number of responses that occurred per preferred
COC trial for the 1-pellet condition (left). There was a significant positive
correlation between the number of oxygen peaks that occurred per preferred
COC trial and the number of responses that occurred per COC trial for the 4pellet (middle) and 4-pellet + FR conditions (right). (B) There was no correlation
between the number of oxygen peaks that occurred per preferred food trial and
the number of responses that occurred per preferred food trial (left). There was a
significant positive correlation between the number of oxygen peaks that
occurred per preferred food trial and the number of responses that occurred per
preferred food trial for the 4-pellet (middle) and 4-pellet + FR (right) conditions.
Note the difference in the x-axis scale between measures. Linear regression, *p
< 0.05.
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Figure 4.13 Number of Oxygen Peaks That Occurred To Forced Choice
Responses
There were no differences in the number of oxygen peaks that occurred to the
(A) 1-pellet, (B) 4-pellet, and (C) 4-pellet + FR conditions. However, the number
of oxygen peaks to COC was generally greater. Note that no behavior is
presented because there

were 3

forced trials for each reinforcer (9

responses/block/reinforcer); thus, the behavior was constant across blocks. LME,
p > 0.05. Data represented as mean ± SEM.
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Figure 4.14 Number of Oxygen Peaks That Occurred to Reinforcer Delivery
More oxygen peaks occurred when COC was earned in the (A) 1-pellet, (B) 4pellet, and (C) 4-pellet + FR conditions compared to when food was earned. Note
that in block 1 (COC dose 0 mg/kg/infusion) no COC reinforcers were earned.
Note that no behavior is presented because an equal number of reinforcers were
earned in each block. LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 4.15 Number of Oxygen Peaks That Occurred to Preferred Choice
Responses
There were no differences in the number of oxygen peaks that occurred to
preferred choice responses in the (A) 1-pellet (right), (B) 4-pellet (right), and (C)
4-pellet + FR (right) conditions. LME, p > 0.05. Data represented as mean ±
SEM.
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Figure 4.16 Correlation Between Number of Preferred Choice Responses &
The Number of Oxygen Peaks That Occurred to Preferred Choice
Responses
(A) The percentage of oxygen peaks that occurred to preferred COC choices
relative to all preferred choices was positively correlated with COC preference for
the 1-pellet condition (left). No correlation was observed between the number of
oxygen peaks that occurred to COC preferred responses and COC preference
for the 1-pellet condition (middle). The number of oxygen peaks that occurred to
preferred food choices was negatively correlated with COC preference for the 1pellet condition (right). (B) The percentage of oxygen peaks that occurred to
preferred COC choices relative to all preferred choices was not correlated with
COC preference for the 4-pellet condition (left). No correlation was observed
between the number of oxygen peaks that occurred to COC preferred responses
and COC preference for the 4-pellet condition (middle). The number of oxygen
peaks that occurred to preferred food choices was not correlated with COC
preference for the 4-pellet condition (right). (C) The percentage of oxygen peaks
that occurred to preferred COC choices relative to all preferred choices was
positively correlated with COC preference for the 4-pellet + FR condition (left).
The number of oxygen peaks that occurred to COC preferred responses was
positively correlated with COC preference for the 4-pellet + FR condition
(middle). The number of oxygen peaks that occurred to preferred food choices
was not correlated with COC preference for the 4-pellet + FR condition (right).
Note the difference in the x-axis scale between measures. Linear regression, *p
< 0.05.
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Figure 4.17 Percentage of Oxygen Peaks That Occurred to COC or Food
Forced Choice Responses Per Block Relative to The Number of Oxygen
Peaks That Occurred to COC or Food Forced Choice Responses in A
Session
There were no significant differences observed in the percentage of oxygen
peaks that occurred to COC or food forced choice responses per block relative to
those found to COC or food forced responses over a session between the (A) 1pellet, (B) 4-pellet, and (C) 4-pellet + FR conditions. LME, p > 0.05. Data
represented as mean ± SEM.
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Figure 4.18 Percentage of Oxygen Peaks That Occurred to COC or Food
Reinforcers Per Block Relative to The Number of Oxygen Peaks That
Occurred to COC or Food Reinforcers in A Session
The percentage of oxygen peaks that occurred to COC or food reinforcer delivery
per block relative to those found to COC or food reinforcers delivered over a
session increased as a function of block in the (A) 1-pellet, (B) 4-pellet, and (C)
4-pellet + FR conditions. LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 4.19 Percentage of Oxygen Peaks That Occurred to Preferred COC
or Food Choices Per Block Relative to The Number of Oxygen Peaks That
Occurred to Preferred COC or Food Choices in A Session
The percentage of oxygen peaks that occurred to preferred COC choices per
block relative to those found to preferred COC choices over a session increased
as a function of block in the (A) 1-pellet, (B) 4-pellet, and (C) 4-pellet + FR
conditions. The percentage of oxygen peaks that occurred to preferred food
choices per block relative to those found to preferred food choices over a session
decreased as a function of block in the (A) 1-pellet, (B) 4-pellet, and (C) 4-pellet
+ FR conditions. LME, *p < 0.05. Data represented as mean ± SEM.
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Figure 4.20 Number of Oxygen Peaks That Occurred to Preferred Choice
Responses Per The Number of Preferred Responses
There were no differences in the number of oxygen peaks that occurred to
preferred choice responses per the number of events that occurred in the (A) 1pellet (right), (B) 4-pellet (right), and (C) 4-pellet + FR (right) conditions. LME, p >
0.05. Data represented as mean ± SEM.
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Figure 4.21 Correlation Between Number of Preferred Choice Responses &
The Number of Oxygen Peaks That Occurred Per Preferred Choice
Responses
The percentage of oxygen peaks that occurred per preferred COC choices
relative to all preferred choices was not correlated with COC preference for the
(A) 1-pellet, (B) 4-pellet, or (C) 4-pellet + FR conditions. Linear regression, p >
0.05.
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CHAPTER 5
GENERAL DISCUSSION
The purpose of these studies was to better understand the
neurobehavioral mechanisms of cocaine-use disorder. Considering that aberrant
glutamate neurotransmission has been associated with cocaine abuse and
relapse (see Kalivas, 2009 for review) the first of these studies explored
glutamate neurotransmission in freely-moving rats that performed in a
cocaine/food multiple schedule. As previously mentioned, most non-clinical
experiments exploring the effects of cocaine on the glutamate system use
behavioral paradigms that do not expose the same animal to drug and non-drug
reinforcers making cocaine-specific neural changes hard to determine
(Cunningham et al., 2015; Huff & LaLumiere, 2015; Saddoris et al., 2016).
Considering no person takes drugs in isolation and is exposed to a myriad of
reinforcers, here we used multiple schedules of reinforcement (Weissenborn et
al., 1995; Weissenborn et al., 1996; Carelli et al., 2000; Stairs et al., 2010) in an
attempt to isolate cocaine-specific glutamatergic effects. By coupling glutamate
biosensors with the multiple schedule behavioral paradigm, this first experiment
was able to isolate cocaine and food reward-related glutamatergic changes in the
PrL and NAcC.
Previous work has shown that glutamate neurotransmission in the NAcC
and the PrL is involved in drug seeking and relapse (McFarland et al., 2003;
Kalivas et al., 2005) and that cocaine self-administration increases glutamate
levels above baseline in rats chronically exposed to cocaine (Miguens et al.,
2007). Thus, it was not surprising that an increase in glutamate release was
observed from cocaine delivery compared to food delivery. However, a significant
increase in the number of glutamate peaks from food events compared to
cocaine events was also observed. This result was surprising considering that
the probability of glutamate release is shown to increase during cocaine
reinstatement and self-administration (Moran et al., 2005; Madayag et al., 2007;
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Miguens et al., 2007; Kalivas 2009 for review). However, as mentioned, most
studies looking at the effects of cocaine on glutamate use separate animals for
experimental and control conditions. Thus, the increase in the number of
glutamate events to food related behavior compared to cocaine related behavior
observed here could be due to the fact that all animals in this study were
exposed to both reinforcers. Conversely, this increase in the number of
glutamate peaks to food events could be due to the fact that all rats had a greater
history with the food reinforcer. The fact that differential reinforcer histories can
cause different neural adaptations (Nestler, 2001; Kalivas & O’Brien, 2008) lends
credence to this idea.
Results from experiment 1 also showed that the number of glutamate
peaks that occurred to a given behavioral event was positively correlated to that
respective event. This finding is similar to glutamate measures taken from the
basolateral amygdala and OFC in other behavioral paradigms (Malvaez et al.,
2015, Malvaez et al., 2019). However, while these results are reassuring, they
should be interpreted with caution because it is possible that the number of
glutamate peaks increased simply because the amount of behavior increased.
Thus, it could be that more glutamate peaks were more likely to occur simply
because more behavior was emitted. That being said, there is evidence that the
NAcC does not participate in the processing of movements (Shultz et al., 1992;
Carelli & Deadwyler, 1997). Also, the relationship between the number of
glutamate peaks and the number of behavioral responses was not 1:1
suggesting that the number of glutamate peaks occurring to behavioral events
may be due to more than just responding. Confidence in this conclusion comes
from the fact that the number of peaks that occurred to the start of the food
component was greater than the number of peaks that occurred to the start of the
cocaine component even though the number of components was equal. Overall,
these results suggest that the number of glutamate peaks are likely encoding
reinforcer specific information and are not just due to the amount of responding.
In an attempt to control for the problematic nature of the number of peaks
analysis discussed above the number of glutamate peaks that occurred to a
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specific event were divided by the number of responses that occurred.
Standardizing the number of peaks to the number of behavioral responses in
theory should control for the disproportionate number of responses between
event types, thus creating a measure that is less confounded by the amount of
behavior. Interestingly, when the data were expressed as the number of
glutamate peaks that occurred per event type, more glutamate peaks were
observed per cocaine lever press and per cocaine reinforcer earned. Thus, even
though more glutamate peaks were associated with food lever presses overall,
there were more glutamate peaks generated per a single cocaine lever press and
per a cocaine reinforcer. Thus, when looking at this measure, there is
dissociation between behavior and glutamatergic activity further suggesting that
the number of glutamate peaks is encoding reinforcer specific information. This
result is similar to what has previously been found in the literature (e.g.
McFarland et al., 2003; Miguens et al., 2007; Kalivas, 2009 for review) in that
chronic exposure to cocaine causes an increase in the probability of synaptic
glutamate release.
A potential weakness of experiment 1 was in interpreting the meaning of
glutamate frequency data in relation to behavior (i.e. more release events only
because more behavior occurred). Even though controlling for this issue was
attempted, it is likely that these measures are still partially confounded. Thus, it is
difficult to say for certain that there were reinforcer specific effects. Further, even
though animals were exposed to both reinforcers they could still only respond for
one reinforcer at a time. Also, the reinforcer histories were not controlled. These
latter two factors make it difficult to say anything about brain representations of
value in relation to these two reinforcers or the actions taken to earn them.
Experiment 2 addressed some of the issues in experiment 1. First, a novel
choice procedure was used that controlled for the positive feedback function
between choices and reinforcement as well as reinforcer history (Beckmann et
al., 2019). Also, choice procedures more easily allow for the assessment of the
relative value of cocaine and food compared to multiple schedule procedures due
to the fact that reinforcers are concurrently available. Also, considering a number
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of behavioral responses were held constant between cocaine and food events in
this choice procedure, this allowed for a more straightforward interpretation of
brain measures between cocaine and food events. Further, considering that
reinforcer history was held constant, this allowed for behavioral and brain
measures of preference to not be confounded by reinforcer intake (Chow, 2018;
Beckmann et al., 2019).
It may seem disjunctive that in experiment 2 oxygen was measured
instead of glutamate and that these measurements were taken from a completely
different brain region (OFC) than in experiment 1. However, this was decided due
to the fact that the interest of experiment 2 was in exploring drug-related
decision-making and value. Thus, there was more precedence for taking
measures from the OFC compared to the PrL (Kable & Glimcher, 2009). Note
that there was equal precedent for taking oxygen measures from the NAcC
(Salamone et al., 2007) and in retrospect this should have been done first for
reasons of comparison. However, at the time the experiment was designed,
evidence from our lab (unpublished) showed that OFC lesions changed choice
behavior in our experimental paradigm in distinctive ways. Due to that finding, as
well as others (Schoenbaum et al., 2006; Padoa-Schioppa & Conen, 2017),
measures were taken from the OFC first. Further, there is a paucity of data
exploring glutamate dynamic in decision-making. Thus, it made more sense to
explore overall brain activity (here measured by oxygen dynamics).
Although not significant, it was surprising that drug preference increased
when 4 food pellets could be earned compared to the 1-pellet condition as
previous research suggests the opposite (Nader & Woolverton, 1991). However,
this was likely because rats became sated on food pellets and thus the relative
subjective value of cocaine was increased. Expectedly, drug preference
decreased when 4 pellets could be earned and rats were food restricted, a
finding that is supported by previous work (Beckmann et al., 2019). Overall,
these data are in line with other published reports showing that environmental
manipulations, including changing reinforcer magnitude, can affect drug-related
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decision-making (Carroll & Lac, 1993; Nader & Woolverton, 1991; Schierenberg
et al., 2012; Hutsell et al., 2015; Chow, 2018; Beckmann et al., 2019).
There were also generally a greater number of oxygen peaks seen to
forced cocaine responses compared to forced food responses even though the
number of responses was approximately equal (however, this was not
significant). Considering, this effect was seen even when the number of
responses was held constant lends support to this being a cocaine specific
effect. This result is consistent with previous literature that showed that OFC
activity during cocaine sampling was greater than the activity observed during
food sampling (Guillem & Ahmed, 2017). Considering reinforcer delivery was not
included in the forced choice analysis, the increase in the number of oxygen
peaks observed could be due to an increase in cue reactivity to the cocaine lever
oppose to the food lever. In fact evidence suggests that BOLD activity in the OFC
has been associated with craving (Risinger et al., 2005). However, it is worth
noting that after the first block cocaine can be earned and can thus potentially
affect brain signaling to other behavior. Considering acute cocaine administration
has been shown to increase BOLD activity in the OFC (Kufahl et al., 2005) it is
possible that the changes in the number of oxygen peaks observed (during and
after the second block) were due to the pharmacological properties of cocaine.
However, the oxygen responses here were in a general U-shaped pattern similar
to those found to be associated with ‘chosen value’ by Padoa-Schioppa & Assad
(2006). Considering this general trend, and the fact that oxygen signaling to
forced responses looked markedly different than when the reinforcer was earned,
it suggests that the oxygen signals found in experiment 2 to forced responses
may represents some relative encoding of value. However, note that in this study
the preference measure is independent of forced responses. Thus, oxygen
changes in forced trials should not directly relate to choice preference making
these findings hard to compare to Padoa-Schioppa & Assad (2006).
Differences were also observed when the reinforcer was earned. Namely,
the number of oxygen peaks was increased when cocaine was earned compared
to when food was earned. Again, this is similar to results showing that neuronal
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activity increased in the OFC to actions associated with a cocaine reinforcer
compared to a food reinforcer (Guillem & Ahmed, 2017). Further, the increased
activity to cocaine reinforcer delivery observed here is also similar to studies
showing increased OFC activity to drug-related cues and to acute cocaine
administration (Kufahl et al., 2005; Risinger et al., 2005; for review Schoenbaum
et al., 2006; for review Dom et al., 2007). Considering the number of reinforcers
per block is held constant this again suggests dissociation between cocaine and
food events. However, considering that drug was being delivered when the
increase in oxygen peaks were observed it is likely this increase in oxygen has
more to do with the direct effects of cocaine oppose to changes in value per se.
Unlike most choice studies, here the major measure of choice preference
was responses on the cocaine or food lever when reinforcement was not
available. No differences were observed in the number of oxygen peaks to
preferred choice responses. However, there were significant correlations
between the number of oxygen peaks observed to cocaine and food preferred
responses and cocaine preference. Specifically, the percent of oxygen peaks
observed to preferred cocaine responses was positively correlated with cocaine
preference. These correlations seem to be driven by a general positive
correlation with the number of oxygen peaks that occurred to cocaine preferred
responses and cocaine preference and a general negative correlation between
the number of oxygen peaks that occurred to food preferred responses and
cocaine preference. Again, these results are similar to others found in the
literature. For example, Guillem and Ahmed (2017) found that neuronal activity in
the OFC was positively correlated with cocaine preference. However, Chow
(2018) found no correlation between the percent cocaine cFos+ cells in the OFC
and cocaine preference. Considering the procedure used in experiment 2 was
the same used in Chow (2018) it is unclear why these results differ. However, it
could be due to the fact that the oxygen measures shown here were collected in
real-time and are a bit more dynamic than cFos measures. Conversely, it could
be that the cFos measure is a more accurate representation of neural activity
than oxygen measures. Nevertheless, this study, Chow (2018), and Beckman et
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al. (2019) all support the idea that preference is a relative measure determined
by different reinforcement dimensions (e.g. frequency, magnitude) and not drug
intake (Iglauer & Woods, 1974; Anderson et al., 2002).
Even though experiment 2 controlled for many of the issues observed in
experiment 1 it was not without pitfalls. For example, the number of preferred
choice responses was still free to vary and was susceptible to being confounded
with the amount of behavior that occurred in a similar way as was discussed in
experiment 1. However, it is worth noting that, as in experiment 1, there was not
a 1:1 relationship between the number of oxygen peaks that occurred to
preferred responses and the number of preferred response that occurred
suggesting that these results were not completely confounded. Further, there
were positive correlations between the number of oxygen peaks that occurred
per preferred food and cocaine trials and cocaine preference. Considering the
trial measure looked at all oxygen peaks in a trial and not just those related to
behavioral events suggest that the oxygen signal to preference is not solely due
to the amount of behavior.
These experiments showed a number of interesting results. However,
there were several changes that could have been made that may have allowed
richer comparisons. For example, brain manipulations could have been made
(using pharmacology, DREADDs, etc.) in experiment 1 to assess if the
glutamatergic signal could be specifically manipulated and behavior specifically
changed. Further, glutamate could have been measured in the PrL and NAcC in
experiment 2 so that results could have been more comparable between the two
experiments. Conversely, oxygen measures could have been taken from the PrL
and NAcC in experiment 2 so that comparisons could be made between the two
experiments more easily. In experiment 2, frequency manipulations in the choice
procedure (like those made in Chow, 2018 and Beckmann et al., 2019) could
have been done to assess how oxygen dynamics in the OFC change to those
manipulations in order to make cross-study comparisons more direct. The data
could have also been analyzed such that we looked at signaling some time
before an event occurred in order to see if pre-event signaling was predictive of
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behavior. Considering that BOLD fMRI measures have a slower temporal
resolution than electrochemical measures (second vs. millisecond timescale; see
Glover, 2011 for review) the oxygen measures here could have been taken at a
lower frequency (e.g. 1 Hz) in order to increase translational efficacy. Thus, if the
oxygen measures were taken at a slower temporal resolution than the measures
here would have been more easily comparable to clinical BOLD fMRI studies.
Further, in both studies only signal peaks were analyzed. However, it is possible
that decreases (troughs) are also an important aspect of glutamate and oxygen
signaling. Considering the temporal properties of the troughs observed in
experiment 1’s glutamate signals it is more likely the downward signals are due
to electrical noise oppose to a sudden increase in glutamate uptake especially
because the rate of glutamate uptake (Danbolt, 1998) could likely not account for
this decrease. Nevertheless, the physiological relevance of dips in the glutamate
signal cannot be assumed to be trivial. Note that dips in oxygen signaling are
reported to be related to neuronal oxidative metabolism (Malonek et al., 1997)
and thus are likely to be of physiological importance. Thus, in future studies
signal peaks and troughs should both be analyzed in order to gain a more robust
picture of the processes that occur during reward-related behavior. Nevertheless,
the studies herein highlighted results not previously observed.
The findings from experiment 1 and experiment 2 add to the current body
of knowledge in a number of ways. First, from a methodological point of view,
these experiments show the feasibility of coupling biosensor technology, drug
self-administration, and fairly complex behavioral paradigms. At the very least,
this lays the groundwork for others to use these methodologies to further explore
substance-use disorder. Second, experiment 1 is the only experiment (to the
knowledge of the author) comparing glutamate measures from the PrL and NAcC
in the same animal exposed to cocaine and food, and experiment 2 is the only
experiment that assessed oxygen dynamics in the OFC in a procedure that can
separate preference from drug intake.
Specifically, experiment 1 highlighted that cocaine caused an increase
above baseline in glutamate compared food; however, the number of glutamate
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peaks was greater to food related events. That being said, the number of
glutamate peaks per response and reinforcer was greater for cocaine. Thus, this
experiment did show reinforcer specific changes in glutamate signaling in both
release amplitude and frequency measures. Overall, these data show that
differential glutamate signaling does happen between food and cocaine.
However, the glutamate system does participate in signaling to both reinforcers
in a similar way in both brain regions. Thus, this highlights the impetus to further
study these interactions and to be cautious when considering glutamatergic
drugs for substance-use disorder. Further, experiment 2 showed that
environmental manipulations (namely food magnitude changes) shift cocaine
preference. Further, it was found that responses associated with cocaine and
earning cocaine cause more activity in the OFC than events related to food.
Further, there was some evidence that OFC oxygen (as measured through the
number of oxygen peaks that occurred) followed cocaine preference. Thus,
overall these data cautiously suggest that the OFC plays a role in the subjective
valuations that occur in drug-related decision-making.
Taken together, both studies suggest that the PrL, NAcC, and OFC are
related to drug-taking and drug-related decision-making, respectively. Further,
these experiments show that environmental manipulations can shape drug-taking
behavior, that cocaine can be substituted with a non-drug commodity, and that
oxygen dynamics during drug-related behavior are relative in nature. Overall,
these experiments lay the groundwork to further study drug-specific
neurobehavioral changes and allow for the exploration of behavioral and
pharmacological treatments that specifically decrease drug-taking behavior.
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